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Summary.
The detection, in situ or in tissue extracts, of 
post-translationally modified isoforms of a host-encoded 
protein, PrP, is diagnostic for scrapie, bovine spongiform 
encephalopathy (BSE) and the other transmissible spongiform 
encephalopathies (TSEs). Specific PrP gene mutations and 
polymorphisms have been linked to the incidence of naturally 
occuring TSEs in sheep and man, and to predisposition to 
experimental disease in sheep and mice.
Initial restriction fragment length polymorphism (RFLP) 
analyses of bovine genomic DNA with the enzyme PvuII failed 
to establish a PrP genotype linkage with the incidence of 
BSE. Bovine PrP genes were then amplified by the polymerase 
chain reaction (PCR), cloned, and sequences obtained which 
agreed with previously published data. Bovine alleles contain 
a cytosine or thymidine at base 576 (the switch is silent) 
and encode five or six copies of an octarepeat motif, but no 
linkage with these polymorphisms was observed from studies of 
a large dairy herd with multiple BSE cases.
Direct automated sequencing from PCR amplified genes was 
developed and validated by comparing results with manually 
derived sequences. No new polymorphisms were identified 
following sequencing of (6) experimental and (6) natural BSE 
cases, and (6) normal cows.
Sequencing the PrP genes of pig and kudu, species also
11
exposed to contaminated feed but with apparent differing 
susceptibilities, was performed. The pig gene has five copies 
of the octarepeat motif and encodes a protein of 257 amino 
acids, with unique residues preceding the attachment of a 
possible glycosylphosphatidylinositol anchor. The kudu 
alleles contained five or six octarepeats, encoding proteins 
of 256 and 264 amino acids respectively, with four amino 
acid differences between the alleles within the octarepeat 
region. This novel occurrence may be significantly linked to 
the kudu's apparent susceptibility.
Overall, comparison of the genes from different species 
demonstrated that primary and predicted secondary structures 
were highly conserved.
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CHAPTER 1. 
Introduction.
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1.1. General Introduction.
1.2.1. Historical background.
The transmissible spongiform encephalopathy (TSE) family of 
diseases affect a number of species and include: scrapie in
sheep and goats, the human diseases Creutzfeldt-Jakob (CJD) , 
Gerstmann-Straussler-Scheinker syndrome (GSS) and kuru, 
transmissible mink encephalopathy (TME) in farmed mink , 
chronic wasting disease (CWD) of captive mul^and elk and 
bovine spongiform encephalopathy (BSE) of cattle and exotic 
bovids. The chronology of recognition of the TSEs is
summarized in Table 1.1.
1.2.2. Scrapie.
Scrapie is the archetypal member of this family of diseases 
and the most widely studied. It is a natural disease of sheep 
and goats and has been known in Europe , sometimes in
epidemic form, since the eighteenth century. The earliest
record of scrapie in Britain was in 1732 (McGowan, 1922) , 
although the first description of scrapie was made by
Leopoldt (1759), in Germany.
The characteristic brain vacuoles associated with this group 
of diseases were first described by Besnoit and Morel (1898). 
Attempts at transmitting the disease by the use of a variety 
of body fluids (blood, cerebrospinal fluid, allantois) and 
tissues (fetal cotyledons) were negative after 18 months 
(M'Fadyean, 1918) . The same study also showed the absence of 
any visceral lesions.
-2-
Table 1.1. Chronology of recognition of naturally 
occurring TSEs.
- Creutzfeldt-Jakob Disease (CJD).
- Gerstmann Straussler Scheinker Syndrome (GSS).
- Transmissible Mink Enecephalopathy (TME).
- Chronic Wasting Disease (CWD).
- Bovine Spongiform Encephalopathy (BSE).
- Feline Spongiform Encephalopathy (FSE).
-3-
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The first conclusive demonstration that scrapie was a 
transmissible disease was provided by Cuille and Chelle 
(1936). These researchers transmitted scrapie by intraocular 
exposure to an emulsion of either spinal cord or cerebral 
hemispheres. Chelle (1942) also reported the first natural 
case of scrapie in goats. Inadvertent confirmation of scrapie 
transmission came in 1939 (Gordon et al., 1939), when, sheep 
inoculated with a sheep brain-dervived, formalin inactivated, 
louping ill vaccine developed the disease. One batch of 
vaccine contained scrapie and this resulted in 7% out of a 
total of 18,000 sheep vaccinated, acquiring the disease.
Gordon (1946) also showed that infectivity could be diluted 
out and very crude titrations of infective agent were 
possible by subcutaneous injections in sheep. This work also 
demonstrated that the disease could be produced by 
intracerebral injections.
In 1945 D.R.Wilson started the SSBP/1 (scrapie sheep brain 
pool) passage line which has played a major role in scrapie 
research, notably transmission and bio-assay studies. SSBP/1 
consisted of brains from three natural scrapie cases (one 
Cheviot and two Cheviot crosses). Subsequently, this brain 
pool was shown to consist of three scrapie strains which 
differed in biological properties and the type of lesions 
produced. These strains were maintained by repeated passaging 
mainly in Cheviot sheep; however goats were also used.
Wilson et al. (1950) were the first to demonstrate that the 
agent was filterable, like a virus, through a gradocol 
membrane.
—5—
Experiments studying the distribution of scrapie agent (Stamp 
et al.. 1959) showed that agent was present in the central
nervous system (CNS), lymph nodes, spleen and, cerebrospinal 
fluid, but was absent from serum and skin. Infection could be 
achieved by routes other than by intravenous injections into 
the brain such as intradermal inoculations, skin 
scarifications and orally by administration of brain 
suspensions.
Purification of the scrapie agent was hampered by the 
necessity of having to bio-assay each sample in sheep and/or 
goats (Pattison and MilIson., 1960). To establish the titre
of a single sample, a whole herd of animals was required. In 
addition, highly susceptible breeds of sheep gave 
inconsistent results. One reason for the inconsistency was 
that there was no way of knowing whether or not an animal was 
infected naturally before being experimentally infected. 
Goats were better hosts for scrapie infection because they 
exhibited more uniform susceptibility, although incubation 
periods were not substantially reduced. A large step forward 
was made when Chandler (1961) succeeded in developing the 
mouse model for scrapie. Chandler induced a scrapie-like 
disease in mice by intracerebral inoculation of brain 
homogenates from SSBP/1 (passaged in goats). Since mice have 
comparatively short lifespans, the longer incubation period 
subjects did not survive as long as experimentally infected 
sheep. Consequently the accepted bio-assay for a single 
sample required the inoculation of 5-60 mice and incubation 
periods extending up to 12 months before final scoring. A 
second animal model was developed when Marsh and Kimberlin
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(1975) inoculated golden Syrian hamsters with scrapie. 
Experimental hamsters developed high titres of agent in the 
brain (10-100 fold higher than those assayed in mice) and had 
the shortest incubation periods of any experimental host. The 
shorter incubation periods of hamster is offset by the lack 
of inbred strains as compared to mice. At present, the only 
methods for measuring scrapie infectivity remain the 
end-point titration and the incubation time interval assay.
Another experiment started in 1961 which was of great 
relevance to scrapie research was described by Dickinson 
(1968). A group of Cheviot sheep (303 ewes and 15 rams) with 
no record of exposure to scrapie were split into two lines 
(positive and negative) on the basis of their response to 
subcutaneous injection with SSBP/1. Positive line sheep 
developed scrapie after an incubation period of around 300 
days, whereas, negative line sheep survived a natural 
lifespan. Subsequently, the negative-line sheep were shown 
not to be truly resistant, as they contract scrapie when 
inoculated intracerebrally after 1000 days incubation, 
whereas, positive line sheep developed the disease within 200 
days of inoculation by this route. On the basis of these 
results the two Cheviot phenotypes were referred to as 'short 
incubation period' (SIP) and 'long incubation period' (LIP). 
Subsequent line-cross and back-cross experiments showed that 
incubations periods were under the control of a single gene 
(Dickinson. 1968).
1.2.3. Kuru.
The investigation of kuru formed an important step in the
-7-
study of TSE. It was an obscure disease confined to the Fore 
linguistic group in the Eastern Highlands of Papua New Guinea 
(Gajdusek and Zigas, 1957; Zigas and Gajdusek, 1957). The 
disease was transmitted by the ritualistic cannibalism 
performed by certain tribe members. Early attempts at 
transmitting kuru to a variety of laboratory animals proved 
negative (Gibbs and Gajdusek, 1965). Hadlow (1959) drew 
attention to the similarity between the neuropathology, 
clinical and epidemiological picture of scrapie and kuru. He 
suggested that transmission experiments using primates might 
be more rewarding. This proved to be the case (Gajdusek, 
1966), with positive results being obtained by intracerebral 
inoculation of primates, including chimpanzees, with tissue 
from the brain of a patient with kuru.
1.2.4. Creutzfeldt-Jakob disease (CJD) and Gerstmann
Straussler Scheinker syndrome (GSS).
The first case of CJD in man was described in 1920 
(Creutzfeldt). A year later two more cases were described,
one by Jakob (1921) and the other by Creutzfeldt. For many
years investigators have tried to implicate scrapie infected 
sheep or goats as a source of human CJD. Numerous
epidemiological studies have failed to establish a convincing 
relationship, but speculation about this route of exposure 
continues (Bobowick et al.,1973; Alter and Khana, 1976; 
Masters et al.. 1978; Brown,1980; Lo Russo et al.,1980) . CJD 
can occur in a familial pattern but it is typically sporadic 
and with a remarkably uniform incidence world-wide of about 
one case per million of population per annum. The occurrence 
of CJD throughout the world is largely independent of the
—8 —
distribution of scrapie and the consumption of sheep 
products. It seems clear, therefore, that sheep and goats are 
not a reservoir of CJD and no other animal reservoir has been 
identified.
The first report of transmission of CJD was to apes and 
monkeys (Gibbs et al.. 1968). Subsequently, rodents were used 
with variable degrees of success (Gibbs et al., 1979). It
would appear that Japanese cases of CJD are more readily 
transmitted to rodents than Caucasian cases (Tateishi et 
^.,1983). Accidental transmission of CJD to humans appears 
to have occurred with corneal transplants (Duffy et— al 
.,1974), contaminated electroencephalogram (EEG) electrode 
implantation (Bernouilli et al., 1977), treatment with growth 
hormone derived from the pituitaries of cadavers (Buchanan et 
al., 1991) and surgical operations using contaminated
instruments or apparatus (Masters et al.,1978; Kondo and 
Kuroina, 1981; Will and Matthews, 1982; Davanipour et 
al.,1984).
GSS was first described by Gerstmann (1928; Gerstmann et al., 
1936) . The transmissibility of GSS was demonstrated by 
Masters (1981). It is usually regarded as a variant of CJD; 
but until the molecular structure of the agents causing both 
GSS and CJD have been have been determined it remains unclear 
whether GSS represents a variation of CJD or is a distinct 
disease.
1.2.5. Transmissible mink encephalopathy (TME).
TME occurs among ranched mink (Burger and Hartsough, 1965)) 
and bears a remarkable resemblance to experimental scrapie
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from both the clinical and pathological points of view. It 
was not uncommon for mink ranchers to include untreated 
abattoir waste and dead stock in mink feed (Zurhein et al., 
1974). Therefore, the disease could have been introduced into 
herds by the feeding of contaminated feed. Since sheep and 
goats are the only known animal reservoirs of the 
scrapie-like agents in nature, a direct link between scrapie 
and TME is likely even though it has not been possible to 
document the feeding of sheep material in all outbreaks. One 
important aspect of TME is that it is a "dead-end" host with 
no natural routes of transmission from mink to mink unless 
there is cannibalism.
1.3.1. Nature of TSE infectious agents.
Studies in which the nature of the infective agents causing 
TSEs, have been characterized principally using rodent 
scrapie models. The agents are best known for their unusual 
properties, particularly their resistance to inactivation. 
This is related, at least in part, to their association with 
cellular membranes which has also led to great difficulties 
in isolation and purification. A summary of the results 
obtained with physical and chemical treatments to inactivate 
TSE infectivity are shown in Table 1.2. The agent can survive 
heat treatments at 100°C for 30 minutes, which explains why 
some activity survived the rendering process (section 1.7.5. 
source of the BSE infection). Although like viruses, the 
agent can pass through bacteriological filters, it is not 
inactivated by UV (254nm) and ionizing (X-rays) irradiation, 
characteristics which are atypical of viruses. The agents 
are however susceptible to certain proteases and strong
—10—
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denaturing agents such as phenol, chlorox, potassium 
' and sodium hydroxide. The inactivation profile 
has suggested an essential protein component as part of the 
infectious agent with, possibly, a very small nucleic acid 
molecule (lOObp). Despite the potential for the generation of 
an immune response, the agents fail to induce an antibody or 
cellular reaction in the host. This is consistent with the 
non-inflammatory nature of the central nervous system lesions 
and is the major reason why there are no laboratory tests for 
the diagnosis of infection in the live animal. The 
combination of long incubation, unusual stability and no 
immune response has led to the scrapie group of agents being 
known as the "unconventional slow viruses".
The agents replicate in tissue culture (Clark and Haig, 1970; 
Gibson et al.,1972; Clark and Millson ,1976; Asher et 
al.,1979; Clark,1979; Markovits et al.,1983; Rubenstein et 
^.,1984); but do not induce cytopathic effects. The 
recognised marker for the presence of these agents is 
infectivity, therefore their presence is revealed by the 
induction of disease. Most of the conventional virological 
markers or detection systems have not been applicable to 
these diseases. This has hampered research progress because 
studies are critically dependent on bio-assays of infectivity 
in laboratory animals such as hamsters and mice, with the 
attendant long incubation periods.
A major advance in TSE research was the discovery of the 
abnormal fibrils, scrapie associated fibrils (SAFs), which 
were consistently present in cellular extracts from diseased
-12-
brains of the spongiform encephalopathies (Merz et al.,1981). 
SAFs were similar to the pathological fibrils known as 
amyloids, which have been observed in many human diseases 
(Merz, 1983a, 1983b). Electron micrographs showed that SAFs
consist of two or four subfilaments exhibiting a regular 
periodicity wound into a helical structure 300-800 nm in 
length. The two filament structures were 12-16 nm in diameter 
and the four filament structures were 27-34 nm in diameter. 
There were no SAFs present in brain extracts from normal 
animals.
Subsequently, a 27-30 kDa protease resistant protein (PrP) 
was identified in infectious fractions from hamster and mouse 
brains (Bolton et al. .1982) . Figure 1.1. sho\JS€L y&^sC^nM^f 
PrP proteins obtained from Proteinase K/detergent extracts of 
BSE-affected brains. Using these extraction protocols only 
the diseased modified PrP (BSE brains) can be seen as 
characteristic diffuse bands (27-30 kDa), normal PrP is 
completely disrupted. The 27-30 kDa polypeptide is a 
glycosylated cleavage product of a larger host glycoprotein 
of 33-35 kDa (Prusiner et al..1984. Bolton et al., 1985).
Experiments designed to isolate infectivity have shown that 
SAF, both forms of the PrP protein (27-30 and 33-35 kDa) and 
infectivity co-purify together (Diringer et al., 1983).
However, a large amount of modified PrP accumulates in brains 
of clinically affected animals and it still remains to be 
proved whether SAF, hence PrP, represents a form of the agent 
or infectivity is merely trapped among these structures 
during purification.
—13—
Figure 1.1a. shows Proteinase K/detergent and d e t e r g e n t /O 
(only) extracts from a normal and BSE infected cow
brain. The extracts were run in a PAGE gel and after
Western blotting onto a nylon membrane reacted against a 
control antiserum (-ve AS, i.e. no antibodies against 
PrP). This figure shows that all extracts from normal 
and infected brains produced identical results.
Figure 1.1b. shows Proteinase K/detergent and detergent 
(only) extracts from a normal and BSE infected cow
brain. The extracts were run in a PAGE gel and after
Western blotting reacted against a PrP antiserum (+ve 
AS). Results from the BSE infected cow brain show a 
diffuse band (about 28 kDa) in the Proteinase 
K/detergent extract (partially digested) and diffuse 
bands of higher molecular weight from non Proteinase 
K/detergent extracts. In both cases the extracts from 
normal animals failed to produce these diffuse bands 
(completely digested).
(Photographs kindly provided by P. Keyes, CVL)
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There are still major uncertainties about the chemical nature 
of the scrapie agent; despite such ignorance some 
understanding of its biological properties has still been 
possible. For example, many different strains of scrapie can 
be identified by their incubation periods (under standard 
conditions of experimental infection in rodents) and by the 
severity and distribution of histological lesions in the 
central nervous system. More than 20 different strains of 
scrapie are easily recognised by their biological properties 
in mice and at least three have been identified in hamsters 
(Fraser and Dickinson, 1973; Dickinson and Outram, 1979; 
Bruce and Dickinson, 1979; Dickinson, 1984). Mutation of the 
scrapie agent has been documented in both mice and hamsters, 
and it does not appear to be a rare event. For example, 
mutant strains of scrapie were selected following mouse to 
hamster passage of strain 139A. Passage across the species 
barrier resulted in permanent change in the scrapie agent
genome following reisolation in mice (Kimberlin et al.,
1987) ; but this is not an invariable consequence of 
interspecies transmission.
1.3.2. Aetiological Models.
The properties of the infectious agent outlined in the 
previous sections paint a very contradictory and often 
confusing picture of the agents responsible for TSEs. Some of 
the properties, such as strain variation and capacity to 
mutate, suggest scrapie agents closely resemble other 
microbial pathogens. This suggests the presence of agent 
specific genomes, and on a priori basis, the genome is likely 
to be nucleic acid. Other experimental evidence, such as
—16“
exposure to UV light which failed to inactivate the agent, 
suggests that either no nucleic acid is present in the 
infectious agent or, that a putative nucleic acid molecule is 
very small. The estimated target size to ionizing radiation 
predicts nucleic acid(s) no bigger than 100 bp in length 
(Riesner et al.. 1992). This may be too small to code for a 
protein but is a necessary component of the infectious agent, 
as shown by studies with proteases.
Over the years several hypotheses have been put forward as 
models of the aetiological agents for these diseases. These 
models not only have to accommodate the properties mentioned 
above, but have also to consider that these diseases are 
infectious, sporadic and genetic as illustrated by kuru, CJD 
and GSS respectively (Prusiner, 1987).
Based on the familial appearance of scrapie. Parry (1960) 
advocated that these diseases were purely genetic caused by 
a defective and recessive gene, and invoked the term provirus 
(first used by Darlington in the 1940s) . The major problem 
with Parry's view for a number of people has been the 
existence of contagious spread of scrapie between unrelated 
animals (Brotherston et al.. 1968; Hourrigan et al.. 1979).
The action spectra in the UV range, the lethal effects of 
lipid peroxidation on the scrapie agent and the association 
of the infective agent with cellular membranes, led to the 
membrane hypothesis (Gibbons and Hunter, 1967). As a 
precedent for their proposal Gibbons and Hunter cited the 
observations of Beisson and Sonneborn (1965), who had found 
that foreign pieces of Pareunecium cortex could be grafted
-17-
into a whole cell, yielding a new pattern which was 
maintained through both sexual and asexual reproduction. This 
hypothesis would then predict that a cell might become 
infected by incorporation of a modified PrP molecule forming 
a PrP membrane complex. Each subsequent cell division giving 
rise to one other infected cell. This model has to accommodate 
how different strains might evolve.
The "virino" hypothesis was proposed to take into account
(J>Col^ insonoAcl
strain variationshence the presence of nucleic acid, and 
the fact that PrP is a host-coded protein. This model 
proposes that the PrP protein protects the informational 
nucleic acid, which controls the characteristics of each 
strain. The use of a host coded protein in this way would
also explain the lack of immune response to TSE infections
because of the absence of foreign antigens. Taxonomically 
this puts virinos in between conventional viruses and viroids 
(a class of plant pathogens which neither need nor code for 
proteins to be infectious). An argument against this 
hypothesis has been the inability to detect the proposed 
nucleic acid molecule.
The term "prion" is currently defined as " small 
proteinaceious infectious particles that resist inactivation 
by procedures modifying nucleic acids and contain an abnormal 
isoform of a cellular protein which is major and necessary"
(Prusiner, 1991). The prion hypothesis suggests , similar to
older theories, that proteins alone are sufficient for 
infectivity (Griffiths, 1967; Alper et_al.,1978; Prusiner, 
1982). This theory speculates that when diseased PrP protein
-18-
is introduced into a normal cell it is propagated by causing 
the conversion of normal PrP or its precursor into the 
abnormal kind. The proposed mechanism by which replication 
can occur is summarized in Figure 1.2. This theory takes into 
account experiments in which PrP has been shown to co-purify 
with infectivity and physical and chemical treatments which 
appear to inactivate nucleic acids but where infectivity is 
still retained. At present this theory needs to explain how 
strain variations and mutations can be based on a 
post-translationally modified host-coded protein.
In order to reconcile the differences between the "virino" 
and the "prion" hypotheses, Weissmann (1991), proposed the 
"unified theory" of prion propagation. According to this 
theory the diseased isoform of the PrP protein (the 
apoprion), by itself, can induce disease. The phenotypic 
properties which define strain differences are ascribed to a 
a nucleic acid (the coprion), which is usually associated 
with the diseased PrP ; but can also be recruited or 
exchanged within the host cell. The possible ways in which 
the proposed 'coprion' and 'apoprion' cause disease and 
replicate are summarized in Figures 1.3a and 1.3b. The 
unified theory takes into consideration why the scrapie agent 
is resistant to ionizing and non-ionizing radiation and other 
nucleolytic agents, because destruction of nucleic acid does 
not affect infectivity. Conversly, the characterization of 
different strains were usually carried out with crude brain 
extracts in which the conjectured phenotype-determining 
nucleic acid would be present.
—19—
Figure 1.2. Proposed model for prion (protein only) 
replication (taken from Prusiner et al., 1992).
This one component model assumes that prions are devoid 
of nucleic acid. Diseased PrP binds to normal PrP 
forming heterodimers that function as intermediates in 
the synthesis of diseased PrP. Repeated cycles of this 
process results in an exponential increase in diseased 
PrP.
-20-
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Figure 1.3a. Unified theory model of prion propagation 
via an infectious agent containing protein/nucleic acid.
(taken from Weissman, 1992).
In this model protein/nucleic acid (called the 
holoprion) invades a cell. Conversion of normal PrP to 
diseased PrP is mediated by diseased PrP, the holoprion 
or nucleic acid (coprion), and involves either a 
chemical modification or a conformational change. The 
coprion nucleic acid is replicated by a cellular 
polymerase, a process which is promoted or dependent on 
its association with diseased PrP. The diseased PrP then 
binds coprion nucleic acid reforming the holoprion.
-22-
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Figure 1.3b. Unified theory model of prion propagation 
via diseased protein only.
In this model the holoprion (protein/nucleic acid 
complex) is subjected to nuclease treatment and/or 
purification to yield diseased PrP (the apoprion). After 
penetrating the cell, the apoprion may associate with a 
potential coprion, namely a cellular nucleic acid to 
which it has affinity and which can be replicated by a 
cellular polymerase in the presence of diseased PrP. The 
resulting holoprion may have phenotypic properties which 
differ from those of the original holoprion.
—24—
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The last major theory, which has lost ground in recent years, 
is that the infectious agent is a conventional virus-like 
agent whose unusual properties haVe impaired its detection 
(Rohwer, 1983, 1984a, 1984b, 1991; Braig et al.. 1985;
Manuelidis and Manuelidis, 1986; Manuelidis et al.. 1987). 
The virus theory best accommodatesagent strain variations and 
mutations; but to date no virus has been identified.
1.4.1. Molecular biology of the PrP protein.
Numerous experiments have implicated the neuronal membrane 
protein, PrP, as forming at least part of the infectious 
agent responsible for TSEs. Purification of the PrP protein 
produced a molecule of size 27-30 Kda (section 1.4.1.). The 
N-terminal end of the PrP protein was sequenced (Prusiner et 
al.. 1982, 1984). Based on this N-terminal sequence,
isocoding mixtures of oligonucleotides corresponding to a 
portion of this sequence were synthesized and used as a probe 
to select a clone encoding PrP 27-30 from a scrapie-infected 
hamster brain cDNA library (Oesch et al ..1985). The 
identification of the PrP cDNA was confirmed by sequencing 
additional peptides from PrP 27-30 generated by CNBr 
cleavage. These results showed that all the CNBr peptide 
fragments were within the translated sequence of the cloned 
cDNA insert. Southern blotting with PrP cDNA revealed a 
single gene with the same restriction pattern in normal and 
scrapie-infected hamster brain DNA. A single PrP gene was 
also detected in murine (Chesebro et al.. 1985; Oesch et 
al.,1985) and human genome DNA (Oesch et al.. 1985). PrP mRNA 
was found at similar levels in both normal and 
scrapie-infected hamster brains, thus indicating that the
—26—
levels of expression were not altered by the disease process. 
Antibodies were raised against PrP 27-30 were found to bind 
PrP from both normal and infected brains (Oesch et al.,
1985); but the molecular size in each case was between 33-35 
Kda. The PrP protein content of diseased brain was higher 
than in normal brains, reflecting the accumulation of 
modified PrP. Proteinase K digestion of PrP 33-35 yielded in 
the case of infected brain extracts partially digested PrP 
proteins of 27-30 Kda; but it completely degraded PrP from 
extracts of normal brain.
Experiments in which the expression of mRNA was studied in 
rodents showed that levels were unchanged throughout the 
course of scrapie infection; but the expression of the PrP 
gene was developmentally regulated (McKinley et al., 1987). 
During the first 8-10 days after birth, PrP mRNA increases in 
the neonatal hamster brain as measured by Northern blot 
analysis of poly(A) RNA and cell free translation of total 
brain RNA. By 10 days of age, PrP mRNA levels reach a maximum 
and remain constant throughout the adult life of the hamster.
1.4.2. Structure of PrP genes and deduced amino acid 
sequences.
Based mainly on work carried out on the hamster PrP gene and 
using three distinct genomic clones together with two 
preexisting cDNAs (Easier et al., 1986), the structure of
the PrP gene and its mRNA were determined and is summarized 
in Figure 1.4. The main features of the PrP gene are: the
entire open reading frame (ORF) or protein coding region is 
contained within a single exon. This would suggest that there
-27-
Figure 1.4. Organization of the hamster PrP gene.
The hamster PrP consists of two exons separated by a 
lOkb intron. the entire ORF of the PrP gene is contained 
within the second exon, therefore there are no 
possibilities for alternative splicing to separate 
potential strain variation. Normal PrP is converted to 
diseased PrP on exposure to the infectious agent.
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are no possibilities for alternative splicing within the ORF 
to generate potential strain variation. A 5'untranslated exon 
is located approximately lOkb from the ORF containing exon in 
hamsters. The structure of the mouse PrP gene is similar, 
though an additional 5' exon has been identified in the 
I/LnJ strain of mice (Westaway et al.. 1991). Other features 
of the hamster PrP gene show that the promoter has multiple 
transcription initiation sites, lacks a TATA box, contains an 
AP-1 consensus binding sequence and is GC rich. These 
features are similar to those exhibited by so-called 
housekeeping genes, though this term does not imply that the 
PrP gene is expressed constituitively.
The deduced amino acid sequences of hamster (Easier et al., 
1986), human, mouse (Westaway_et_al., 1986) and sheep 
(Goldmann et al.. 1990) PrP genes show that they are highly 
conserved (Prusiner et al.. 1987). The PrP proteins from the 
four species are 254, 253, 254 and 256 amino acid long for
hamster, human, mouse and sheep respectively. The amino 
terminus of all sequences contain 22-24 residues that are 
typical of a signal peptide (von Heijne, 1985). This signal 
peptide is cleaved leaving a mature protein commencing at the 
lysine residue at amino acid 23-25. The amino terminal 
portion of PrP proteins contain two hexapeptide repeat 
segments - GG(N/S)RYP. The hexapeptide repeat segments are 
followed by five nonapeptide/octapeptide repeat segments 
P(H/Q)GGG(-/G)WGQ. There are two hydrophobic domains long 
enough to span a membrane (Prusiner et al..1987) . Each PrP 
protein from the different species have two potential 
glycosylation sites to which carbohydrate groups could be
-30-
attached, and two cysteine residues which forms an 
intra-disulphide bond thus creating a loop of about 34 amino 
acids. In hamsters it has been shown that the hydrophobic 
C-terminus is removed and glycosylinositol phospholipid 
anchor (GPI) attached.
Antigenic similarities between the PrPs from different 
species were established by demonstrating that antibodies 
raised against hamster scrapie PrP 27-30 or synthetic 
peptides derived from PrP cross reacted with human 
CJD-derived PrP (Bockman et al., 1985) and GSS-derived PrP
(Kitamoto et al., 1986). This cross-reactivity data was taken 
as providing further support for the highly conserved 
sequences amongst PrP molecules.
The degree of sequence conservation observed between hamster, 
mouse, sheep and human PrP is consistent with the results 
from filter hybridization experiments, which revealed that in 
addition rat, goat, nematode, drosophila and possibly yeast 
harbour candidate PrP DNA sequences (Westaway and Prusiner,
1986). The relative hybridization signal strengths were in 
the order rat, goat, sheep> nematode> drosophila» yeast.
1.4.3. Post-translational modifications.
Both the normal and diseased forms of the PrP protein is 
encoded by the same host gene, this has led many 
investigators to put forward the hypothesis that the 
differences between normal and diseased PrP arose due to a 
post-translational events (Easier et al., 1986; Borchelt et 
al., 1990; Caughey et_al., 1991; Palmer et al., 1991). For
example, pulse-chase radiolabelling experiments in scrapie
-31-
infected neuroblastoma cells have revealed that diseased PrP 
acquires one of its principle properties, that of protease 
resistance, post-translationally (Borchelt et al.. 1991). It 
is not known whether this post-translational event represents 
a chemical modification, a stable conformational change of 
some sort or is due to the tight binding of the diseased PrP 
protein to other cellular components (Stahl and Prusiner,
1991).
The post-translational events that are known are:-
1) Removal of the N-terminal signal peptide from both normal 
(Turk et al.. 1988) and diseased (Hope et al.. 1988; Turk et 
al., 1988) PrP proteins upon transfer of the proteins to the 
endoplasmic reticulum (ER).
2) There are two N-1inked carbohydrate acceptor sites, both 
of which are occupied for the majority of normal and diseased 
PrP molecules (Bolton et al.. 1985; Haraguchi et al.. 1989)
3) In Syrian hamsters a C-terminal peptide is removed and a 
glycosylinositol phospholipid (GPI) anchor attached.
4) Both normal and diseased forms of the PrP protein contain 
only two cysteine residues that form a single disulphide 
bridge (Turk et al., 1988).
1.4.4. Glycosylation.
Glycosylation accounts for up to 30% of the mass of both the 
normal and diseased PrPs (Endo et al., 1989; Bolton et al.,
1985; Haracfuchi et al.. 1989). The addition of tunicamycin 
(which abolishes N-1inked glycosylations) to cell cultures 
infected with the agent resulted in diseased PrP of Mr 
19,000. This PrP, which was unglycosylated, was insoluble in
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detergent and resistant to digestion with proteinase K, 
unlike the product from normal control cells similarly 
treated with tunicamycin (Taraboulos et al.. 1990). These 
results showed that N-1inked glycosylation was not required 
for the production of diseased PrP.
1.4.5. Glycosylinositol phospholipid anchor.
The majority of the work elucidating the structure of the GPI 
anchor has been carried out studying the 27-3OkDa PrP protein 
derived from hamsters. Results show that six different GPI 
structures (glycoforms) were present (Baldwin et al.. 1992).
Two glycoforms contained N-acetylneuraminic acid (sialic 
acid) which has not been previously reported as a component 
of GPI anchors. One other glycoform contained the 
monosaccharide galactose and no other GPI from a mammalian 
source has been shown to have this monosaccharide. Analysis 
of the GPI structures from two different strains of Syrian 
hamsters, specifying different incubation times,
neuropathology and distribution of diseased PrP were found to 
be identical. Although the PrPs from the different strains
had identical masses, retention times in reverse-phase high 
performance liquid chromatographic and capillary 
electrophoretic systems, and the same apparent level of 
heterogeneity it cannot be ruled out that the two PrPs could 
differ in the type of glycosidic linkage or the type of
lipids attached. Normal PrP has been shown to have a GPI 
anchor by studies in which the protien was released from cell 
membranes after incubation with the enzyme phospholipase C. 
Analysis of the GPI from normal PrP is not as advanced as 
that for the diseased protein because of the limited
-33-
availability of the former. Nevertheless, normal PrP has been 
shown to have sialylated glycoforms, which would suggest that 
the presence of this monosaccharide at least does not 
distinguish between the normal and the diseased PrPs.
1.4.6. Synthetic pathway and metabolism of normal and 
diseased PrP proteins.
Numerous studies have been carried out attempting to 
establish subcellular site(s) at which the conversion of 
normal PrP or a precussor is converted to the diseased 
protein. These studies have been facilitated by the 
development of mouse neuroblastoma, hamster brain and rat 
phaeochromocytoma (PC12) cell culture lines in which normal 
and diseased PrP synthetic pathways could be followed.
1.4.7. Kinetics of PrP synthesis.
Pulse chase experiments in which cells are grown in the 
presence of [^^S]-methionine followed by periods of growth in 
the absence of labelled methionine have shown that in 
uninfected mouse neuroblastoma cells PrP is synthesized, 
processed, and transported to the plasma membrane within 30 
minutes (Caughey et al.. 1989). Similar studies carried out 
using infected cells, have shown that there is a lag period 
before the appearance of diseased PrP. This result is 
consistent with the view that diseased PrP is derived from 
normal PrP. Pulse chase experiments using uninfected cells, 
in which labelling was allowed to proceed for between 2-10 
minutes, gave rise to PrP species of 25, 28 and 33kDa.
Digestion of these PrP species with endoglycosidase H 
converts the larger of the two species to 25kDa, suggesting
—34 —
that the different sizes are due to differing amounts of 
glycosylations (Caughey et al.. 1989). Incubation with the 
drug tunicamycin abolishes glycosylation reactions and 
therefore only the 25kDa species is produced. Similar studies 
using infected cells showed that diseased PrP of differing 
sizes (19, 23 and 28kDa) were produced (Taraboulos et al.,
1990a). The difference in size between PrP species derived 
from normal and diseased PrPs was due to the partial 
digestion of the latter by proteinase K. Diseased PrP from 
cell cultures had the same properties as those derived from 
diseased hamster brain i.e. insoluble in detergents and 
resistance to complete digestion by proteinase K. The 28 kDa 
and 33kDa precursors labelled in neuroblastoma and PC12 cells 
were further processed to yield mature 30 and 35-41 kDa 
proteins (Race et al.. 1988; Caughey et al.. 1989). These
mature PrPs are no longer susceptible to digestion by 
endoglycosidase H, indicating that the high mannose glycans 
are converted to hybrid or complex forms similar to the 
complex carbohydrate moieties derived from hamster brains 
(Bolton et al.. 1985; Manuelidis et al.. 1985; Haraguchi et 
al.. 1989; Endo et al.. 1989).
1.4.8. Cell surface localization.
The presence of normal PrP on the surface of a variety cell 
membranes has been demonstrated using different labelling 
techniques such as immunefluoresence (Stahl et al.. 1987; 
Caughey et al.. 1988b, 1990; Borchelt et al.. 1990; Cashman 
et al., 1990), biotinylation (Borchelt et al., 1990) and
radio-iodination (Caughey and Raymond, 1991). Cell surface 
PrPs have been shown to be sensitive to proteases (Stahl et
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al.. 1987; Caughey et al.. 1989, 1990). Puise chase
experiments have shown that within 90 minutes, 90% of pulse 
labelled 30 and 35-41 kDa PrP species can be digested by 
extracellular trypsin and phosphatidylinositol-specific 
phospholipase C (PIPLC), showing that these PrP species 
reached the cell surface (Caughey et al.. 1990; Caughey and 
Raymond, 1991). Once on the cell surface, normal PrP has a 
half life of between 3-6 hours in the absence of exogenous 
protease (Caughey et al.. 1989; Borchelt et al., 1990; 
Caughey and Raymond, 1991). Only a small proportion of PrP is 
recovered from the cell culture medium after extended chase 
periods, therefore, it appears that catabolism rather than 
secretion or release from the cell surface is the major fate 
of PrP in these cells (Caughey et al.. 1989; Borchelt et al., 
1990). Diseased PrP is resistant to removal from both intact 
and permeabilized cells and membranes with PIPLC or proteases 
(Caughey et al.. 1990; Borchelt et al.. 1990; Stahl et al., 
1990; Safar et al.. 1991). However, treatment of intact pulse 
labelled neuroblastoma cells with PIPLC or trypsin prevented 
the . subsequent incorporation of label into diseased PrPs 
(Caughey and Raymond, 1991). This experiment showed that 
diseased PrP is made from a PIPLC and trypsin sensitve 
precursor. The accessibility of diseased PrP to 
radio-iodination indicated that it resides, at least 
transiently, on the cell surface. These properties make the 
precursor of diseased PrP similar if not identical to normal 
PrP.
1.4.9. Intracellular sites of diseased PrP formation.
Numerous studies have been carried out in order to delineate
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the intracellular pathways involved in the synthesis of 
diseased PrP. These have been made easier with the discovery 
that dénaturation of diseased PrP enhanced its 
immunoreactivity (Serban et al., 1990). Dénaturation of
hamster cells followed by reaction to antibodies raised 
against the PrP27-30 core produced a speckled cytoplasmic 
signal in diseased but not normal cells (Taraboulos et al., 
1990). Further studies showed that diseased PrP accumulated 
in vesicular structures similar to lysosomal structures, and 
the lysosomal marker, acid phosphatase, was found in some 
vesicles (Taraboulos et al.. 1992). Other studies supporting 
this view came from labelling experiments in which diseased 
PrP was found to be exposed to lysosomal hydrolases shortly 
after its formation (Caughey et al., 1991; Taraboulos et al., 
1992).
The fungal metabolite brefeldin A causes redistribution of 
Golgi stacks and resident Golgi proteins into the endoplasmic 
reticulum thus blocking the export of proteins into the 
secretory pathway, and inhibiting their transport through 
endosomes (Lippincott-Schwartz et al.. 1989, 1991). This
metabolite has been used to show that the distribution of 
diseased PrP in hamster cells was not modified and was 
consistent with the localization of diseased PrP outside of 
the Golgi stacks (Taraboulos et al.. 1991, 1992), and
suggests that the ER is not the site of synthesis of diseased 
PrP.
Studies have already been described in which digestion or 
release of normal PrP from the plasma membrane prevents the
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synthesis of diseased PrP (section 1.4.8.), and others which
show that diseased PrP is found in lysosomes. This raises the
question as to whether the conversion of normal PrP to
diseased PrP occurs on the surface or interior of cells. At
present the answer is not clear but immunogold labelling
studies by Jeffrey et al.(1992) indicate that modified PrP is 
found, and may be formed , on the plasmalemma. Other studies 
have shown that the synthesis of diseased PrP was found to be 
reversibly inhibited by incubation of cells at 18°C (Borchelt 
et al., 1992). Many studies have shown that exposure of cells 
to 18°C selectively inhibits the endosomal pathway.
Alternatively, diseased PrP may be recycled using a different
pathway. Recent studies have shown that many GPI anchored 
proteins on the surface re-enter through vesicles termed
'caveolae' (Anderson et al.. 1991). Whether exposure of cells 
to 18°C also inhibits caveolae dependent transport of PrP is 
not known. The possible subcellular sites at which conversion 
of normal to diseased PrP might occur is summarized in Figure
1.5.
1.4.10. Anti-PrP protein.
While analysing the PrP gene in CJD and GSS patients 
Goldgaber (1991) found a large overlapping ORF in the DNA 
strand opposite to the PrP transcriptional unit. The deduced 
amino acid sequence for this putative protein was unique and 
for simplicity the name anti-PrP ascribed to it. The ORF of 
the anti-PrP protein was considered to be of possible 
biological importance firstly, because it was as large as the 
PrP ORF. Secondly, none of the differences in PrP sequences 
found in patients or animals resulted in additional stop
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Figure 1.5. Route of PrP trafficking and likely sites of 
diseased PrP formation and deposition (Caughey et al.,
1992).
Normal PrP, once synthesized passes to the endoplasmic 
reticulum (ER) and Golgi apparatus where various 
postranslational procedures are performed before their 
passage to the surface of the cell membrane. 
Experimental evidence suggests that conversion of normal 
PrP to diseased PrP occurs somewhere between the surface 
of the cell membrane and their accumulation in 
lysosomes.
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codons in the anti-PrP ORF. Although it was noted that two 
mutations found in the PrP ORF of GSS patients also resulted 
in changes in the corresponding codons of the anti-PrP 
protein, whereas, two changes found in the PrP of CJD 
patients did not. Thirdly, there were ATG or CTG codons at 
the beginning of this ORF which could serve as translation 
initiation sites. When this theory was proposed existing data 
on PrP gene expression did not exclude the possible 
expression of the anti-PrP gene as double stranded probes 
were used to detect PrP messenger RNA. Work using sense 
riboprobes (to detect anti-PrP messenger RNA only) showed 
that a 4.5 kb RNA was detected in bovine brain and other 
tissues (Hewinson et al.. 1991). Recently, Moser et al. 
(1993) working with 'wild type' mice and mice homozygous for 
partially deleted PrP genes detected a 4.5 kb RNA in both 
sets of mice using a sense riboprobe. However, using an 
additional sense riboprobe which lay entirely within the 
deleted region of the PrP gene (deleted mice) detected the 
same 4.5 kb RNA in both sets of mice. These results showed 
that the 4.5 kb RNA detected in these experiments was not 
derived from the opposite strand of the mouse PrP gene; 
however, it appears to share considerable homology with the 
antisense strand of the PrP gene. These results do not 
exclude the possibility that the anti-PrP strand may be 
expressed as well.
The possible expression of an anti-PrP gene (however derived) 
introduced a new player into the TSE field and raises several 
questions. Do the PrP and anti-PrP proteins interact in 
diseased cells? Experiments have been described in which
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peptides encoded by antisense sequences have corresponded to 
structurally binding proteins or receptors (Brentani et al., 
1988; Elton et al.. 1988; Host et al., 1985; Westaway et 
al.. 1987) Can the mutations in GSS, which unlike CJD
mutations, results iu amine acid changes in both proteins 
explain the differences between the two diseases? Does the 
enzyme RNA unwindase, which is capable of modifying 
double-stranded RNA substrates, produce changes in 
complementary PrP and anti-PrP mRNAs, thus altering these 
proteins? Some of these questions are presently being 
addressed by various research groups.
1.5. The role of incubation time genes and route of infection 
on disease susceptibility.
1.5.1. Incubation time genes.
Genetic analysis of natural and experimental scrapie 
infections in sheep established that host genes exert a 
profound influence on disease susceptibility and course 
(Dickinson and Fraser, 1979; Parry, 1983). Early sheep 
experiments in which the transmission of scrapie was studied 
often gave confusing and contradictory results. For example, 
Gordon (1966) injected 24 different breeds of sheep with 
SSBP/1 scrapie by the intracerebral route and observed them 
over a two year period. The proportion of each breed 
developing scrapie ranged from high (Herdwicks, 78%) to low 
(Dorset Downs, 0%} i.e the latter appeared to be resistant. 
Other work gave different results with Herdwicks showing 30% 
susceptibility and some Dorset Downs developed scrapie after 
a prolonged incubation period (Dickinson, 1976). These
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experiments showed that there was as much variation in the 
"take" of scrapie between different flocks as there was 
between different breeds (Nussbaum et al., 1975)• Such
studies in sheep were hampered because it was extremely 
difficult to ensure that test animals came from scrapie-free 
environments, were not already harbouring infection, and at 
the same time were susceptible to disease.
This led to the establishment of sheep lines that were " 
scrapie susceptible" and "scrapie resistant" (section
1.2.2.). From line-cross and back-cross segregation 
experiments it became clear that a single gene controls 
susceptibility to SSBP/1. This gene was subsequently called 
SIP (scrapie incubation period). Incubation period is defined 
as the time interval from inoculation of infectious material 
to the appearance of illness. SIP has two alleles sA and pA 
(short and prolonged incubation respectively; Dickinson and 
Outram, 1988). The negative ("resistant") line sheep are.all 
SIP pApA. The positive ("susceptible") sheep are either SIP 
sAsA or SIP sApA, as sA is thought to be dominant. Scrapie 
isolates can be classified according to their relative 
effects on sheep of different SIP genotypes. Most isolates 
(group A) produce disease in carriers of the sA allele faster 
than in SIP pApA sheep; but with at least one isolate 
(CH1641, group C) the ranking is not clear-cut and may even 
be reversed (Foster and Dickinson, 1988a).
Following the transmission of scrapie to mice (Chandler, 
1961), the mammal of choice for genetic analysis (because of 
numerous strains and relatively short incubation periods), a
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partially inbred strain of mice with greatly prolonged
scrapie incubation periods was identified (Dickinson and
Mackay, 1964) . Subsequently , this influence on scrapie
incubation period was shown to be the effect of a single gene
designated Sine (scrapie incubation; Dickinson et al., 1968).
VM/DK and the related IM/DK mouse strains are homozygous for
the Sinc^^ (prolonged incubation) allele. After inoculation
with the ME7 scrapie isolate, incubation periods of
approximately 300 days are recorded. Most other mouse strains
s7are homozygous for the Sine (short incubation) allele and 
exhibit short incubation periods of 150 days or less 
following challenge with ME7. The extensive work by Dickinson 
showed that the pathogenesis of scrapie in the experimental 
mouse model is very predictable over the long time courses 
involved, provided eight factors are controlled (Dickinson 
1975). These factors are equally divided between the host and 
thé inoculum. In the host the Sine genotype and sex , the 
route of injection and the age of the host at the time of 
injection are important factors. Considering the inoculum, 
the strain and dose of agent together with genotype and organ 
source are significant.
1.5.2. Route of transmission.
Studies of experimentally induced scrapie in mice using 
peripheral routes of inoculation are believed to mimic 
natural infection more closely than intracerebral (ic) 
injection. Using intraperitoneal (ip), intravenous (ivj and 
subcutaneous (sc) routes, various studies have suggested that 
replication of scrapie agent in the mouse takes place first 
in the lymphoreticular system (LRS) and that fatal disease
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only develops if infection spreads to the CNS. Within the CNS 
scrapie agent is found first in the thoracic spinal cord 
(always at predictable stages in the incubation period) and 
later in the brain (Kimberlin and Walker, 1979, 1980, 1982).
These findings are similar to those described by Hadlow et al 
(1982), for the detection of infectivity in Suffolk sheep 
with natural scrapie. Kimberlin and Walker (1989) also 
describe mouse studies using an intragastric injection route 
which it was hoped would compare well with the postulated 
natural oral route in sheep. Replication was found to start 
in Peyer's patches which preceded replication in the spleen, 
and in contrast to other routes e.g. ip, splenectomy did not 
change the incubation period. Infection seemed to be 
spreading directly to the CNS via the enteric and sympathetic 
nervous system.
Early experiments showed that incubation periods were dose 
dependent (Chandler, 1963). Incubation periods lengthened as 
the amount of infectivity in the inoculum was reduced. At
very low levels of scrapie challenge, replication of the 
agent may be at such a low level that the disease does not 
develop within the animal's normal lifespan (Dickinson at 
al., 1975). If a similar situation existed in sheep under
natural conditions then it could lead to the maintenance of a 
low level of infection in a flock without any evidence of
disease.
The route of transmission in natural scrapie is not known, 
though field evidence and infectivity studies of tissues from
naturally infected sheep indicate that oral exposure is
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probably important. Tissues were taken from sheep known to be 
at high risk of developing scrapie, and varying in age from 
newborn to 8.5 years and tested by mouse bio-assay for the 
presence of infectivity (Hadlow et al., 1982). Scrapie was
detected in lymphatic tissue and, interestingly, in 
intestines from clinically normal 10-14 month old lambs 
(infectivity titres were low). The first detection of 
infectivity in the CNS was in a clinically normal ewe was at 
25 months of age. By the time disease developed in nine 
animals at approximately 3.5 years of age, scrapie agent was 
present in the alimentary tract from tonsil to the distal 
colon as well as spleen and the CNS. Scrapie agent was not 
detected in other tissue such as heart, lung, kidney and 
skeletal muscle, nor was it found in contact sheep that 
remain clinically normal until 4.5-8.5 years of age.
The early involvement of the alimentary tract in these 
experiments has led to the proposal of an oral route of 
transmission. Hourrigan et al. (1979) assayed milk, colostrum 
and faeces for infectivity in mice but found no detectable 
agent. Pattison et al.(1972. 1974) demonstrated that it was 
possible to produce scrapie in Herdwick sheep by feeding them 
infected placental material from Swaledale ewes. Infection
did not seem to be present in the foetus (Hourrigan et al .,
1979) . From these experiments the idea of the oral route of 
transmission was further extended, by suggestions that 
scrapie agent can be transmitted via contaminated pasture. 
Support for this idea came from findings in Icelandic scrapie 
(Palsson, 1979; Greig, 1940a, 1940b, 1950), and further
suggested that pasture can retain infectivity for some time
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which is in keeping with the resistance of these agents to 
inactivation.
Although studies of the natural transmission of scrapie are 
fraught with problems (outlined in section 1.5.3. "incubation 
time genes"), two studies were carried out which showed that 
both maternal and lateral (contagious) transmission can 
occur. Dickinson et al. (1974) used Scottish Blackface sheep 
as the indicator because no scrapie case had been reported in 
this breed for the previous 30 years. The source flock was 
kept on a remote hill farm and observed for 13 years during 
which time no case of scrapie was reported in a total of over 
18,000 animals. Seventy five animals were removed and mixed 
with scrapie-affected sheep (Suffolk x Scottish Blackface) in 
normal field conditions in an area not previously used for 
scrapie studies. The incidence of scrapie in the indicator 
animals was 28% in 5-6 years. All suspected cases were 
subjected to confirmation by histopathology and rejected if 
negative. Besides lateral transmission, the possibility of 
maternal transmission was highlighted in this study , with 
the scrapie status of the ewe being much more important than 
that of the ram in predicting which lambs would ultimately 
succumb.
In the other study lateral and maternal transmission 
(Hourrigan et al., 1979) were assessed by running
scrapie-free animals in field conditions with sheep known to 
have been exposed to the disease. Stringent conditions were 
used throughout e.g. a scrapie free label was only assigned 
after observation for eight years following introduction to
—47—
the programme at two years of age. Dying animals were 
examined carefully for any signs of scrapie and 
histopathology carried out. Any animals over which there was 
any doubt either clinically or pathologically were eliminated 
from the final report. The exposed group of animals (total of 
546) comprising different breeds (Cheviot, Hampshire, 
Montadale and Suffolk in 21 blood lines), were known to be 
from scrapie flocks but were apparently healthy. The 
unexposed group also comprised different breeds (Targhees, 
Rambouillets, Hampshires, Suffolks and 17 goats). In the 
exposed group 29% of the animals developed scrapie (2.5-5 
years), and in their offspring (446 animals) 34% succumbed to 
disease. Of the unexposed indicator animals five (3.5%) 
contracted scrapie and all at the later age of 6-8 years. 
Their progeny, exposed from birth to infection, developed 
scrapie at the rate of 27%, and at the more usual age of 
2.5-5 years. This study showed that both lateral and maternal 
transfer could occur, and that the maternal rate was higher.
One of the problems involved in controlling disease in 
scrapie-infected flocks is the reluctance to destroy certain 
blood lines, hence, conserving valuable genetic lines. An 
attempt to address this problem was made by studying 
reciprocal transfers of embryos between scrapie-inoculated 
and scrapie-free sheep (Foote et al., 1986, 1988). The
objective of these studies was to determine if embryo 
transfer could provide a means of obtaining scrapie-free 
sheep from infected flocks. In these studies donor ewes were 
inoculated with scrapie by either the s.c. or oral route, or
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both. Embryos from the inoculated animals were collected, 
washed three times and then transferred to recipients from a 
source with no known exposure to scrapie, i.e. free of any 
evidence of clinical scrapie. The recipient ewes were 
observed for at least five years post-implantation. A total 
of 99 offspring resulted from the transfers. Fifty six of 
these offspring reached 60 months of age or more, while the 
remaining 43 died prior to 60 months. Twenty nine of the dead 
animals originated from donors which developed scrapie; but 
none of the offspring were reported to exhibit signs of 
scrapie (Detwiler, 1992). Histopathology results on all 
offspring are pending.
The experiments also involved the transfer of embryos from 
scrapie-free sheep to scrapie-inoculated recipients and then 
removing the lambs by caesarian section at term. The
objective of these experiments was to explore the possibility 
of in utero transmission. Nineteen progeny from a total of 58 
taken by caesarian section reached 60 months of age or more. 
There was no evidence of scrapie observed in these animals. 
Out of the nineteen survivors, nine were produced by dams 
which developed scrapie. Again, the histopathology results 
are pending. Based on clinical observations both these
experiments suggest the absence of scrapie in embryo
transferred offspring.
Another experiment (Foster et al.. 1992) which examined the 
risk of scrapie transmission via the embryo has cast some 
doubt on the previous assumption that embryos did not play a 
role in scrapie transmission. In this experiment embryos were
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collected from six donor ewes of the SIP genotype sAsA or 
sApA which were inoculated s.c. with SSBP/1 brain homogenate. 
The embryos were transferred unwashed into recipient females 
of the SIP genotype pApA (with the exception of one ewe which 
was sAsA). All donor ewes developed clinical scrapie which 
was confirmed by histopathology. All the recipient ewes 
remained free of any evidence of scrapie. Twenty-six lambs 
resulted from the transfers. Six of these died before a year 
of age from conditions unrelated to scrapie. Six of the 
remaining twenty-six offspring (all sAsA) were confirmed to 
have scrapie at approximately two years of age. The remaining 
animals (eleven sAsA and three pApA) are to date still 
healthy. The authors suggested that the infected donor ewes 
passed scrapie infection to their embryo transferred progeny 
via the embryo. Although they did not rule out the 
possibility that the pApA recipients may have harboured a 
subclinical infection and transferred the disease in utero. 
If the histopathological results from experiments carried out 
by Foote and colleagues support the clinical absence of 
scrapie from embryo transferred offspring, then additional 
experiments will be required to determine what factors have 
made the difference in allowing disease transmission in one 
study but not the other. For example, in one study (Foote et 
al.. 1986) embryos were washed three times before transfer to 
the recipient ewe; but in the other study (Foster et al., 
1992) embryos remained unwashed.
1.5.3. Relationship between the PrP gene and incubation time 
genes.
Studies of scrapie in inbred and congenic strains of mice
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(Kingsbury et al., 1983) identified I/LnJ mice as having long 
incubation periods following inoculation with, the Chandler 
scrapie isolate. I/LnJ (p7) strains of mice have incubation 
times of between 200-400 days, whilst most other mouse 
strains die within 160 days after inoculation (Carp et 
al.,1987; Carlson et al.. 1986). When mice with long 
incubation periods were crossed with a mouse strain 
(NZW/LacJ) having a short incubation period (s7, 113 ± 2
days) offspring (FI) were produced which had longer 
incubation periods (223 ± 3 days). These FI mice were
subsequently backcrossed with the short incubation mouse 
strain. Animals were produced which fell into two groups (in 
terms of incubation periods), one group having an incubation 
time of 130 ± 1 day and the other an incubation time of 195 ± 
2 days. This result is compatible with single gene control of 
scrapie incubation period. Using a hamster PrP cDNA probe, 
restriction fragment length polymorphisms (RFLPs) 
distinguised between NZW (s7) and I/Ln (p7) alleles of the 
PrP gene. Analysis of DNA from backcross animals indicated 
that the gene controlling scrapie incubation period was 
tightly linked to the PrP gene (Carlson et al., 1986). These 
experiments were confirmed by Hunter (1987) using congenic 
mice, which suggest that PrP may be the incubation gene 
product.
Further evidence that the PrP gene controls scrapie 
incubation time was provided by nucleotide sequence of the 
cDNA clones encompassing the entire ORFs of NZW/LacJ and 
I/LnJ alleles (Westaway et_al_.,1987). Two codons differed 
between the long and the short incubation time mice i.e. in
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I/LnJ (p7) the amino acid at codon 108 is changed from 
leucine to phenylalanine, and at codon 189 from threonine to 
valine. This result was shown to be consistent in other 
strains of mice with long incubation periods.
Studies in other species have shown that sequencing the PrP 
gene of patients with the human familial disease, GSS, has 
revealed two alleles, one allele has a mutation at codon 102 
causing a transition from proline in the wild-type allele to 
leucine (diseased condition). This mutation creates a Ddel 
restriction site and this polymorphism was used to 
demonstrate linkage between leucine at codon 102 and disease 
in two unrelated families , one in the UK and the other in 
the USA. Similarly in sheep, restriction fragment, length 
polymorphism analysis and codon changes have been able to 
differentiate between animals that are susceptible and those 
that are more resistant (Hunter et al., 1991; Goldmann et 
al.. 1991). In a laboratory flock of Cheviot sheep the
restriction enzymes EcoRI and Hindlll produce fragments of 
6.8kb and 3.4kb respectively in genomic DNA extracts from 
animals that are susceptible to scrapie. In animals that are 
"resistant" to scrapie 4.4kb (EcoRI) and 5.Okb (Hindlll) 
fragments are produced (Hunter et al., 1991). Sequencing
studies on sheep have shown that codon 136 can code for 
either valine or alanine. In Cheviot sheep, valine and 
glutamine at codons 136 and 171 respectively, appear to be 
associated with susceptibility to scrapie whereas alanine and 
arginine at the equivalent codons, appear to be associated 
with "resistance". Table 1.3. shows the polymorphisms within 
the coding region of PrP protein from different species and
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Table 1.3. Polymorphisms within the coding region of 
Tf'Fs linked to disease.
This table shows that in humans, mice and sheep codon 
changes and insertions within the PrP gene has been 
associated with disease susceptibility, e.g. in humans, 
a mutation changing the PrP status from homozygous to 
heterozygous at codon position 102 (proline to leucine) 
has been found in patients with familial GSS.
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their relationship to disease.
1.6. Transgenic mice.
Transgenic mice have been used to study the molecular basis 
of the species barrier and the mechanism of scrapie 
replication. Four lines of transgenic mice (Scott et al.,
1989) were produced that harboured a cosmid insert containing 
the entire Syrian hamster PrP gene, including 24 kb of 5' and 
6 kb of 3' flanking sequences. These transgenic mice 
expressed both normal mouse and normal hamster PrP. Most 
nontransgenic mice inoculated with brain homogenates derived 
from diseased hamsters failed to develop scrapie, and the 
incubation times for the few that became ill were greater 
than 600 days. In contrast all four transgenic lines that 
expressed normal hamster PrP were susceptible to scrapie. 
Each of the four transgenic lines had incubation periods 
which ranged from 47 to 277 days, when inoculated with brain 
homogenates derived from diseased hamsters (Prusiner et al.,
1990). Since Syrian hamsters normally have incubation periods 
of 75 days, the difference in incubation periods between the 
four transgenic lines reflected the number of copies of 
hamster PrP genes inserted into the mouse genome i.e 
transgenic mice with 30-50 copies of the hamster PrP gene had 
the shortest incubation period of 47 days, whereas, 
transgenic mice with less than 10 copies of the hamster PrP 
gene had incubation periods of 277 days. The expression of 
hamster PrP in transgenic mice challenged with mouse scrapie 
appeared to impede the synthesis of diseased mouse PrP. In 
nontransgenic lines, incubation periods of 128 and 148 days 
were seen, whereas in the corresponding transgenic mice, the
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higher the copy number of hamster PrP transgene the longer 
the incubation period. Consequently, transgenic mice with 
greater than 30 copies of the hamster PrP gene had incubation 
times of 194 days when challenged with brain homegenates 
derived from diseased mice while transgenic mice with less 
than 10 copies of the hamster PrP transgene had incubation 
periods of 165 days (Prusiner et al., 1990). These results
suggested that both the quantity and primary structure of 
normal PrP modulated disease susceptibility.
The source of the inoculum determined whether the transgenic 
mice produced hamster or mouse PrP as determined by type of 
lesions. For example, transgenic mice inoculated with brain 
homegenates derived from infected hamsters overwhelmingly 
produced diseased hamster PrP whilst those inoculated with 
brain homogenates derived from diseased mice produced 
modified mouse PrP. Infectious material taken from these 
hamster scrapie challenged mice were in turn as infectious 
for hamsters as the original hamster isolate. The authors 
suggested that the "species barrier" between mouse and 
hamsters most probably can be explained by the difference in 
PrP sequence between the two species, which differ at 16 of 
the 254 amino acids.
Missense and insertional mutations have been linked to the 
human encephalopathies GSS and CJD (section 1.5.3.). 
Substitution of the amino acid proline by leucine at codon 
position 102 (creating pro/leu heterozygotes) have been found 
in several families with GSS. Transgenic mice were created in 
which this leucine mutation was studied (codon 102 in humans
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corresponds to codon 101 in mice). These transgenic mice 
spontaneously developed neurologic symptoms of ataxia, 
lethargy and rigidity accompanied by spongiform degeneration 
throughout the brain (Hsaio et al., 1990). Although protease 
resistant PrP is associated with scrapie-like diseases 
(Jendroska et al., 1991)., there was no evidence that this
was the case with these transgenic mice. Preliminary studies 
suggested that the disease produced in transgenic mice can 
sometimes be transmitted by inoculation of infected brain 
tissue to Syrian hamsters (7 out of 10 hamsters succumbed to 
disease).
1.7. Bovine Spongiform Encephalopathy (BSE).
1.7.1. Clinical signs.
The original clinical description of BSE was based on the 
first six cases of TSE in cattle to be recorded (Wells et al 
., 1987). Subsequent accounts have shown that the frequency
of different clinical signs has remained constant during the 
course of the epidemic (Cranwell et al .,1988; Gilmour et 
al.. 1988; Wilesmith et al ..1988, 1991; Scott et al., 1988, 
1989; Winter et al ..1989; Wilesmith and Wells ., 1991). A
comprehensive study of 192 cattle was made by Wilesmith et 
al. (1988), and supplementary clinical data has been obtained 
from the reports of over 17,000 confirmed cases (Wilesmith et 
al., 1991). Truncation of the clinical course by euthanasia,
initially for humane and economic reasons, but later also 
because of regulatory control measures (Order, 1988), has 
inevitably limited information on features of the advanced 
disease.
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Cases of BSE show a combination of neurological and general 
signs of disease. Clinically affected animals initially 
appear apprehensive of both humans and the rest of the herd, 
and can become frenzied and nervous when confronted by 
doorways and entrances. This altered behaviour was exhibited 
by 98% of all cases. Abnormalities of posture were seen in 
93% of all cases and commonly presented as hind-limb ataxia 
with hypermetria (a swaying gait and high stepping of the 
rear legs being evident), tremors and falling. There were 
also changes associated with sensory perception (95% of 
cases), with increased reaction to sound and touch. A large 
majority of cases (87%) exhibited all the signs described 
above. This is consistent with a diffuse CNS disorder 
(Kimberlin, 1992 ).
Many of the clinical signs described for BSE also apply to 
natural infection of scrapie in sheep. However in scrapie, 
one of the two main clinical signs, pruritus (scratching) and 
inco-ordination of gait, usually emerges to dominate the 
clinical course (Palsson and Sigurdsson, 1958; Zlotnik and 
Katiyar, 1961; Palmer, 1976; Kimberlin, 1981). The most 
obvious difference between the clinical signs shown in 
scrapie and BSE was that pruritus was only occasionaly seen 
in BSE.
In addition, to the neurological disease described above 
other more general clinical signs were observed. The most 
frequent were loss of body condition (78%) , liveweight loss 
(73%) and reduced milk yield (70%). At some stage in the 
clinical course, about 79% of all cases showed at least one
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of the general signs. Nevertheless, a good appetite was 
maintained in the great majority of cases. From the earliest 
clinical signs to either slaughter or death can take from 
less than two weeks to twelve months, with the average being 
two months.
1.7.2. Geograpical distribution of BSE.
BSE was first reported in the UK, and it is only in this 
country that a large scale epidemic has occurred. The 
geographical distribution of BSE cases within the UK is shown 
in Figure 1.6. The outbreak started simultaneously in several 
parts of the country and the widespread distribution has been 
maintained (Wilesmith, 1991). Every county in Great Britain 
has seen cases of BSE. However, the regional variation in the 
occurrence of BSE is quite marked with a considerably greater 
incidence in the south of England (Wilesmith et al., 1987).
This is a reflection of variation in exposure to the 
infectious agent, which will be discussed below (section
1.7.3.).
As of November 1992, a total number of 75,569 cases have been 
confirmed on 21,806 farms (MAFF, 1992). The adult cattle 
population of Great Britain is around 4.5 million cattle. The 
current annual incidence of the disease is 1% and the 
incidence of affected dairy herds is ten times that of beef 
suckler herds. This can be explained by the different feeding 
practices adopted between the two types of herd, which, in 
turn resulted in different exposure rates to the infectious 
agent. The risk of a herd experiencing BSE is increased with 
increasing herd size irrespective of the type of herd
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Figure 1.6. Distribution of confirmed BSE cases 
throughout Great Britain.
This figure shows the north/south gradient in the 
distribution of confirmed BSE cases. The vast majority 
of cases occurred in the south where 50% of dairy herds 
in some counties had cases of BSE. This contrasts with 
the north of England and Scotland.
(map provided by J.Wilesmith. Epidemiology Unit, CVL) .
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(Wilesmith et al.. 1988). Taking these factors into account 
Wilesmith (Wilesmith et al.. 1988) computed that the crude 
difference in risk for beef suckler herds compared to dairy 
herds was reduced by fourfold. There was no evidence of any 
breed or sex predisposition.
The cumulative number of histologically confirmed cases in 
the UK and worldwide is shown in Table 1.4. Several cases of 
BSE have occurred in the Republic of Ireland (Basset and 
Sheridan, 1989). Some of these have been associated with
importations of live animals or meat and bone meal
(contaminated feed) from Great Britain. Although scrapie is 
also present in the Republic, and large amounts of meat and 
bone meal are produced there, not much is fed to Irish
cattle. Two cases of BSE have occurred in Jersey cows in the
Sultanate of Oman (Carolan et al., 1990). These animals were 
part of a consignment of 14 pregnant heifers imported from 
England in 1985. The heifers were born on the same farm in 
1983 and investigations into their feeding history suggests 
exposure to the infectious agent during calfhood. Likewise, 
BSE has occurred in the Falkland Islands in an animal 
imported from Britain.
The first case of BSE reported in continental Europe was 
reported in Switzerland in 1990 (Anon, 1990). Subsequently 
there have been other cases in Switzerland. Switzerland has a 
small sheep and goat population, and scrapie has been 
recorded in the latter.
A case of BSE in Brittany was reported by the French 
authorities in 1991 (Anon, 1991), followed by four other
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cases. A feed source of infection is suspected. Whether or 
not the infection was imported is not known; but France has 
aiarge sheep population and scrapie is endemic in several 
regions.
1.7.3. Epidemiology.
Following the recognition of BSE in 1986 (Wells et al.,
1987), the geographical distribution of the disease became 
apparent and an epidemiological study commenced in June 1987.
Results from this initial study (Wilesmith et al .,1988)
indicated that the form of the epidemic curve was typical of 
an extended common source epidemic. Although exposure to an 
infectious agent was probably the cause of BSE, it was 
important to eliminate other possibilities, particularly as 
the transmiseibility of BSE had not been demonstrated at that 
time. There was no association between the time of onset of 
BSE with the stage of pregnancy or with calender month, as 
might occur following the seasonal use of various 
pharmaceutical products or agricultural chemicals. Many 
products were specifically excluded as causes of BSE, for 
example vaccines, hormones, organophosphorus fly sprays, 
synthetic pyretbroid sprays, antihelmintics, herbicides and 
pesticides (Wilesmith, 1988).
There was no evidence that BSE had been introduced into Great 
Britain by imported cattle, semen or animal products. The 
transmission of the infectious agent from sheep to cattle via 
direct or indirect contact on affected farms was also 
precluded (Wilesmith et al., 1988).
By a process of elimination, these initial epidemiological
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findings, taken together with the clinico-pathological 
similarity of BSE and scrapie, indicated that the epidemic 
was caused by exposure of cattle to a scrapie-like agent and 
consumption of commercial cattle feedstuffs was a common 
factor. Commercial calf pellets, cow cake or protein 
supplements to home mixed rations had been fed to all cases 
for which accurate records are available (Wilesmith et al.,
1988). Two animal carcase derived products may be 
incorporated into proprietary feedstuffs: tallow, and meat
and bone meal. The balance of evidence suggested that meat 
and bone meal is the probable vehicle of infection. The first 
piece of evidence is based on the physicochemical properties 
of the scrapie agent making it more likely to partition with 
the protein fraction rather than with the lipids of tallow. 
It was mentioned previously (section 1.7.2.) that there was a 
striking north-south gradient in the occurrence of BSE, with 
the greater number of cases occurring in the south. The basis 
of this pattern was more likely to be due to the distribution 
and consumption of contaminated batches of meat and bone 
meal, which is localized to the area of production. The same 
is not true of tallow.
Support for the food-borne hypothesis comes from several 
pieces of evidence. Firstly, the occurrence of BSE was 
higher in dairy herds than beef-suckler herds (section
1.7.2.). It is usual for diary herds to be fed concentrates 
containing meat and bone meal, especially to calves during 
the first six months of life. Such feeds are rarely used for 
beef suckler calves whose food consists of milk from the dam, 
supplemented mostly by conserved forage and cereals
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(Kimberlin, 1992). About 85% of all BSE cases in beef suckler 
herds occur in purchased animals and a high proportion of 
these were cross-bred animals that were born in dairy herds 
and most likely became infected there before being sold. 
Secondly, the incidence of BSE affected herds of either type 
increases progressively with herd size (section 1.3.2.)• The 
reason for this is that the bigger the herd the more feed is 
required and the greater the chance of buying infected 
batches of feed. Thirdly, about 50% of all affected herds 
have had only one case of BSE and another 20% have had only 
two cases of BSE. These observations indicate a low average 
exposure to a source of infection outside the cattle 
population.
Outbreaks of TME in ranched mink (section 1.2.5.), involved 
the exposure of animals to an exogenous source of infection 
via contaminated feed. The same assumption has been made in 
the case of BSE , therefore, TME provides a precedent for the 
origin of BSE, although the circumstances of infection are 
different. TME involved comparatively high levels of exposure 
to untreated abattoir waste and was geographically localized. 
In contrast BSE is due to a widespread and prolonged exposure 
to very low levels of infection in processed animal waste 
(Kimberlin, 1990).
A computer-based simulation model has been constructed to 
analyse the epidemiology of BSE (Wilesmith et aT.,1988) and 
shows that exposure of the cattle population must have 
started abruptly, around the winter of 1981/82. Although both 
adults and calves had been exposed, the majority of affected
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animals were exposed as calves. Originally, the estimated 
incubation period range was from 2.5 to at least 8 years. The 
computer model predicts that during the earlier years of the 
epidemic, more and more cases will occur in older animals as 
the full effect of the incubation period distribution becomes 
manifest. This prediction has been fulfilled by the 
observation of a higher incidence of BSE in animals 5 year 
old and above in 1988 compared to 1987 (Wilesmith et al , 
1991a, 1991b). The age incidence up to 30th September 1992 is 
shown in Table 1.5. This figure shows that the incidence of 
BSE is highest in 4-5 and 5-6 year old cattle. The oldest 
recorded case was 15 years old and the youngest case 22 
months.
1.7.4. TSE in other species.
Associated temporally with the BSE epidemic, although, not 
always consistent with the oral exposure from consumption of 
contaminated feedstuffs, is the occurrence of spongiform 
encephalopathies in several species of exotic ruminants 
captive in Britain (Jeffrey and Wells 1988; Wilesmith et al., 
1988; Fleetwood and Furley 1990; Kirkwood et al., 1990, 
1992). Whilst in the majority of these cases the implication 
of contaminated feed by the oral route seems likely (animals 
born before the food ban), spongiform encephalopathies in two 
greater kudu born after the food ban have been reported 
(Kirkwood et al.. 1992; Cunningham et al.. 1993). This would 
suggest that in these cases maternal or lateral transfer of 
infection may be involved.
The first account of a TSE-like disease in cats was reported
—67 —
Table 1.5. Age incidence (%) of BSE cases.
This table shows that the incidence of BSE was highest 
in animals between 4 — 6 years of age for the years 1990 
to 1992. For example, between the ages of 4 - 5 years in 
1991, 5.34% of all animals in that age group were 
confirmed as having BSE.
(Table provided by J.Wilesmith. Epidemiology Unit, CVL)
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in May 1990 (Wyatt et al., 1990). Subsequent cases were
reported (Leggett et al.. 1990; Wyatt et al.. 1991) and up to 
February 1992 a total of 24 histopathologically confirmed 
cases were reported (MAFF, unpublished data). The incidence 
of TSE in cats is consistent with the consumption of 
contaminated feed. TSE has also been found in a captive puma 
(Willoughby et al.. 1992) altough the source of infection was 
unclear.
1.7.5. Source of infection and reasons for the occurrence of 
BSE in Great Britain.
In the previous section, evidence was provided for the 
involvement of contaminated feedstuffs in the origins of BSE. 
The inclusion of meat and bone meal in animal feedstuffs is 
not a recent event having been used as a protein source for 
several decades (Monopolies and Mergers Commission, 1985). 
The occurrence of scrapie in sheep and the inclusion of sheep 
tissues in the production of meat and bone meal are also long 
established. A survey of the rendering processes used in the 
UK (Wilesmith et al 1990) has established that, irrespective 
of the type of process employed, the maximum temperatures 
achieved were insufficient to inactivate the scrapie agent. 
Therefore, the inclusion of meat and bone meal in cattle 
rations could not in itself account for an abrupt exposure of 
cattle (in 1981/82) to a sufficient dose of infectious agent 
to result in clinical disease. The survey of rendering 
processes suggested two major changes which could have had 
important consequences in altering the exposure of cattle to 
infectious agent. Firstly, there was a move away from batch 
rendering to continuous rendering processes, and secondly the
-70-
Figure 1.7. Flow diagram of the production of meat and 
bone meal.
This diagram shows the principle steps involved in the 
production of meat and bone meal by two rendering 
processes. In 1980-1983 there was a switch away from the 
use of hydrocarbon solvents to extract fats. The use of 
live steam to remove the solvent was thought to 
inactivate the infectious agent.
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reduction in the use of hydrocarbon solvent extraction of fat 
from meat and bone meal. A flow diagram of the major steps 
involved in the rendering process is shown in Figure 1.7. The 
move away from batch processes commenced in 1972, and from 
then until the end of 1988 there was a gradual shift towards 
the continous rendering process. However, reduction in the 
use in all but two rendering plants in Scotland, of 
hydrocarbon solvent extraction of fat from meat and bone meal 
was co-incident with the estimated time that exposure of 
cattle to infection commenced. The proportion of meat and 
bone meal produced using solvent extraction was reduced by 
46% in the period 1980-1983. The use of hydrocarbon solvents 
are not thought to inactivate the infectious agents by 
themselves; but the use of steam to drive off the solvents
will have sterilizing properties. The change in the use of 
hydrocarbon solvents is currently considered to be the most
significant factor for the occurrence of BSE in Great
Britain. This would also explain the north south gradient in 
the occurrence of BSE. In Scotland, where there have been 
fewer cases of BSE, rendering plants retained the hydrocarbon 
solvent step; but the southern rendering plants all removed 
this step from their processes.
In Great Britain a change in the rendering process played a 
significant role in the origin of BSE. The apparent absence 
of BSE in other countries cannot be explained by this
argument alone. Other factors which contributed to the 
exposure of British cattle to a scrapie-like agent via meat 
and bone meal include: a large sheep population: endemic
scrapie within this sheep population and the feeding of diets
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containing meat and bone meal. Therefore, studies need to be 
carried out in other countries to investigate if the 
combination of risk factors outlined above were present. 
Epidemiological findings in Great Britain are consistent with 
two possibilities regarding the origin of the scrapie-like 
agent found in cattle (Wilesmith and Wells, 1991). The first 
suggests that cattle have experienced an increase in exposure 
to a pool of sheep scrapie agents, infection with one or more 
resulting in disease. The second suggests that BSE resulted 
from a similar increase in exposure but to a cattle adapted 
strain of a scrapie-like agent possibly generated in sporadic 
cases of an unrecognised cattle TSE. Prior to the onset of 
exposure to a food-borne scrapie-like agent, subclinical and 
perhaps a low incidence of clinical disease may have 
occurred. Such cases would probably have been in relatively 
old animals, and may therefore have been attributed 
alternative clinical diagnoses. A precedent for this latter 
hypothesis can be drawn from mouse models of scrapie (Bruce 
and Dickinson, 1988). It may be that such subclinical 
infection of cattle with a scrapie-like agent resulting in a 
very low incidence of clinical BSE may be present in other 
countries. There has been a suggestion that this may be so in 
the United States (Marsh and Hartsough, 1988) .
1.8. Aetiology of BSE.
BSE is a neurological disease producing distinctive 
microscopic lesions in the central nervous system. In this 
respect it is exactly like the other TSEs. An example of the 
characteristic vacuolation of certain grey matter areas of 
the brain produced in animals with BSE is shown in Figure
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1.8. Extracts from infected cattle brains contain abnormal 
fibrils, and examples of these are shown in Figure 1.9a. 
These abnormal fibrils are morphologically similar to the 
characteristic fibrils obtained from extracts of scrapie 
infected sheep brain. By way of a comparison Figure 1.9b. 
provides an example of scrapie associated fibrils (SAF) 
obtained from scrapie-affected sheep brain. Both sheep and 
cattle fibrils are composed of aggregated host-coded neuronal 
membrane protein, PrP.
The transmiseibility of BSE was first demonstrated in mice. A 
disease very like murine scrapie developed about 300 days 
after the combined intracerebral and intraperitoneal 
injection of brain homogenates from affected cattle (Fraser 
et al.. 1988). The same material was injected intracerebrally 
and intravenously into cattle and produced cases of BSE after 
500-600 days (Dawson et al., 1991). BSE could also be 
experimentally transmitted to pigs (Dawson et al., 1991) by
intracerebral inoculation of brain homogenates from infected 
cattle. Other studies showed that BSE could be transmitted to 
mice by feeding BSE affected cattle brain (Barlow and 
Middleton, 1990a, 1990b). These studies using the oral route 
mimiced the route of natural transmission identified by 
epidemiological studies. Direct evidence for the transmission 
of scrapie from sheep and goats to cattle, by the injection 
of infected brain, was provided by unconnected experiments 
begun in 1979 (Gibbs et al., 1990). All these experiments
show that BSE has the characteristic features of related 
TSEs i.e. similar lesions, SAFs and transmissibility of the 
disease, and is therefore caused by scrapie-like infectious
—75—
Figure 1.8a. shows a solitary tract nucleus (medulla) of 
an unaffected cow and Figure 1.8b shows vacuolation of 
grey matter neuropil in the solitary tract nucleus 
(medulla oblongata). Bar = 50um.
(photographs kindly provided by G.A.H.Wells, CVL)
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Figures 1.9a shows scrapie associated fibrils obtained 
from detergent extracts of infected cow brains
and Figure 1.9b shows scrapie associated fibrils from
detergent extracts of^ru^'einfected sheep brains.
(photographs kindly provided by M.Chaplin, E.M. Unit, CVL)
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agents after long incubation periods.
1.9. Species barrier.
During the time that cattle received a feed exposure that led 
to a major epidemic of BSE, pigs would have received an even 
greater exposure, because their diet contained higher 
inclusion rates of meat and bone meal, without any evidence 
of natural transmission of TSE. Epidemiological studies 
(Wilesmith, personal communication) have calculated that from 
the size and age structure of the breeding sow population and 
if the assumption that the effective exposure to infectious 
agent had been the same for pigs as it was for cattle then 
about 1000-2000 cases of porcine spongiform encephalopathy 
would have been seen by now. This led to the conclusion that 
the species barrier has not been breached in pigs and that 
they are less susceptible to UK strains of scrapie and BSE 
than cattle.
Similarly, there is no evidence of naturally occurring TSEs 
in chickens, but the relatively short commercial life span of 
birds may limit the value of this negative evidence. A gene 
which may be the chicken equivalent to the mammalian PrP gene 
has been discovered (Gabriel et al.. 1992) and whether or not 
this gene has any influence on disease susceptibility remains 
to be determined.
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Aims of Thesis.
The overall aim of this thesis was to study PrP genes from 
different species exposed to contaminated food sources during 
the current BSE epidemic. This was to be achieved by first 
performing restriction fragment length polymorphism analyses 
on bovine samples using some of the restriction enzymes which 
have been shown to act as disease markers in other species 
with TSE infections. Secondly, sequencing strategies were to 
be developed to sequence the PrP gene. Finally, the 
nucleotide and deduced amino acid sequences, of PrP genes 
from pig, kudu and bovines were compared to those published 
for other species.
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CHAPTER 2.
General Materials and Methods
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Introduction 2.1.
This chapter describes some of the more routine methods that 
were applied to this study. Those methods that were more 
specific to a particular piece of work are dealt with in 
their respective chapters alongside the appropriate 
experiments.
2.2.1. Extraction of Genomic DNA from Blood and Tissues.
This was achieved by using one of two procedures, each of 
which required the processing of blood and tissues in 
different ways before DNA extraction could commence. The 
first, a manual method, was utilized to extract DNA from the 
early samples and was replaced by a second automated 
procedure.
2.2.2. Manual Method.
Blood Sampling.
Whilst processing blood samples gloves and face masks were 
used throughout.
Blood samples were taken by venipuncture into heparinized 
vacutainers. It was suggested (Hunter, personal 
communication) that heparin might interfere with the optimum 
functioning of restriction enzymes, therefore, subsequent 
samples were taken in vacutainers containing EDTA as the 
anti-coagulant. Samples were centrifuged (2,000g, lOmins, 
2^C). White cells, at the interphase between the plasma and 
red cell layers were carefully aspirated and stored at -70^c 
until required.
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DNA extraction from blood.
Proteinase K (lOOpg/ml) was auto-digested in lysis buffer 
0 k 'S^/o Sarcos y c •
(5m!^ ) at 50 C for 1 hour to remove any contaminating
nucleases which might be present. Frozen white cells (from
10ml of blood), were allowed to thaw sufficiently to allow
their manipulation using a microspatula and transferred to
the reaction flask. Incubation was allowed to proceed, with
gentle shaking, for a further 3 hours. Samples were extracted
twice with an equal volume of phenol/chloroform (1:1),
centrifuging in silanized glass tubes at 8,000g for 15
minutes at 4^C. In each case the aqueous phase was carefully
aspirated avoiding thel' white precipitate at the interphase of
the organic and aqueous layers. The samples were further
extracted twice with equal volumes of chloroform/isoamyl
alcohol (24:1), removing the aqueous phase after
centrifugation. RNA was removed by incubation with pre-boiled
(lOO^C for 10 minutes) RNase A (lOOjug/ml DNA solution) at
37^C for 2 hours. Removal of RNase was achieved by digestion
with proteinase K (10pg/ml)for 15 minutes at 37^C for two
hours. Further extractions with phenol/chloroform and then
with chloroform were used to remove the proteinase K.
Finally, the DNA was precipitated by the addition of 0.1
volume of sodium acetate (3M) and 2.5 volumes of absolute
alcohol and placed at -70^C for 30 minutes. The precipitated
DNA was dissolved in T.E.(10mM Tris pH 8.0, ImM EDTA pH 8.0)
buffer (3ml) and lOOpl ethidium bromide (lOmg/ml) added
followed by solid CsCl (Ig/ml of solution). Samples were spun
in a Beckman TL100.3 rotor (152,000g, 16 hours, 20^C). The
ethidium bromide was removed by successive extractions with
- 8 4 -
butanol saturated with CsCl until the DNA solution became 
colourless. Caesium chloride and traces of butanol were 
removed either by dialysis against four changes of T.E. 
buffer or by extraction with 10 volumes of an 
isopropanol:water mixture (1:1). The concentration of the DNA 
was determined.
DNA extraction from tissues.
All manipulations involving tissue samples were carried out 
in a Class I microbiological safety cabinet. Thermal gloves 
and face masks were necessary when handling liquid nitrogen. 
Slivers of frozen tissue (l-2gj were placed in a mortar, 
pre-cooled with liquid nitrogen, and ground to a powder with 
a little liquid nitrogen. The frozen, powdered tissue, was 
added to the lysis buffer (10ml) which included auto-digested 
proteinase K a little at a time with gentle swirling of the 
incubation flask between additions. Subsequent incubations 
and extractions were as previously described for the 
extraction of DNA from leucocytes.
2.3.1. Extraction of Genomic DNA using a 340A Nucleic Acid 
Extractor.
The basic chemistries involved with the automated process 
were the same as those for the manual method i.e. proteinase 
K digestion followed by phenol/chloroform and chloroform 
extractions , isopropanol precipitation and two washes with 
80% ethanol. An RNase step was not found to be necessary as 
the isopropanol precipitation step removed about 75% of 
contaminating RNA. However, a different procedure was 
required when preparing white cells or tissues for
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extraction.
2.3.2. Preparation of Leucocyte Nuclei from Whole Blood.
Nuclei were prepared from either fresh or frozen whole blood 
for which different procedures were necessary.
Fresn 0-^^KCi, o CaCU .in o
Ice-cold balanced salt solution (BSSw,10ml) was added to an
equal volume of blood and, after mixing, 7 drops of 
lyzoglobin added (J.T.Baker) . After gentle mixing, samples 
were incubated on ice for 5 minutes. This should result in 
the lysis of cell membranes, with the solution turning ma­
genta in colour. Samples were centrifuged at 1500g for 10 
minutes at room temperature. The supernatant was carefully 
decanted and the pellet washed twice with ice-cold PBS (0.15M 
NaCl, 20mM NaP04 buffer pH 7.2) . PBS (3 ml) was added to the 
final pellet which was either stored at -70^C and used at a 
later date or loaded (1.5ml) directly onto the extractor. On 
completion of the extraction process the DNA was dissolved in 
water (1ml) . This process usually took a day as the DNA 
obtained by this process was of high molecular weight (in 
excess of 150,000 bp).
Frozen Whole Blood.
Tubes containing frozen whole blood were individually sealed 
in plastic bags and thawed quickly by placing them in a 37^C 
water. The contents of the tubes were transferred to 
universels containing an equal volume of ice cold NaCl/EDTA 
(lOmM each). After gentle mixing, the samples were 
centrifuged (l,500g for lOminutes at 20^C), the supernatant 
carefully decanted and the pellet washed twice in ice-cold
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NaCl/EDTA. The pellet was resuspended in PBS (3ml) ready for 
loading onto the extractor.The remainder of the protocol was 
as previously described.
2.3.3. Crude Tissue Nuclei from Brain or Liver.
Wet (or frozen) brain or liver tissue (0.4g) was minced and 
transferred to a cooled dounce homogenizer. The dounce of the 
homogenizer had the required clearance (0.0010-0.0030 in) for 
preparing nuclei. Ice cold PBS (5ml) was added and the tissue 
homogenized (15-20 strokes). Connective tissue was removed by 
filtering the sample through sterilized muslin. The
homogenizer was rinsed with PBS (5ml) and the washings
similarly filtered and added to the original filtrate. The 
samples were transferred to suitable centrifuge tubes and 
spun at l,500g fo 15 minutes at 4^0. The supernatant was 
carefully decanted and the pellet taken up in PBS (1.5 ml), 
ready for loading onto the extractor.
2.4.1. Concentration Determination of DNA Samples.
Two methods were used to determine the concentration of DNA 
samples. The first was a spectrophotometric method and was 
used exclusively for genomic DNA or bulk plasmid
preparations. The second was dye based (ethidium bromide)
and reserved for samples where the concentration of DNA was
likely to be less than 250 ng, e.g. sequencing template.
2.4.2. Spectrophotometer Method.
Absorbances were measured at 260 and 280 nm. The value at
260nm determined the contribution to the absorbance made by
DNA ( and RNA) and the value at 280nm the contribution made 
by proteins. By taking a 260:280 ratio the purity of the DNA
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preparation could be assessed. Values above 1.7 were 
considered to be acceptable and free from protein 
contamination.
The Philips PU8730 UV/VIS spectrophotometer used for these 
measurements has a dual wavelength feature which enabled the 
260:280 ratio to be determined automatically. The 
concentration of DNA in a sample was calculated using the 
following formula:
DNA Concentration = (O.D.260 x 50 x dilution factor) jug/ml.
2.4.3. Ethidium Bromide Method.
Ethidium bromide is a carcinogen and was handled with gloved
was
hands only. Suitable face protection^worn when exposed to UV 
irridation.
A DNA concentration gradient was constructed using salmon 
sperm DNA. Starting with a stock solution of 32pg/ml, serial 
dilutions were made in T.E. buffer. A gradient consisting of 
the following concentrations was constructed :- 
32pg/ml; 16jug/ml; 8pg/ml; 4pg/ml; 2pg/ml; l;ag/ml.
A piece of saran wrap^ was stretched over a UV 
transilluminator (in the off position) and 2ul of each of the 
DNA solutions dispensed onto it. This was followed by 
dispensing 2jil of ethidium bromide ( 2pg/ml) directly onto 
the DNA spots and the two solutions mixed by pipetting up and 
down several times. DNA samples to be measured (neat and 1/10 
dilutions) were similarly treated. The gradient and samples 
were photographed (CU5, Polaroid camera) over UV light. The 
concentration of each sample was estimated from the 
photograph by comparing the intensity of the spot produced by
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the sample with that of the gradient. An example of a DNA 
concentration gradient together with samples is shown in 
Figure 2.1.
2.5. Restriction Digestion of Genomic DNA.
A standard protocol was used for the restriction digestion of 
genomic DNA. Each enzyme had its own buffer at which optimum 
activity occurs. All the restriction enzymes except TaqI were 
incubated at 37®C. TaqI was incubated at its optimum 
temperature of 65^C.
Standard Restriction Digestion Reaction Mix.
Water )gil
Restriction Buffer (lOX) 20pl
Spermidine (lOmM) 20pl
DNA (15ug) ypl
Restriction Enzyme (75U) 7.5jil
The total incubation volume was 200ul, the amount of water 
added depended on the volume of DNA sample required to give 
15pg/sample. Samples were incubated for 4 hours at the 
optimum temperature for that enzyme. After digestion an equal 
volume of ammonium acetete (4M) was added, followed by 1ml of 
absolute alcohol. After complete mixing the samples were 
placed at -70^C for 30 minutes, followed by centrifugation 
at 12,000 g for 15 minutes. The supernatant was removed with 
a drawn out pipette and the precipitate washed twice with 
ice-cold 70% alcohol. The samples were centrifuged for 10 
minutes at 12,000 g after each of the wash steps and the 
supernatant removed with a drawn out pipette. Samples were 
dried under vacuum to remove any remaining alcohol, and
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Figure 2.1. Estimation of DNA concentration using Ethidium 
Bromide.
A DNA concentration gradient was constructed by serially
diluting a stock solution of salmon sperm DNA (lOrng/ml) .
spot 1: Ipg/ml
spot 2: 2pg/ml
spot 3: 4jag/ml
spot 4: 8pg/ml
spot 5: 16pg/ml
spot 6: 32pg/ml
Samples were spotted neat (si), diluted 1/5 (s2) and
1/20 (s3). As an example the middle spot in line s3
would have an approximate concentration of 320pg/ml.
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the precipitate taken up in 25jul of water. It was important 
at this stage to agitate the tubes gently with the fingers 
making sure that the water reached the sides of the tubes. 
This ensured that all the DNA, including any on the sides of 
the tube was taken up as well. Samples were usually left 
overnight to dissolve slowly before being electrophoresed 
through a 1% Agarose gel.
2.6.1. Agarose Gel Electrophoresis^ ,
■i'fOryi F M C J
Three different types of agarose gels^were used in this study 
depending on the desired application. To separate genomic DNA 
digests a 1% SeaKem GTG gel was used. If there was a
requirement to recover DNA samples, a 1.2% low melting 
SeaPlaque agarose gel was used. When there was a necessity to 
separate DNA differing in size by a few bases a 4% NuSieve 
GTG agarose gel was used. In all cases electrophoresis was 
carried out in submarine tanks.
2.6.2. Electrophoresis of Restriction Digests.
A 75 ml, 1% SeaKem GTG agarose gel in TBE (90mM Tris, 90mM
Boric acid, 2.5mM EDTA, pH 8.2) buffer was poured to a
( aoJL iS c ^  Oy /o C/ziv
thickness of 0.5cmy4, Loading buffer (5pl) was added to each 
sample, and after mixing, the samples were loaded and 
electrophoresed through the gel together with a separate 
track with lamha/Hindlll digest molecular weight marker, at 
constant 60V for 4 hours. The gel plus buffer were
transferred to a tray and stained for 10 minutes with
ethidium bromide ( . After viewing on a
transilluminator the gel was photographed and prepared for 
blotting onto a nitrocellulose membrane.
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2.6.3. Low Melting Agarose Gel.
The 1.2% low melting agarose gel was prepared in TAE (40mM 
Tris acetate pH 8.3, 20mM sodium acetate, ImM EDTA) buffer. 
Preliminary work suggested that the percentage recovery of 
DNA was substantially higher from TAE gels than from TBE 
gels. The ethidium bromide was included in the gel because 
these gels are more fragile and can disintegrate when stained 
post electrophoresis. The sample loading, and electrophoresis 
running conditions were identical to those used above. DNA 
bands were cut out of the gel ready for subsequent 
extraction. This was achieved by using a separate sterilized 
scalpel for each sample and performing the task as quickly as 
possible in order to minimize 'nicking' the DNA.
2.6.4. Nusieve GTG Agarose Gels.
NuSieve GTG gels can .separate DNA fragments differing in 
size by only a few bases, providing the fragments are less 
than Ikb in size. The gel was made by first measuring the 
appropriate quantity of TBE buffer into a conical flask, then 
gently floating the required amount of agarose (4%) on top of 
the buffer. Failure to follow this procedure with this type 
of agarose results in undissolved clumps. The agarose was 
then melted by heating in a water bath at 70^C, ethidium 
bromide was added to the gel before pouring, and 
electrophoresis allowed to proceed at a constant 50V for 4 
hours. A 100 bp ladder was included in each run. On 
completion of the run the gel was viewed and photographed.
2.7. Southern Blotting.
Transfer of DNA to nitrocellulose was based on the method of
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Southern (1975). After the DNA samples were electrophoresed
through a 1% agarose gel, stained and photographed, the gel
was immersed in HCL (0.25M) and gently shaken for seven and a
half minutes at room temperature. The acid depurinates the
DNA by hydrolysing the phosphodiester backbone breaking the
DNA into smaller pieces thereby, facilitating the transfer of
C p H 19 j Schleyic/i^r andScAccUQ 
larger fragments of DNA onto nitrocellulos^^at a subsequent
stage. The acid was decanted and the gel washed in water
before immersion in 0.5M NaOH/1.5 M NaCl for 1 hour at room
temperature, with constant shaking. The NaOH solution was
decanted and the gel washed in water before a final immersion
in neutralizing buffer (IM Tris/HC^/1.5 M NaCl, pH 7.4) for 1
hour at room temperature with constant shaking. The
neutralizing buffer was decanted and the DNA in the gel
transferred to pre-treated nitrocellulose (soaked in 6x SSPE
buffer) by capillary action using 20 x SSPE (3.6M Na Cl,
200mM NaH2P04, 20mM EDTA, pH 7.4) as the transfer medium.
Blotting was allowed to proceed for 18 hours. The
nitrocellulose filter was air dried for 30 minutes,
sandwiched between two sheets of filter paper and baked in an
oven at 80^C for 2 hours. The membranes were now ready for
pre-hybridization.
2.8.1. Pre-Hybridization and Hybridization.
Pre-hybridization and hybridization was achieved by using two 
different procedures. Both procedures employed exactly the 
same reagents but in one a plastic bag and shaking water 
bath was used to carry out the process and the other utilized 
glass bottles placed in an oven. The former procedure was 
used for the earlier experiments and was rep feed by the
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latter which offered greater convenience and increased
capacity. The same solution (6 x SSPE, 0.5% SDS, 5 x
Ip v rS o o ml 0-5^ Fi’cctL, 0 p o L y v in y i  p y r r o C f H O r i e / o  Sc^
Denhardt's solution/^ lOOpg/ml denatured salmon sperm DNA) was 
used for both pre-hybridization and hybridization except that 
the latter in addition to the other reagents included 
radiolabelled probe DNA (8ng/ml hybridization fluid).
2.8.2. Hybridization using plastic bags.
Pre-hybridization was achieved by floating the baked filter 
on 6 X SSPE buffer to wet it from below. The filter was
placed in a plastic hybridization bag and hybridization fluid 
added (10 ml for a 10cm x 15cm filter). As much of the air as 
possible was removed from the bag before sealing. The 
hybridization bag was placed in a sandwich box which in turn 
was placed in a shaking water bath held at 42^C. 
Pre-hybridization was allowed to proceed for a minimum of 2 
hours. A corner of the filter bag was cut away and the 
hybridization fluid drained and replaced with an equivalent 
amount of fresh fluid. Labelled probe (^^-P radio-labelled 
hamster or bovine PrP DNA) at a concentration of 8ng/ml was
carefully added to the bag. It was important that this
procedure was carried out behind a perspex safety screen. 
The air was removed from the bag and the corner sealed. The 
bag contents were mixed thoroughly and hybridization allowed 
to proceed for a further 18 hours at 37^C. After 
hybridization the contents of the bag was emptied behind the 
safety screen into perspex containers. The membrane was 
washed for 5 minutes with an excess (200ml) of washing fluid 
1 (2 X SSPE, 0.1%SDS) pre-heated to 60®C. This wash step was 
repeated twice more. This was followed by two washes in an
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excess (200ml) of washing fluid 2 (0.1 x SSPE, 0.1%SDS) 
pre-heated to 65°C. Each of these washes lasting for a 
minimum of 45 minutes. The membrane was blotted onto 
filterpaper to remove excess liquid then placed onto a fresh 
piece of filter paper, sealed in saran wrap ready for 
autoradiography. The filter was not allowed to dry out in 
case re-probing was required.
2.8.3. Hybridization Oven Method.
Wetting of filters was the same as the procedure used above. 
The filter was sandwiched between two pieces of nylon mesh 
(2cm larger than the membrane). The membrane sandwich was 
rolled up and placed in a hybridization bottle together with 
30mi of 10 X SSPE. After capping, the bottle was slowly 
rocked to unfurl the membrane sandwich. The SSPE solution was 
decanted and replaced with 6ml of hybridization fluid. 
Pre-hybridization was allowed to proceed for at least 2 hours 
at 42^C in a hybridization oven. Radio-labelled probe 
(8ng/ml) was added to the pre-hybridized membranes by 
pipetting directly into the fluid at the bottom of the bottle 
avoiding any part of the membrane (this prevented local 
"hotspots"). After mixing the bottles were placed back in the 
oven and hybridization allowed to proceed for 18 hours at 
37^C. After hybridization the radioactive fluid was drained 
into a safe container and the membranes washed as previously 
described ( bag method) except that all washings were carried 
out in the bottles themselves.
2.9.1. Radio-labelled Probes.
Important Safetv Aspects;-
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1. All work with radioactivity took place with the 
radioactive source placed behind a perspex shield and with 
the operator wearing two sets of gloves.
2. All radioactive liquid waste was poured into perspex 
containers until disposed under the local safety rules.
3. All radioactive solid waste (gloves, membranes, tubes 
etc.) were placed in correctly labelled sharpesafe containers 
until disposed under the local safety rules.
4. After work with the radioactivity was completed, the 
operator should scan himself, the immediate surroundings and 
any equipment used. His/Her actions were recorded in the 
safety logbook.
2.9.2. Probe Preparation.
In the early experiments a cDNA Hamster probe was used. This
probe was 974 bp long and covered the whole of PrP coding
region. Later experiments used a Bovine DNA probe. This probe 
was 918 bp long and also covered the whole of the PrP coding 
region.
An Amersham multiprime labelling kit was used. This kit is 
based on the random primer method of Feinberg and Vogelstein 
(1983). The DNA was denatured by boiling in a water bath for 
10 minutes and then rapidly cooled on ice. A 1.5ml Eppendorf 
tube was placed on ice and the following additions made in 
the order stated
denatured DNA (50 ng) 2^1
nucleotide mix 20^1
primer solution 20pl
water 54pl
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32p-dCTP 0^  ^T£(yj/^FnoO lOjul
Klenow enzyme (4 a) 4pl
The total incubation volume was lOOul. After thorough mixing 
the tube was spun briefly to bring the contents down and the 
reaction allowed to proceed behind a safety screen at room 
temperature for 3 hours. The radiolabelled probe was 
separated from free nucleotides using a Nick (Pharmacia G50 ) 
column. The column was equilibrated by running 3ml of T.E. 
buffer through it. The radiolabelled probe mix (lOOpl ) was 
run into the column followed by T.E. buffer (400pl ). A
further 400pl of T.E. buffer was added to the column and the
eluted probe collected in a 1.5 ml Eppendorf containing 2ul
CU-o/^ 9 ; 3 oC/Ar iM
glycogen/^ and 40jul 3M sodium acetate (pH 5.2). Absolute 
alcohol (iml) was added to the tube and after thorough mixing 
the tube was placed in a lead pot which was left in a -70^C 
freezer for 30 minutes. The tube was centrifuged at 12,000 g 
for 15 minutes and the supernatant carefully removed with a 
drawn out pipette. The precipitate was washed with 80% 
alcohol. A plug of cotton wool was placed in the top of the 
Eppendorf and the tube sealed with a piece of parafilm. Holes 
were made in the parafilm which allowed the contents of the 
tube to be dried under vacuum. The parafilm and cotton wool 
were removed and the precipitate taken up in 50ul of water. 
The probe was denatured by heating in a boiling water bath 
for 10 minutes then quickly chilled on ice. The probe was now 
ready to be added to the hybridization fluid.
2•10• Autoradiography•
Prior to the setting up of the autoradiograph, the membrane
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was scanned to provide a rough estimate of the strength of 
the radioactive signal. This determined the length of 
exposure of the film to the membrane. All subsequent steps 
were carried out in a darkroom. The previously prepared
nitrocellulose membrane was placed in a cassette and covered
(X/fg- 2.  ^/COJiftK)
with X-ray film! sandwiched between two Cronex amplification
C3>i^?onO
screens^, The cassette was sealed, then put inside a black 
dustbin bag and placed in a -70^C freezer for 2-5 days. After 
a suitable exposure time the film was developed in a darkroom 
using the recommended developer and fixer. The autoradiograph 
was washed thoroughly in tap water and air dried.
2.11. Cell Culture.
Two strains of E.Coli cells were maintained. The hamster PrP 
probe used in some of these experiments (pEA974) was a gift 
from 0r .N.Robakis. This fragment was inserted into the 
plasmid pBR322 and supplied in this form. The plasmid was 
transformed into E.Coli HBlOl c e l l s .
The bovine PrP gene was cloned into the plasmid Bluescript 
KS+/\and subsequently transformed into DH5 alpha cells.
ffo*- /  C ’ t r - y p t o n e . /■5‘f j t c j f t r r a c t s ^
Both strains were plated onto LB agar^plates for routine use. 
Cells containing plasmids were similarly treated except for 
the inclusion of the antibiotic ampicillin (lOOug/ml).
Long term storage of both strains was achieved by 
inoculating LB broth^ (10ml) with a single colony and growing 
overnight at 37^0. Overnight culture (8.5ml) was transferred 
to a sterile universal containing sterile glycerol (1.5ml). 
The contents of the universal were mixed thoroughly by 
vortexing. The glycerinated cultures were stored at -70^C.
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The same procedure was used for cells containing plasmids 
except that the growth medium contained ampicillin 
(lOOpg/ml).
2.12.1. small Scale Plasmid Preparation.
Small scale plasmid preparations were used routinely for the
screening of clones and when small amounts of plasmids were
required. The protocol used was a modification of the method
developed by Birnboim and Doly (1979)• 1ml of an overnight
culture of E.Coli containing the required plasmid was
pelleted in a 1.5 ml Eppendorf tube. The pellet was
resuspended in lOOjul of lysis solution (20 mg/ml lysozyme in
25% sucrose, 0.05M Tris/HCl pH 8.0) by vortexing briefly. The
suspended cells were stored at O^c for 30 minutes. 200 p.1 of
freshly prepared alkaline SDS( 1% w/v SDS in 0.2M sodium
and
hydroxide) was added, vortexed briefly/\left on ice for a 
further 5 minutes. 150 ul of 3M sodium acetate (pH 4.8) was 
then added, vortexed briefly, and placed on ice for 60 
minutes. The samples were centrifuged at 12,000 g for 15 
minutes to pellet proteins and cellular debris. The 
supernatant (400pl) was transferred to a fresh tube and an 
equal volume of isopropanol added. After thorough mixing the 
samples were left at room temperature for 5 minutes. The DNA 
was pelleted by centrifuging at 12,000 g for 5 minutes. The 
supernatant was removed with a drawn out pipette and the 
pellet washed twice with ice-cold 70% alcohol. The DNA could 
be used at this stage if required. If long term storage was 
desired then TEN buffer (lOmM Tris pH 8.0, lOOmM NaCl, ImM 
EDTA pH 8.0) was added (300pl) to the precipitate followed by 
300ul phenol (equilibrated by adding 0.1% hydroxyquinoline
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followed by IM Tris/HCl pH 8.0, after mixing the aqueous 
phase was removed and the phenol repeatedly extracted with 
O.IM Tris/HCl pH 8.0 until the pH of the phenol was greater 
than 7.8) and lastly chloroform (300pl), with brief vortexing 
after each addition. The samples were spun at 12,000 g for 5 
minutes. The aqueous layer (250pl) was removed carefully and 
transferred to a fresh tube. After the addition of 3M sodium 
acetate (25pl) and absolute alcohol (725jal), the contents of 
the tube were mixed thoroughly and the tubes left at -70°c 
for 30 minutes. The DNA was pelleted by spinning at 12,000 g 
for 15 minutes, and the supernatamt removed with a drawn out 
pipette. The pellet was washed twice with ice cold 70% 
alcohol, dried under vacuum and finally taken up in T.E. 
buffer (50pl) containing RNase A (Ipg/ml).
2.12.2. Large scale Preparation.
Large scale plasmid preparations were used principally to 
isolate relatively large amounts of cloned PrP for use either 
as a hybridization probe or for sequencing. The method used 
took three days to complete.
A suitable colony was picked from an L.agar plate and 
inoculated into L.broth (10ml) containing ampicillin 
(lOOpg/ml) . The culture was grown overnight at 37^C in a 
shaking incubator. Overnight culture (0.4ml) was inoculated 
into 200ml of L.broth containing ampicillin (lOO^g/ml). The 
culture was grown overnight at 37^C with vigorous shaking. If 
the plasmid could be amplified (pBR322) then chloramphenicol 
(170pg/ml) was added when the culture reached an O.D. of 0.65 
- 0.90. The cells were harvested by centrifuging at 4,000g
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(Sorvall GSA rotor) for 10 minutes at 4^C. The supernatant 
was carefully decanted. The last traces of supernatant was 
removed using a bent Pasteur pipette. Freshly prepared 
lysozyme/lysis buffer solution ( 0.4ml of 6mg lysozyme in a 
solution containing 50mM glucose, lOmM EDTA, 25mM Tris/Hcl pH 
8.0) was added . The cells were gently resuspended in the 
lysis solution using a Pasteur pipette and left on ice for 10 
minutes. Alkaline SDS solution (8ml, 0.2M NaOH, 1%SDS) was
added, the contents shaken gently to mix then left on ice for 
a further 10 minutes. The suspension was transferred to a 
50ml Oak Kidge centrifuge tube. An addition of 4ml of 3M 
sodium acetate (pH 4.8) was made to the viscous solution, 
vortexed, then left on ice for 30 minutes. A white 
precipitate should form at this stage. Samples were 
centrifuged in a Sorvall SS—34 rotor (33,000g, 10 min, 4 C). 
The supernatant was decanted very carefully into another oak 
ridge pot taking care not to disturb the precipitate. 
Iso-propanol (0.6 volumes) was added to the supernatant, 
mixed thoroughly, then left at room temperature for 5 
minutes. Samples were centrifuged in an SS-34 rotor (20,000g 
, lOmin, 4®C). The supernatant was decanted carefully, 
removing any residual liquid with a Pasteur pipette. The 
pellet was dried under vacuum and then dissolved in 6.5ml of 
T.E. buffer, and ethidium bromide (soCfA^ jntC) added to the 
solution. Ig of Caesium chloride was added for every 1ml of 
solution giving a density of 1.6^ml. The tubes were capped 
and placed on a spiromix until the caesium chloride has 
dissolved completely. This was important as crystals of 
undissolved caesium chloride could eat their way through the
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plastic centrifuge tubes. The DNA/CsCl solution was 
transferred to a Beckman fi^ uick j.eal centrifuge tube using a 
16 gauge needle. The tubes were sealed and centrifuged in a 
Beckman TL-100.3 rotor (Beckman TL-100 centrifuge), at 
271,000g for 18 hours at 20^C. The lower band, containing 
intact circular plasmid, was removed using a syringe attached 
to a 21 gauge needle and transferred to a 2ml Eppendorf tube. 
The ethidium bromide was removed by successive extractions 
with butanol saturated with CsCl until the DNA solution 
became colourless. Caesium chloride and traces of butanol 
were removed either by dialysis against four changes of T.E. 
buffer or by extraction with 10 volumes of an 
isopropanol;water mixture (1:1). The isopropanol/water 
mixture was added to the DNA sample and after thorough mixing 
the tubes were incubated at room temperature for 15 minutes. 
The DNA was pelleted by centrifuing at 12,000g for 15 
minutes. The supernatant was removed with a drawn out pipette 
and the precipitate washed twice with 70% ethanol. The 
precipitate was dried under vacuum, then dissolved in T.E. 
buffer (usually 1ml).
2.13.1. Extraction of DNA from Agarose Gels.
There were numerous occassions when it was necessary to clean
up or isolate a DNA fragment e.g. for cloning and sequences
purposes. The best results, with acceptable yields, were
point agarose
achieved by electrophoresis through a low meltingA gel 
followed by extraction from the gel. Several methods were 
used to extract DNA from gels and found to be acceptable; but 
as this study progressed newer techniques became available 
and when they offered advantages over original techniques,
-103-
they replaced them. Experimentation with the various 
techniques (chapter 6) showed that in all cases the use of 
TAE as an electrophoresis buffer gave far higher yields than 
a TBE based buffer.
2.13.2. Phenol/Chlorofom Method.
This technique was used in the early experiments to isolate 
PrP probe DNA. The band of interest was excised from the gel 
and placed in a 1.5 ml Eppendorf tube. An equal volume of
T.E. buffer was added to the gel slice. The gel was melted by
placing in a water bath held at 70^C. An equal volume of
phenol was added to the molten gel and after thorough mixing 
the phases were separated by centrifuging at 12,000 g for 10 
minutes. The upper aqueous phase was transferred to a fresh 
tube avoiding the precipitated agarose at the interphase. A 
similar volume of phenol/chloroform (70/30) was added to the 
aqueous phase and after thorough mixing the phases were again 
separated by centrifugation. The upper aqueous phase was 
transferred to a fresh tube ready for the final extraction 
with an equal volume of chloroform:iso amyl alcohol (24:1). 
The phases were mixed and after centrifuging the upper
aqueous phase transferred to a fresh tube. The DNA was 
precipitated by the addition of 3M sodium acetate (pH 5.2, 
0.1 volume) followed by 2.5 volumes of absolute alcohol. 
After thorough mixing the samples were placed at -70^C for 30 
minutes. The samples were spun at 12,000 g for 15 minutes and 
the supernatant removed with a drawn out pasteur pipette. The 
precipitate was washed twice with 70% alcohol, dried under 
vacuum and finally taken up in an appropriate volume of T.E. 
buffer or water.
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2.13.3. Prepagene.
Prepagene was supplied as a kit (Bio-Rad)• It was found to be 
particularly useful for the isolation of both PrP and vector 
before cloning. The basic operation involved the 
solubilization of the agarose gel slice with sodium iodide. 
The DNA present was bound onto a silica matrix. After washing 
away unwanted components, the DNA was released from the 
matrix with an elution buffer.
2.13.4. Magic PCR Preps System.
The Magic PCR Preps System was supplied as a kit (Promega). 
It formed part of a group of methods that were investigated 
in order to assess which of them consistently gave the best 
results in terms of quality and yield of sequencing template. 
All components described here were supplied as part of the 
kit. The desired gel slice was melted by heating to 70^C. 
Resin was added to the molten gel and after thorough mixing, 
was filtered through a magic minicolumn. The column was 
washed with 70% iso-propanol. The column was placed in a 
1.5ml eppendorf and spun at 12,000g for 20 seconds to remove 
excess iso-propanol. The bound DNA was eluted by adding 
water, waiting 1 minute and repeating the centrifugation 
step.
2.13.5. Gelase.
Gelase is an enzyme which digests agarose. The method was 
found to give excellent results with DNA used for sequencing. 
The gel slices were melted at 70^C. Gelase buffer was added 
to the molten agarose, and after thorough mixing, the tubes 
were transferred to a water bath (45^C). After the contents
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of the tube equilibrated to 45^C, gelase (lU, supplied by 
Cambio) was added, the contents mixed, and incubation
continued overnight. It was important to mix the contents of 
the tube periodically to ensure that any gel bound to the 
sides of the tube was dislodged, thus allowing access to the 
enzyme. An equal volume of 5M ammonium acetate was added, the 
contents mixed, and 2 volumes (total volume) of absolute 
alcohol added to precipitate the DNA. The digested agarose 
remained in solution. The precipitated DNA was washed twice 
with 80% alcohol, dried, and taken up in water.
2.14.1. Ligation.
The purified cut vector and the purified PrP gene fragment 
were mixed together then extracted again using the 
Prep-A-Gene kit (Bio-Rad). It was found that by carrying out 
this stage the efficiency of ligation was improved markedly. 
Ligation reaction:
PrP gene/ vector lOpl
ligation buffer ( 3TX) 3pl
water Ipl
T4 DNA ligase (1U,3<?0 Ipl
The ligation reaction was allowed to proceed overnight at 
room temperature (21^C). Cut vector was used as a ligation 
control.
2.14.2. Preparation of Competent Cells.
A single colony of DH5 alpha cells was picked from a LB agar 
plate and inoculated into 10 ml of L.Broth. The culture was 
grown overnight at 37®C in a shaking incubator. The next day 
0.4 ml of culture was inoculated into 40 ml of L.Broth . This
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was grown at 37^C with shaking for 2 hours. The absorbance of 
the culture at 550nm was measured. An absorbance of 0.5 O.D. 
units was desired for competent cell preparation. The cells 
were pelleted in a pre-cooled Sorvall rotor at 4000g for 10 
minutes. The pellet was carefully resuspended in 20 ml of 
ice-cold calcium chloride (50mM) and left on ice for 30 
minutes. The cells were again pelleted at the speed and 
temperature described above. This time the pellet was 
resuspended in 4 ml of ice-cold calcium chloride. The cells 
were treated very gently at this stage as they were very 
fragile.
2.14.3. Transformation.
Ligation mixture (1.5pL) was made up to 50pl with T.E. buffer 
and added to lOOul of competent cells, placed in a pre-cooled 
eppendorfj\. After very gentle mixing the tubes were left on 
ice for 40 minutes. Cells were heat-shocked at 42^0 for 3 
minutes, then left at room temperature for 10 minutes. The 
contents of the Eppendorf tube were transferred to a sterile 
bijou containing 1 ml of SOC medium (per litre: 20g
bacto-tryptone, 5g bacto-yeast extract, O.Sg NaCl, 20mM 
sucrose, pH 7.0). The bijou was shaken at 37^C for 60 
minutes. 0.2 ml of cell culture was plated onto L.Agar plates
A4
containing ampicillin (lOOpg/ml) and X-gal (20/ml). Control 
plates testing for ligation and transformation efficiency 
were also set up. The agar plates were incubated overnight in 
a 37^C incubator.
2.15.1. Sequencing Protocols.
In this study two different sequencing protocols were used.
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The first protocol, a manual method using a Sequenase kit 
(United States Biochemicals), was used for the sequencing of 
PrP genes cloned into the plasmid vectors. The second 
protocol was based on a "cycle sequencing " method and was 
used to sequence PCR amplified PrP templates directly using 
an automated sequencer.
2.15.2. Manual Method.
The manual protocol is based on the didoxy method of Sangergfo^ 
(1977) and uses the enzyme sequenase for primer extension. 
Although the bovine PrP fragment was cloned into a plasmid 
vector the decision was made to sequence double stranded DNA 
rather than produce single strands. The reason for this 
decision was that both strands of the PrP gene were to be 
sequenced, and it was easier to denature large amounts of 
double stranded DNA than to produce two single stranded 
templates. It was found that better sequencing results were 
obtained when the template was denatured using NaOH rather 
than heat alone. The DNA was denatured in 0.2M NaOH, 0.2mM 
EDTA (30 minutes at 37®C). The mixture was neutralized by 
adding 0.1 volumes of 3M sodium acetate (pH 5.2) and the DNA 
precipitated with 2.5 volumes of absolute alcohol (-70^C, 15
minutes). The precipitate was washed with 70% alcohol and 
dried under vacuum. The pellet was dissolved in a suitable 
amount of water.
The DNA was annealed to the relevant primer by mixing the 
primer, reaction buffer and DNA together before heating to 
65^C for 2 minutes. The temperature of the tube was allowed 
to cool slowly to room temperature by placing it in a beaker
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(2.00 m I)
of 65^C watei^lplaced on a bench. The sequencing reaction mix 
contained :-
DNA template - Primer lO.Opl
(5 f> mo Lts)
DTT (O.IM) l.Opl
Diluted labelling mix 2.0pl
[^^S]-dATP (51 riylmmoO O.Sjil
Diluted sequenase (1:8) 2.0pl
After thorough mixing the tubes were incubated at room 
temperature for 3 minutes, then aliquots (3,5>il) were 
transferred to pre-warmed (37^C) tubes containing one, of 
each of the four dideoxy terminators. The contents of the 
tubes were mixed thoroughly and incubation continued for 
further 4 minutes. Stop solution (4pl) was added to each 
tube, mixed thoroughly, then stored on ice until required. 
Before loading onto a gel the samples were heated to 80^C. 
Usually 2-3ul were loaded per lane.
2.15.3. Automated Protocol.
The automated protocol is a fluorescent-based dideoxy 
method, for which a dye terminator kit (Applied Biosystems) 
was used. This method employs the enzyme Amplitaq (Perkin 
Elmer) for primer extension. First, a reaction premix was 
prepared by mixing reaction buffer, dNTPS, dideoxy 
terminators and Amplitaq polymerase. The contents of the 
sequencing reaction tube is as follows :- 
Reaction premix 9.5pl
ds DNA template (300ng) S.Opl
primer (3.2 pmol) l.Opl
water xpl
Final volume 2 Opl
—109—
After mixing the contents of each tube and overlaying with 
mineral oil the tubes were placed in a thermal cycler 
preheated to 96^C. The sequencing cycling parameters were as 
follows :-
Dénaturation : 96^C for 30 seconds.
Annealing temperature : 50^C for 15 seconds.
Extension temperature : 60^C for 4 minutes.
A total of 25 cycles were run. The samples were held at 4®C 
after the last cycle. Samples were cleaned by extracting 
twice with phenol/chloroform, twice with chloroform 
collecting the aqueous phase after centrifugation at 12,000g 
for 5 minutes. The sequencing product was precipitated by the 
addition of 0.1 volume of 2M sodium acetate and 2 volumes of 
absolute alcohol. The product was collected by centrifugation 
at I2,000g for 15 minutes, and washed twice with 80% alcohol, 
then dried briefly. Before loading onto the sequencing gel, 
the residue was dissolved in 4ul of fo^oi^^de/EDT^ pH 8.0, 
heated to 90°C for 2 minutes then rapidly cooled on ice.
2.16.1. Sequencing Gel Electrophoresis.
Sequencing reactions were analysed by electrophoresis through
CA/dftonciL Diagnostics)
6% polyacrylamide/urea gels^. This gel composition was used 
for both manual and automated sequencing. It was important, 
particularly in the case of automated sequencing that the 
highest quality reagents were used to make the gel. 
Impurities in the reagents were found to introduce spurious 
flares which interfered with genuine peaks.
2.16.2. Manual Sequencing.
C^5om ^  Cm)
Wedge gels)were cast which tapered from 0.1mm - 4mm. Wells
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were cast using sharks-tooth combs and the gel pre-run for 30 
minutes at 55W. This pre-run was necessary for raising the 
temperature of the gel to between 50 - 55^C, thus ensuring 
that re-annealing of DNA did not take place during the run. 
Sequencing samples (3pl) were loaded per lane and 
electrophoresis re-started at 55W till the end of the run. 
The gel was fixed in acetic acid, dried , then set up for 
autoradiography.
2.16.3. Automated Sequencing.
i  cm  ^
After casting/\^ gels were pre-run for 30 minutes. This not 
only performed the function of raising the temperature but 
provided the opportunity for gel quality to be assessed. If 
any flares were observed the gel was abandoned, and a new one 
cast after the glass plates had been cleaned thoroughly. 
Sequencing samples (3pl) were loaded and the gel run at 33W 
four 14 hours. After 30 minutes the data collection system 
was triggered.
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CHAPTER 3.
PrP Restriction Fragment Length Polymorphisms Within the 
Bovine Genome
-112-
3.1. Summary.
Bovine genomic DNA was extracted from 60 cattle and digested 
with some of the restriction enzymes which have identified 
PrP restriction fragment length polymorphisms in other 
species. Six out of the seven enzymes used failed to identify 
any PrP polymorphisms in or around the bovine PrP gene. The 
seventh enzyme, PvuII, identified a bovine PrP polymorphism 
but there was no evidence that this polymorphism was linked 
to disease susceptibility.
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3.2. introduction.
Scrapie associated fibrils (SAFs) have been detected in 
detergent extracts of affected brain from all species 
affected by scrapie-like diseases (Mer^ et al.. 1981 and 
Merz et al.. 1983.). The demonstration that similar extracts 
of BSE affected brains also contained these characteristic 
fibrils (Hope et al..19881 provided further evidence of the 
link between this new cattle disease and the other 
Transmissible Spongiform Encephalopathies (TSE). BSE fibrils, 
like those from the other TSEs contain the neuronal membrane 
protein, PrP. PrP co-purifies with infectivity in extracts of 
TSE-affected brain (Prusiner et al.. 1982; Bolton et al., 
1982; McKinley et al.. 1982; Hope et al.. 1986; Turk et al., 
1988 and Safar et al., 1990), is coded for by a cellular gene
the PrP gene (Easier et al.. 1986). The PrP gene is highly
conserved being found not only in all the mammalian species 
studied to date but also in diverse species such as the fruit 
fly (Westaway and Prusiner., 1986).
Independent of the studies which identified the PrP gene, 
earlier classical genetic studies of scrapie in mice and 
sheep revealed the presence of a single gene which controlled 
the incubation period of this disease (Dickinson and 
MacKay,1964). This incubation period gene was designated 
"Sine" in mice and "Sip" in sheep. The incubation period gene 
has two alleles designated s7 and p7 in mice, and sA and pA
in sheep - where the s and p refer to short and prolonged
incubation periods respectively and the number 7 and letter A
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to the type strain of scrapie. Subsequent molecular genetic 
studies in mice (Carlson et al.. 1986; Hunter et al., 1987) 
and sheep (Hunter et al.. 1989) revealed that mutations in
and around the PrP gene were linked to the Sine and Sip
alleles. These mutations could be detected by restriction 
fragment length polymorphism (RFLPs) assays using several 
different restriction enzymes.
Carlsone^<1986), working with the inbred I/LnJ mouse strain 
(long incubations- 200 to 385 days) and NZW/LacJ (short 
incubations- 113 ±2.8 days) showed that FI hybrid mice had
incubation times of 223 + 2.8 days. Therefore longer
incubation times were dominant. Incubation periods in the 
backcross progeny of ( NZW/LacJ x I/LnJ )FI x NZW/LacJ 
segregated into two groups, 64 mice having incubation times 
of 130 ± 1.1 days and 66 mice with incubation times of 190 ±
1.9 days. These results indicate single gene control. 
Furthermore, restriction fragment length analysis using the 
enzyme Xbal and subsequent hybridization with a cDNA hamster 
probe showed that NZW/LacJ and 20 other strains identified 
with a 3.8kb fragment. I/LnJ mice and 3 others identified 
with a 5.5 kb fragment. These results were confirmed by 
Hunter (1987) using VM strains of mice congenic for the 
incubation period gene i.e. VM (Sine p7) and VM congenic 
(Sine s7). VM congenic (Sine s7) identified with a 3.8 kb 
Xbal restriction fragment and VM (Sine p7) identified with a 
5.5 kb fragment. VM (Sine s7) x VM(Sinc p7) mice had both 3.8 
kb and 5.5 kb fragments (Fig.3.1.). RFLP studies in sheep 
using the restriction enzymes EcoRI and Hindlll also revealed
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Figure 3.1.RFLP analysis of mouse DNA using Xbal (based 
on Hunter et al..1987).
The link between the mouse PrP gene and the mouse 
incubation period gene (Sine) was demonstrated by 
digesting mouse genomic DNA with the restriction enzyme 
Xbal, and after Southern blotting hybridizing to a 
hamster PrP probe.
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the link between the PrP gene and the incubation period gene. 
Sip (pApA) identified with a S.Okb Hindlll fragment and Sip 
(sAsA) a 3.4kb fragment. Heterozygotes (sApA) had both 
fragments. Similarly, with EcoRI sAsA identified with a 6.8kb 
fragment, pApA with a 4_kb fragment and heterozygotes had 
both fragments. RFLP analyses in humans also revealed the 
existence of polymorphisms in some of the human 
encephalopathies (GSS and CJD). The enzymes identifying these 
polymorphisms were PvuII and Ddel (Hsaio et al., 1989).
Identification of the incubation period gene and its link to 
the PrP gene was possible in mice because of the existence of 
inbred strains and the relatively short lifespan of the 
mouse. The work in sheep was facilitated by breeding lines of 
sheep which differed in their susceptibility to scrapie.
These sheep lines were started in 1961. As yet no bovine
equivalent of the incubation period gene has been found. The 
existence of an incubation gene may eventually be identified 
by experiments in which cattle can be selected based on their 
differing susceptibilities to infection with BSE, but this 
would take many years.
A faster route might be the identification of polymorphisms 
in or near the bovine PrP gene. Two approaches were
considered. The first was to use several different
restriction enzymes and to search for polymorphisms by 
probing Southern blots. The second approach was to sequence 
the coding region of the PrP gene and identify restriction 
sites which may generate polymorphisms.
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The empirical restriction enzyme approach was chosen in the
first instance. As the PrP is a highly conserved gene i.e.
( nucCùûtydC')
there is an 85% homolg^^ between hamster, sheep and human PrP 
genes, it was decided to use the same restriction enzymes 
which had identified polymorphisms in mice, sheep and humans.
3.3. Experimental Work.
All basic methods used in this chapter are described in 
chapter 2. Any variations to basic methodologies are 
described where appropriate.
3.4.1. Choice of Samples.
As yet there are no lines of cattle segregated on the basis 
of their susceptibility to B.S.E. Therefore, unclotted blood 
samples were taken from the following groups
- From a multiple case herd samples from cattle clinically 
and later histo-pathologically diagnosed as having B.S.E.
- Age-matched cattle in the same herd but in which no 
clinical signs of the disease were observed.
- Herds where no B.S.E. had been reported.
- Animals where the disease had been acquired 
experimentally.
Samples were taken from 4 Jersey cows, 1 Hereford bull, 1 
Friesian bull, and 54 Holstein/Friesian cows. Blood samples 
were taken by venipuncture into vacutainers. Initially, 
vacutainers containing heparin were used but later samples 
were collected in vacutainers containing E.D.T.A. Blood 
samples were stored on ice until processed, usually within 24
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hours.
3.4.2. Restriction Digest and Southern Blots.
Restriction enzymes used in this study included: EcoRI,
Hindlll, Xbal, PvuII, Kpnl, TaqI and Ddel.
In order to determine the size of hybridized fragments 
produced after digestion with each of the restriction 
enzymes, a lambda\HindIII size marker was run on each gel. A 
typical example of a lambda\hindIII standard curve is shown 
in Figure 3.2.
Typical examples of restriction digests and subsequent 
autoradiographs for each of the enzymes used in this study 
are shown in Figures 3.3- 3.9. The size of the various
restriction fragments obtained after digestion and 
hybridization is summarized in Table 3.1.
These results show that six out of the seven restriction
enzymes- Ddel, EcoRI, Hindlll, Kpnl, TaqI, Xbal- gave a
uniform pattern in this study, thereby, failing to reveal the
existence of any polymorphisms in or near the PrP gene. With 
the exception of EcoRI and Hindlll the sizes of the different 
restriction fragments obtained were different from those 
found in other species digested with these four enzymes. For 
example, Xbal gave fragment sizes of 3.8kb and 5.5kb in mice 
whereas in cattle only a 12.7kb fragment was obtained. 
Therefore, although the PrP gene is highly conserved these 
enzyme restriction sites were not. The degree of conservation 
in the non-coding region of PrP genes is not known and this
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Figure 3.2.Plot of Lambda\HindIII Molecular Weight 
Marker.
Lami^ ifda DNA digested with the restriction enzyme Hindlll 
produces restriction fragments of characteric size. When 
this digest is run through an agarose gel, a plot of log 
base pairs vs the distance each band has travelled 
through the gel enables unknown bands to be sized.
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Figure 3.3a.EcoRI restriction digest pattern.
Lanes 1-6 show examples of bovine genomic DNA digested 
with EcoRI, electrophoresed through a 1% agarose gel and 
stained with ethidium bromide. Lane 7 contained a 
lambda/Hindlll molecular weight marker.
Figure 3.3b. Southern blots of EcoRI digests.
Lanes 1-6 show examples on a Southern blot of EcoRI
digests. The blot was probed with a hamster PrP probe.
EcoRI digests produced a 6.5kb fragment.
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Figure 3.4a. Hindlll restriction digest pattern.
Lanes 1-14 show examples of bovine genomic DNA digested 
with Hindlll, electrophoresed through a 1% agarose gel 
and stained with ethidium bromide. Lane 15 contained a 
lambda/Hindlll molecular weight marker.
Figure 3.4b. Southern blots of Hindlll digests.
Lanes 1-14 show examples on a Southern blot of Hindlll 
digests. The blot was probed with a hamster PrP probe. 
Hindlll digests produced a 5.2kb fragment.
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Figure 3.5a. Ddel restriction digest pattern.
Lanes 1-8 and 10-15 show examples of bovine genomic DNA 
digested with Ddel, electrophoresed through a 1% agarose 
gel and stained with ethidium bromide. Lane 9 contained 
a lambda/Hindlll molecular weight marker.
Figure 3.5b. Southern blots of Ddel digests.
Lanes 1-14 show examples on a Southern blot of Ddel 
digests. The blot was probed with a hamster PrP probe. 
Ddel digests produced a O.Skb fragment.
-127-
15 14 13 12 11 10 9 8 7 6 ,5 4 3 2 1
' 2 3 4 .5 6 7 8 9 10 I! 12 l3 l-i 15
0«k
- 1 2 8 -
Figure 3.6a. Taql restriction digest pattern.
Lanes 1-14 show examples of bovine genomic DNA digested
with TaqI, electrophoresed through a 1% agarose gel and 
stained with ethidium bromide. Lane 15 contained a 
lambda/Hindlll molecular weight marker.
Figure 3.6b. Southern blots of TaqI digests.
Lanes 1-14 show examples on a Southern blot of TaqI 
digests. The blot was probed with a hamster PrP probe. 
TaqI digests produced a 6.8 kb fragment.
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Figure 3.7a. Xbal restriction digest pattern.
Lanes 1-14 show examples of bovine genomic DNA digested 
with Xbal, electrophoresed through a 1% agarose gel and 
stained with ethidium bromide. Lane 15 has a 
lambda/Hindlll molecular weight marker.
Figure 3.7b. Southern blots of Xbal digests.
Lanes 1-14 show examples on a Southern blot of Xbal 
digests. The blot was probed with a hamster PrP probe. 
Xbal digests produced a 12.7 kb fragment.
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Figure 3.8a. Kpnl restriction digest pattern.
Lanes 1-13 show examples of bovine genomic DNA digested 
with Kpnl, electrophoresed through a 1% agarose gel and 
stained with ethidium bromide. The sample in lane 14 did 
not digest properly. Lane 15 contained a lambda/Hindlll 
molecular weight marker.
Figure 3.8b. Southern blots of Kpnl digests.
Lanes 1-14 show examples on a Southern blot of Kpnl 
digests. The blot was probed with a hamster PrP probe. 
Kpnl digests produced 5.8 and llkb fragments.
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Figure 3.9a. PvuII restriction digest pattern.
Lanes 1-6 and 8-15 show examples of bovine genomic DNA 
digested with PvuII, electrophoresed through a 1% 
agarose gel and stained with ethidium bromide. Lane 7 
contained a lambda/Hindlll molecular weight marker.
Figure 3.9b. Southern blots of PvuII digests.
Lanes 1-6 and 8-15 show examples on a Southern blot of 
PvuII digests. Lane 7 contained a lambda/Hindlll 
molecular weight marker. The blot was probed with a 
hamster PrP probe. PvuII digests produced 3.4 and 4.8kb 
fragments.
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could have a significant influence on restriction patterns 
produced. The restriction enzymes EcoRI and Hindlll in this 
study produced fragment sizes of 6.5kb and 5.5kb 
respectively, which were similar to the larger fragments 
produced by the same enzymes with sheep DNA samples.
The restriction enzyme PvuII produced a single restriction 
fragment of 3.4kb in 57 out of the 60 animale studied. In the 
remaining three samples two bands of 3.4 and 4.8kb were 
produced. The size of these fragments contrasts quite 
considerably with fragments from PvuII digests of human DNA, 
where, either l.Skb or 1 and O.Skb fragments were produced 
(Wu et al., 1987).
3.5. Discussion.
The results obtained in this study failed to identify any 
polymorphisms with six out of the seven enzymes used. These 
six enzymes produced uniform restriction fragments which may 
be explained, at least in part, by the fact that in Britain 
the size of the cattle "gene pool" is relatively small com­
pared to that of the sheep "gene pool". This is due to the 
widespread use of artifical insemination in cattle reproduc­
tion, thus reducing genetic diversity.
There was some variation in the size of restriction fragments 
between different species using the same restriction enzyme. 
This size difference probably reflects how close the various 
species are in evolutionary terms e.g. EcoRI (6.5-6.8kb) and 
Hindlll (5.2-5.5kb) fragment sizes were similar in cattle and
-138-
s h e e p .
Although the restriction enzyme PvuII identified an RFLP in 
and around the PrP gene in this study, these polymorphisms 
were not linked to disease susceptibility. The group of 57 
animals having one restriction band were found to contain 
affected and unaffected animals. Out of the three animals 
which produced two bands, one animal was affected by BSE and 
the other two were not.
After this study there were two possible courses which could 
have been followed. The first was to create a limited 
restriction map in and around the bovine PrP gene. The second 
was to sequence the coding region of the bovine PrP gene. The 
decision was made to sequence the bovine PrP gene as it was 
considered that more valuable information would be obtained 
by this route.
- 1 3 9 -
CHAPTER 4.
Amplification, Cloning and Sequencing of the Bovine PrP 
Gene.
—140—
4.1. Summary
This chapter describes the development of a protocol for the 
amplification of the bovine PrP coding region. The cycling 
parameters and biochemical reagents involved were optimized 
and the product verified as being PrP by hybridization to a 
hamster PrP probe. The PCR derived product was cloned into 
Bluescript KS+ vector and subsequently sequenced in both 
directions. The coding region of the bovine PrP gene 
consisted of 795 nucleotides with a deduced protein of 264 
amino acids. The PrP gene from three cattle was sequenced and 
two of these sequences agreed with a published bovine PrP 
gene sequence. The third sequence had a silent base change (G 
to A) at position 234. The distribution of bases at each of 
the codon positions was not random with a preponderance of 
guanosine at codon positions 1 and 2 and cytosine at codon 
position 3. The bovine PrP gene was -GC- rich (55%). Analyses 
comparing codon usage of the bovine PrP gene with that from a 
bovine genebank showed both similarities and differences. A 
large ORF was found in the strand opposite the PrP 
transcriptional unit
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4.2.Introduction.
Screening of bovine samples with a variety of restriction 
enzymes (Chapter 3) failed to identify polymorphisms which 
could be linked to disease susceptibility. At the time this 
was undertaken no sequence data on the bovine PrP gene had 
been published so the next step was to clone and sequence the 
coding region of the bovine PrP gene. There were two reasons 
for this, one was that sequencing this region may help to 
identify more specifically whether or not there are any 
polymorphisms within the coding region of the PrP gene. Mouse 
models exhibiting different incubation periods when 
challenged with scrapie had been shown to have two different 
amino acids at codon 108, i.e. mice with short or 
intermediate scrapie incubation periods had a leucine at 
codon 108 whereas mice with long scrapie incubation periods 
had a phenylalanine at that position. The second reason was 
that in the previous chapter a cDNA hamster probe (pEA974) 
was used as the hybridization probe, as this was the only 
probe available at that time. Cloning the bovine PrP gene 
would provide a more specific probe.
The overall cloning strategy adopted was to amplify the 
coding region of the bovine PrP gene by using the Polymerase 
Chain Reaction (PCR). The amplified product would contain the 
restriction sites of two different enzymes i.e. the end 
towards the start codon would contain a Hindlll restriction 
site, and the end towards the stop codon would contain an 
EcoRI restriction site. The use of two restriction sites
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would make directional cloning possible, and eliminate the 
need for treatment with Alkaline Phosphatase to prevent re­
circularization of the vector. The product of the PCR 
reaction (bovine PrP gene) was to be put into the vector 
Bluescript KS+ which would then be transformed into E.Coli 
DH5 alpha cells.
The use of the polymerase chain reaction (PCR) (Saiki et 
al.. 1985; Mullis et al.. 1986; Mullis and Faloona, 1987) has 
made it possible to produce sequence data from defined 
regions of genomic DNA. The advantages of PCR over 
conventional cloning are several; it offers great 
amplification potential and this is especially important as 
the PrP gene from several species has been shown to be a 
single copy gene (Westaway,D. and Prusiner,S.B. 1986; 
Kretzschmar et al.. 1992), the technique also offers faster 
isolation of the desired PrP fragment and less time and 
effort need be expended to identify, clone and sequence 
chosen regions of interest in one or more animals.
PCR involves a cyclical series of relatively complicated 
biochemical reactions where the quantity and quality of the 
final product is determined by constantly changing kinetic 
interactions. Although standard PCR protocols exist there is 
no single protocol which is applicable to every situation. 
Therefore, in order to maximize specificity and yields of the 
bovine PrP gene those reagents and conditions considered to 
have the greatest influence on these aspects were examined 
sequentially.
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4.3. Results.
All the basic methods used in this chapter are described in 
chapter 2. Any variations to basic methodologies are 
described where appropriate.
4.4.1. Non-titrated reagents.
Several reagents were used at concentrations and pH 
recommended by the overall majority of protocols. These 
include :-
1) Tris\HCl (lOmM, pH 8.3 when measured at 20°C). Tris is a 
dipolar ionic buffer which controls the pH to between 6.8 and 
7.8 during typical thermal cycling conditions. The level of 
buffering capacity was left at the concentrations recommended 
by the manufacturer of the Tag polymerase.
2) Potassium chloride (50mM) is thought to facilitate primer 
annealing but concentrations above 50mM are thought to 
inhibit Tag polymerase activity (Innis et al., 1988).
3) Gelatin (100)ig\ml) is thought to help stabilize the Tag 
polymerase. It was chosen instead of bovine serum albumin 
(which carries out the same function) because gelatin can be 
autoclaved.
4.4.2. Titrated reagents and conditions.
The remaining reagents were considered to have a greater 
affect on the quality and quantity of product and were 
therefore titrated.
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1) Deoxynucleotide Triphosphates (dNTP). The first 
consideration is that the four dNTPs should be used at 
equivalent concentrations so that misincorporation errors are 
minimized. Secondly, low dNTP concentrations can minimize 
mispriming at nontarget sites and reduce the likelihood of 
extending misincorporated nucleotides (Innis et al.1988). 
Therefore dNTP concentrations were titrated to determine the 
levels best suited for PrP generation.
2) Primer concentrations that are too high can promote 
mispriming and accumulation of nonspecific product and may 
also generate primer—dimer artefacts (Innis etal.1990). Such 
artefacts can themselves become substrates for PCR, thus 
competing with the desired product for reagents in the 
reaction tube.
3) Magnesium concentration can have a profound affect on the 
quality and quantity of product. It can affect all of the 
following (Innis et al., 1990) :
-Primer annealing.
-Strand dissociation temperatures of both template and PCR 
product.
-Product specificity.
—Formation of primer -dimer artefacts.
-Enzyme activity and fidelity.
Tag polymerase requires free magnesium surplus to that bound 
by template DNA, primers and dNTPs. Therefore, all DNA used 
as a template for PCR wa^ taken up in water and not as 
frequently recommended in Tris buffers containing EDTA.
—145—
In a typical PCR reaction three different temperatures are 
employed! the double stranded DNA is denatured by heating to 
90 to 96°C, followed by primer annealing at 40 to 70°C and 
lastly by primer extension at 70 to 75°C. As genomic DNA 
was to be amplified a decision was made to heat the sample 
DNA at 96°C for 10 minutes to ensure complete strand 
separation. This was important as one common reason for 
failure of a PCR, that of incomplete dénaturation of target 
template DNA, was eliminated straight away. The temperature 
required for primer annealing depends on base composition, 
length and concentrations of the amplification primers. 
Increasing the annealing temperature enhances discrimination 
against incorrectly annealed primers and reduces misextension 
of incorrect nucleotides at the 3' end of primers (Innis et 
al.. 1990). Therefore stringent annealing temperatures,
especially during the first several cycles, will help to 
increase specificity. A series of annealing temperatures were 
investigated to determine the optimum temperature. 
Additionally, in order to maximize specificity Tag polymerase 
was added between 80 and 85°C after the initial dénaturation 
of the DNA template. The temperature at which the extension 
reaction was carried out was kept at 72°C as recommended by 
the manufacturer of the Tag polymerase.
4.4.3. Choice of primers.
The sequence of the oligonucleotide primers used were based 
on the sheep PrP gene sequence. The forward oligonucleotide 
primer had the following sequence:-
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Primer 1 (PrP-Gl):- 5'-AAT AAG CTT AGA GAA GTC ATC ATG GTG 
AAA AGC CAC-3'.
Starting from the 5' end the first three bases -AAT- were 
incorporated to protect the Hind III restriction site (AAG 
CTT), and to facilitate complete restriction digestion at a 
subsequent stage. This primer also incorporated the ATG start 
codon of the PrP gene.
The reverse strand oligonucleotide primer had the following 
sequence:-
Primer 2 (PrP-G4):- 5'-AAT GAA TTC TGA TGA GAC ACC ACC ACT 
ACA GGG CT-3'.
The EcoRI restriction (GAA TTC) site was protected with three 
bases -AAT- at the 5' end. These two primers produced a 
theoretical product of 918 basepairs.
4.5.1. Comparison of annealing temperatures.
Initial studies involved keeping the concentration of the 
chemical reagents constant whilst varying the annealing 
temperature.
The starting component mix used in these studies is given 
below for a lOOjj.1 reaction :
- water 67jal
- PCR buffer 10jul(1.5mM MgCl2, 50mM KCl)
- dNTPS 10pl(2mM each)
- Primers 1 and 2 lyil Çic
- DNA lOpL (2pg)
- Tag polymerase 5U
PCR parameters:
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Initial dénaturation: 96°C for 10 minutes.
Cycling parameters (30 cycles):
dénaturation: 94°C for 2 minutes
annealing: various temperatures for 2 minutes
extension: 72°C for 3 minutes
Final extension 72°C for 10 minutes 
The PCR product was electrophoresed through a 1% agarose gel 
and an initial assessment of quality based on predicted size, 
sharpness of a specific band and whether non-specific 
products (as determined by smearing and other bands) were 
present. A comparison of different annealing temperatures on 
product yield and specificity is shown in Figure 4.1a.
Confirmation of PrP specificity was determined by Southern
blot analysis using the hamster PrP probe and these results
are shown in Figure 4.1b. It was evident that an annealing
temperature of 60°C, Figure 4.1a. gave a clear sharp band of 
the desired size (918bp). The specificity of this PrP product 
was confirmed by hybridization to the hamster probe. Figure 
4.1b.. This annealing temperature was used in all subsequent 
PCR reactions involving these primers.
4.5.2• Effect of magnesium ion concentration on PrP 
amplification.
A titration of magnesium ions was performed to determine the 
optimum levels of this ion for this particular system. A set 
of reactions were set up using the same concentration of 
reagents and PCR parameters as described in section 4.5.1. 
but with different levels of magnesium chloride. The results 
are shown in Figure 4.2. It is clear that the optimal
—148—
Figure 4.1a. The effect of varying annealing 
temperatures on bovine PrP specificity and yield.
Samples were electrophoresed through a 1% agarose gel 
and stained with ethidium bromide.
Annealing temperatures;
Lane 1: 40°C 
Lane 2: 45°C 
Lane 3: 50°C 
Lane 4: 55°C 
Lane 5: 60°C 
Lane 6: 65°C
Lane 7: control (no DNA) AT 60°C
Lane 8: lambda/Hindlll bp ladder.
These results show that non-specific PCR bands were 
produced up to an annealing temperature of 55°C, After 
which PrP specific bands only were obtained.
Figure 4.1b. Southern blot analysis of the eibove gel 
using a hamster pEA974 probe.
The hamster PrP probe hybridized to PCR products from 
lanes 2-6. These results demonstrate that bovine PrP had 
been amplified.
1 4 9 -
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Figure.4.2. Effect of Magnesium Ion concentration on PCR
Yield and specificity.
Magnesium concentration were tried at 0 (lane 1), 
0.5(lane 2), 1.0(lane 3), 1.5 (lane 4), 2.0 (lane5),
4.0(lane 6) and 8mM (lane?) respectively. Lane 8 
contained a ICO bp ladder. Samples were
electrophoresed through a 1% agarose gel and stained 
with ethidium bromide. Visible product was observed only 
in lanes 3-5, with the optimum magnesium concentration 
being ImM.
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concentration of magnesium chloride for this particular set 
of primers is ImM and that near optimal results were obtained 
with a concentration of l.SmM. That magnesium chloride is 
essential for Tag polymerase activity was demonstrated as no 
amplification was achieved without it. The experiment also 
showed that there was no amplification at the lower level of 
0.5mM and the higher levels of 4mM and 8mM, but there was 
some amplification when 2mM magnesium chloride was used.
4.5.3. Effect of different primer concentrations on
amplification of the PrP gene.
A set of reactions were set up in which the same 
concentration of reagents and PCR parameters were used as 
described in section 4.5.1 but with differing concentrations 
of primers. These results (Figure4.3) show that no 
amplification was achieved with a primer concentration of 
3pmoles; but there was some amplification at the 6, 12, 30
and 60 pmoles level. In terms of specificity, as judged by 
the sharpness of band of the correct size (918bp), varying 
the primer concentration between 6 and 60 pmoles had little 
Effect; but this range did affect the yield of product. 
Optimum results (yield), were achieved at a primer 
concentrarion of 30pmoles but these results were difficult to 
distinguish from those obtained with 60pmoles of primer 
therefore, a concentration of 30 pmoles of each primer was 
used in all subsequent PCR reactions.
4.5.4. Effect of different concentrations of dNTPs on the 
amplification of the PrP gene.
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Figure 4.3. Effect of primer concentration on PCR yield
and specificity.
5 4 3 2 1
Each of the primers were tried at 3 (lane 2) , 6
(lane3) , 12 (lane4) , 30 (lane 5) and 60 pmoles (lane 6)
levels. Lane 6 contained a bp marker. No
visible amplification was achieved at the 3pmoles
level; but there was some amplification with the other 
primer concentrations tried.
- 1 5 3 -
A series of reactions were performed using identical 
concentrations of all reagents except for the concentration 
of dNTPs. The results are presented in Figure 4.4. and show 
that at a concentration of 20pM no discernible PCR product 
was observed. The yield increases steadily with increasing 
dNTP concentration until 300pM when no further increase in 
product yield is observed. Varying the concentration of 
dNTPs did not alter the specificity of the desired product. A 
concentration of 300pM of each dNTP was used in all 
subsequent amplifications with this set of primers.
As a result of these series of experiments the following 
concentrations and conditions were used for all subsequent 
amplifications of the bovine PrP gene with this set of PCR 
primers: the annealing temperature was 60°C, magnesium ions
were used at a concentration of ImM, the primers were used at 
a concentration of 30pmoles and dNTPs at a concentration of 
300UM.
4.6.1. Cloning of PCR derived PrP gene product.
The enzyme Tag polymerase does not po^ess any proofreading 
activity (3'to 5') as a result misincorporations can occur. 
PCR artefacts can arise due to the misincorporation of a 
single base which will then be amplified with the correct 
base in subsequent amplification cycles. This problem would 
be more acute if misincorporation occurs in the early cycles 
of amplification, i.e. cycles 1-5 . Therefore, PCR reactions 
were performed in triplicate, the contents of the reaction 
tubes mixed thoroughly, then purified before cloning. Using
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Figure 4.4. Effect of dNTP concentration on the yield
and specificity of the PrP gene following PCR.
Levels of dNTPS tried were: 20 (lanel) , 40 (lane 2 ), 100
(lane3) , 200 (lane 4), 300 (lane 5) and 400}iM (lane 6) #2 conCrtii
respectively. No visible product was observed at a
concentration of 20pM; but some PCR product was observed
at all the other concentrations with the optimum being
300pM.
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these procedures the DNA from three different bovine samples 
were amplified and purified on two separate occasionJ ready 
for cloning, i.e. PCR reactions for each of the bovine 
samples was performed on two separate days in order to 
validate subsequent PrP sequences.
4.6.2. Digestion and purification of Bluescript KS+ vector.
The Bluescript KS+ vector was digested with Hindlll (lOU) and
TmjltCL pHl%j
EcoRI (lOU) in a restriction buffer (BRL^ buffer ^ ) which 
ensured that both enzymes worked to at least 80% efficiency 
(they normally require different buffers). Digestion was 
allowed to proceed for 1-2 hours at 37^0. The digested 
product was electrophoresed through a 1.2% low melting gel, 
stained, viewed on a transilluminator to ensure complete 
digestion, then extracted as above using a Prep-A-Gene kit.
4.6.3. Ligation Reaction.
It was found that the most consistent results were obtained 
when the PrP insert and the Bluescript vector were mixed 
together then re-extracted using the Prep-A-Gene kit. The
insert to vector ratio that worked best was found to be 2:1
moU/v ratio
( insert:vecto^). The ligation reaction was as described in 
the methods chapter section 2.13.1.
4.6.4. Transformation and screening.
The hamster pEA974 probe was used to screen colonies. One of 
the theoretical advantages offered by vectors such as 
Bluescript is that positive clones i.e. those containing an 
insert can be distinguished from negative clones, i.e the
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vector with no insert by a change in colour. Positive clones 
are white and negative clones remain blue. This distinction 
of colour is based on alpha-complementation (and the use of 
the chromagenic substrate X-gal) therefore, only white 
colonies were picked for further study. The results of colony 
selection based on hybridization to a hamster probe are shown 
in Figure 4.5. These results show that whilst numerous 
positive clones were obtained, e.g positions A4, A7 and A8,
there were some negative clones, e.g positions D3, E3 and F3.
Therefore, whilst a sufficient number of positive clones were 
obtained for the purpose of this study, this vector system
produced some false positive clones.
4.6.5. Sequencing the PrP gene.
Sequencing was carried out using a USB " Sequenase" kit. In 
order to check the fidelity of the cloning and sequencing 
reactions it was decided to sequence both strands of the 
cloned PrP gene. To accomplish this a set of 5 primers was 
required for sequencing the forward strand and another set
of 4 primers for the reverse strand. The set of forward and
reverse primers are shown in Table 4.1. The bovine PrP
sequence together with the deduced amino acid sequence is
shown in Figure.4.6. Sequence data was obtained from three 
cattle. The sequence from two of the animals wa5 - identical 
which in turn agreed with a bovine PrP sequence which had 
just been published (Goldmann et al., 1991). The third animal 
sequenced had one silent base change at position 234 (G to 
A). It was demonstrated that the base change found within the 
third animal was genuine and not due to any artefacts
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Figure 4.5. Identification of Colonies containing a 
Bovine PrP Insert.
DH-5 alpha cells (white colonies) were picked from 
ampicillin agar plates and streaked onto nylon membranefZ^l) 
The nylon membranes were placed onto the surface of 
fresh agar plates containing ampicillin and growth al­
lowed to proceed for 2-4 hours. The colonies were lysed 
on the nylon membrane then hybridized to a hamster PrP 
gene probe labelled with 32P. After autoradiography vec­
tors containing a bovine PrP gene insert could be easily 
identified. An example of a positive clone could be seen 
at position A4, and an example of a negative clone could 
be seen at position D3.
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Table 4.1. Forward and Reverse sequencing primers.
Sequencing primers were based on the sheep PrP sequence
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Figure 4.6. Bovine PrP sequence and deduced amino acid 
sequence.
The coding region of the bovine PrP gene was cloned into 
Bluescript KS+ vector and sequenced in both directions 
using a USB 'sequenase' kit. The nucleotide sequence and 
the deduced aminoacid sequence are shown . The coding 
region of the bovine PrP gene consisted of 795 bases and 
a deduced protein of 2 64 amino acids.
! marks are seen after every 50 bases.
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11
AÂTTGATGCTGACACCCTCTTTATTTTGCAGATAAGTCATTCATGGTGAAAAGCCACAÏAGGCAGTTGGATCCTGGTTCTCTTT
Met Val Lys Ser His Ile Gly Ser Trp Ile Leu Val Leu Phe
150 I 100
GTGGCCATGTGGAGTGACGTGGGCCTCTGCAAGAAGCGACCAAAACCTGGAGGAGGATGGAACACTGGGGGGAGCCGATACCCA
Vd Ala Met Trp Ser Asp Val Gly Leu Cys Lys Lys Arg Pro Lys Pro Gly Gly Gly Trp Asn Thr Gly Gly Ser Arg Tyr Pro
I 150 1200
GGACAGGGCAGTCCTGGAGGCAACCGTTATCCACCTCAGGGAGGGGGTGGCTGGGGTCAGCCCCATGGAGGTGGCTGGGGCCAG
Gly Gin Gly Ser Pro Gly Gly Asn Arg Tyr Pro Pro Gin Gly Gly Gly Gly Trp Gly Gin Pro His Gly Gly Gly Trp Gly Gin 
45 60
1250
CCTCATGGAGGTGGCTGGGGCCAGCCTCATGGAGGTGGCTGGGGTCAGCCCCATGGTGGTGGCTGGGGACAGCCACATGGTGGT
Pro His Gly Gly Gly Trp Gly Gin Pro His Gly Gly Gly Trp Gly Gin Pro His Gly Gly Gly Trp Gly Gin Pro His Gly Gly 
75 90
I300 I350
GGAGGCTGGGGTCAAGGTGGTACCCACGGTCAATGGAACAAACCCAGTAAGCCAAAAACCAACATGAAGCATGTGGCAGGAGCT
Gly Gly Trp Gly Gin Gly Gly Thr His Gly Gin Trp Asn Lys Pro Ser Lys Pro Lys Thr Asn Met Lys His Val Ala Gly Ala 
105 120
I 400 I450
GCTGCAGCTGGAGCAGTGGTAGGGGGCCTTGGTGGCTACATGCTGGGAAGTGCCATGAGCAGGCCTCTTATACATTTTGGCAGT
Ala Ala Ala Gly Ala Val Val Gly Gly Leu Gly Gly Tyr Met Leu Gly Ser Ala Met Ser Arg Pro Leu Ile His Phe Gly Ser
135 150
1500
GACTATGAGGACCGTTACTATCGTGAAAACATGCACCGTTACCCCAACCAAGTGTACTACAGGCCAGTGGATCAGTATAGTAAC  
Asp Tyr Glu Asp Arg Tyr Tyr Arg Glu Asn Met His Arg Tyr Pro Asn Gin Val Tyr Tyr Arg Pro Val Asp Gin Tyr S e r Asn
165 180
1550 1600
CAGAACAACTTTGTGCATGACTGTGTCAACATCACAGTCAAGGAACACACAGTCACCACCACCACCAAGGGGGAGAACTTCACC
Gin Asn Asn Phe Val His Asp Cys Val Asn Ile Thr Val Lys Glu His Thr Val Thr Thr Thr Thr Lys Gly Glu Asn Phe Thr
195 210
I650 I700
GAAACTGACATCAAGATGATGGAGCGAGTGGTGGAGCAAATGTGCATTACCCAGTACCAGAGAGAATCCCAGGCTTATTACCAA  
Glu Th r Asp Ile  Lys Met Met Glu Arg Val Val Glu Gin Met Cys Ile  Thr Gin Tyr Gin Arg Glu S e r Gin Ala Tyr Tyr Gin
! 750 1795
CGAGGGGCAAGTGTGATCCTCTTCTCTTCCCCTCCTGTGATCCTCCTCATCTCTTTCCTCATTTTTCTCATAGTAGGATAGGGG
Arg Gly Ala Ser Val Ile Leu Phe Ser Ser Pro Pro Val Ile Leu Leu Ile Ser Phe Leu Ile Phe Leu Ile Val Gly •
240 255 264
CAACCTTCCTGTTTTCATTATCTTCTTAATCTTTAC
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introduced at the PGR , cloning or sequencing stages by 
further sequencing of this animal using an automated 
sequencer (chapter 6). The sequenced open reading frame (ORF) 
consists of 795 nucleotides giving rise to a protein of 264 
amino acids.
4.7. Codon base distribution.
The distribution of bases at each of the codon positions is 
displayed in Table 4.2. and shows that it is not random. At 
codon position 1 there is a preponderance of guanosine 
residues (35.1%) and a relative dearth of thymidine residues 
(14.3%) with both adenosine (25.6%) and cytosine (24.9%) 
somewhere in between. At codon position 2 again the levels of 
guanosine are highest (32.4%) followed by adenosine (29.8%), 
thymidine (21.1)% and cytosine (16.7%). At codon position 3 
the levels of cytosine were highest (31.3%) followed by 
thymidine (25.2%), guanosine (24.1%) and adenosine (19.2%). 
The percent of each base at the different codon positions 
reflects the fact that the high GO content (55%) of the 
coding region of the bovine PrP gene is in keeping with their 
levels in sheep (55.5%) and slightly higher levels in the 
human (58.3%), hamster (58.6%) and mouse (59.3%) genes. These 
levels are in keeping with the highly conserved nature of the 
PrP gene.
4.8. Comparison of codon usage between the bovine PrP gene 
and bovine genes from a genebank.
The results of a comparison of codon usage between the coding 
'region of the bovine PrP gene and 2 61 bovine genes from a
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Table 4.2. Distribution of bases at each of the codon 
positions ; w ith in _the_. boy i ne^ P^ r P ge '
No. of times each Base (%)
base has occurred A C 6 T
Position 1 of codon 25.6 24.9 35.1 14.3
Position 2 of codon 29.8 16.7 32.4.0 21.1
Position 3 of codon 19.2 31.3 24.1 25.2
The base distribution of bases at each of the codon positions 
was not random. There was a preponderance of guanosine at 
codon positions 1 and 2 and cytosines at codon position 3.
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Table 4.3. Comparison of codon usage between the bovine 
PrP gene and a bovine genebank.
This table compares codon usage by the bovine PrP gene 
to codon usage by a bovine ge nbank containing 261 
bovine genes.
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Table 4.3- Comparisons of codon usage between the
bovine PrP gene and a bovine -g&nbank
.no Acid Codon Bovine Genebank Bovine PrP
Fraction Fraction
Gly GGG 0.26 0.12
Gly GGA 0.21 0.29
Gly GGU 0.15 0.29
Gly GGC 0.38 0.29
Glu GAG 0.66 0.50
Glu GAA 0.34 0.50
Asp GAU 0.36 0.17
Asp GAC 0.64 0.83
Val GTG 0.51 0.66
Val GTA 0.08 0.11
Val GUU 0.14 0.05
Val GUC 0.28 0.17
Ala GCG 0.13 0.00
Ala GCA 0.17 0.40
Ala GCU 0.24 0.40
Ala GCC 0.46 0.20
Lys AAG 0.65 0.64
Lys AAA 0.35 0.36
Asn AAU .0.34 0.00
Asn AAC 0.66 1 .00
Met AUG 1 .00 1 .00
lie AUA 0.12 0.27
lie AUU 0.29 0.18
H e AUC 0.59 0.54
Thr ACG 0.16 0.00
Thr ACA 0.22 0.17
Thr ACU 0.18 0.17
Thr ACC 0.43 0.66
Trp UGG 1 .00 1 .00
Cys UGU 0.39 0.33
Cys UGC 0.61 0.67
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Table 4.1. Comparisons of codon usage between the
bovine PrP gene and the bovine genebank
Amino Acid Codon Bovine Genebank Bovine PrP
Fraction Fraction
Tyr UAU 0.32 0.38
Tyr UAC 0.68 0.62
Phe UUU 0.37 0.57
Phe UUC 0.63 0.43
Ser UCG 0.07 0.00
Ser UCA 0.11 0.00
Ser UCU 0.16 0.13
Ser UCC 0.25 0.13
Ser AGU 0.13 0.53
Ser AGC 0.28 0.20
Arg CGG 0.23 0.00
Arg CGA 0.10 0.36
Arg CGU 0.07 0.36
Arg CGC 0.22 0.00
Arg AGG 0.20 0.18
Arg AGA 0.17 0.09
Gin CAG 0.70 0.79
Gin CAA 0.30 0.21
His CAU 0.34 0.67
His CAC 0.66 0.33
Leu CUG 0.49 0.18
Leu CUA 0.05 0.00
Leu CUU 0.10 0.18
Leu cue 0.22 0.64
Leu UUG 0.10 0.00
Leu UUA 0.04 0.00
Pro CCG 0.15 0.00
Pro CCA 0.22 o . 34
Pro ecu 0.27 0.44
Pro CCC 0.36 0.22
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the genebank are displayed in Table 4.3. These results show 
that with some amino acids, such as glutamine, where there 
are two codons - CAG and CAA - both are used in roughly the 
same proportion for the PrP and other bovine genes. In the 
case of asparagine all 11 amino acids found in the PrP gene 
are coded for by one codon -AAC- whereas in the bovine 
0&#bank the ratio of the two codons -AAC and AAU - coding 
for asparagine is 2:1 . With several amino acids the ratio of 
the codons used differed between the PrP gene and the 
cg^tsbank, e.g. with histidine the two codons coding for this 
amino acid -CAC and CAU - are used in the ratio of 2:1 by the 
bovine genebank; but this ratio is reversed with PrP. Those 
amino acids having six different codons e.g. serine, arginine 
and leucine have at least two codons which are redundant 
whereas with the bovine genebank all six codons are employed.
4.9. Predicted structure of the bovine PrP.
A schematic representation of the bovine PrP - could be 
arrived at by considering the deduced primary amino acid 
structure together with computer predictions and experimental 
evidence derived mainly from the numerous experiments 
involving the hamster PrP gene. The result is displayed in 
Figure 4.7. The nascent bovine PrP consists of 264 amino 
acids residues, of which the N-terminal 24 amino acids 
constitutes a putative signal peptide. Signal peptides are 
thought to be involved with the translocation of the PrP into 
the lumen of the endoplasmic reticulum where it is then 
cleaved (Easier et al., 1986; Hope et al.. 1988; Turk et al., 
1988) . Removal of the signal peptide leaves the protein with
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Figure 4.7. Schematic representation of the bovine PrP 
protein.
The main features of the bovine PrP protein are 
presented here. The bovine PrP has a 24 amino acid 
signal peptide which is cleaved leaving the mature 
protein. The N-terminal end has two hexapeptide and six 
octapeptide repeat motifs (some bovine proteins have 
five octapeptide repeat motifs). There is a 20 amino 
acid hydrophobic stretch which meets the criteria of a 
stop-transfer effector (STE), which would aid in 
positioning these amino acids across membranes, e.g. 
endoplasmic reticulum. There are two cysteine residues 
which complex forming a disulphide bridge. The 34 amino 
acid loop created contains two asparigine residues (at 
position 192 and 208) which may be site of attachment of 
N-1inked oligosaccharides . If experiments carried out 
with hamster PrP apply to the bovine PrP then 21 amino 
acid residues would be removed from the C-terminal end 
and a glycophosphatidylinositol anchor attached .
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a highly basic N-terminus. The N-terminus third of the bovine 
PrP protein is dominated by repeated amino acid motifs. The 
first of two hexapeptide motifs starts at codon 37 with the 
second starting at codon 48. This is followed at codon 54 by 
what is the first of six octapeptide repeat motifs which 
directly follow each other. In the first and sixth repeat
motifJ are nonapeptides and the other four motifs
(MM)
octapeptides ; but Collingej^ coined the term octapeptide repeat 
motifs for all (eight and nine peptides) these repeat motifs 
and this has stuck in the literature and will be used in this 
study. A hydrophobic region consisting of 20 amino acids 
begins at codon 123 which meets the criteria of a likely stop 
transfer effector (STE) sequence. The STE would help position 
the hydrophobic residues as a possible membrane spanning 
zone. As with other PrPs there is likely disulphide bond 
formation between cysteine residues 190 and 225. The possible 
34 amino acid loop which this forms has two possible sites 
for the addition of N-1inked oligosaccharides. These 
potential glycosylation sites occur at asparagine residues 
192 and 208. If the comparisons with the hamster PrP are 
correct then it seems likely that the hydrophobic amino acids 
243 to 264 are removed and a glycoinositol phospholipid (GPI) 
anchor attached to serine residue 242.
4.10. Anti-PrP protein.
During the course of these studies a paper was published 
suggesting that the DNA strand opposite to the PrP 
transcriptional unit of patients with CJD and GSS contains a 
large ORF (Goldgaber, 1991). Having observed this large ORF
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Goldgaber predicted that this strand could encode an anti-PrP 
protein. The anti-PrP protein mentioned here does not of 
course refer to an antibody to the PrP protein but is just a 
term Goldgaber used to refer to any possible protein 
resulting from what would normally be the nonsense strand. 
The bovine PrP sequence was observed to have a large ORF and 
stop codon which, if translated would produce a protein of 
273 amino acids. The sequence of the anti-PrP ORF together 
with the deduced amino acid is shown in Figure 4.8
Discussion.
The overall aim of these series of studies was to sequence 
the bovine PrP gene. The initial step in the realization of 
this aim was to develop a reliable, specific amplification 
protocol which could produce sufficient amounts of the bovine 
PrP gene for cloning. As genomic DNA was involved, the 
decision taken to denature the template DNA at a higher 
temperature (96°C) and for a longer period (10 minutes) than 
normally recommended for most PCR protocols proved 
successful. A comparison was performed into the effect of 
different annealing temperatures on the specificity and yield 
of the bovine PrP gene. The results of this experiment showed 
that annealing temperature had a great influence on both 
product yield and specificity. No discernible product was 
observed below an annealing temperature of 50°C. The optimum 
temperature, initially based on sharpness of amplified bands 
of the correct size, was determined to be 60°C. The 
importance of annealing temperature in determining product 
specificity has already been discussed , therefore, the
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Figure 4.8. Nucleotide and deduced amino acid sequence 
of the potential bovine ahbr -PrP.
This figure shows the sequence of the large ORF found 
opposite the bovine PrP transcriptional unit (anti-PrP). 
If this potential anti-PrP were to be transcribed then a 
protein of 273 amino acids would be produced, 
p - refers to the PrP nucleotide and deduced amino acid 
sequence.
A - refers to the anti-PrP and deduced amnio acid 
sequence which is also underlined.
! marks appear every 50 bases.
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11
AATTGATGCTGACACCCTCTTTATTTTGCAGATAAGTCATTCATGGTGAAAAGCCACATAGGCAGTTGGATCCTGGTTCTCTTT A
Met Val Lys Ser His lie Gly Ser Trp lie Leu Voi Leu Phe fT
I JAAGTACGACTGTGGGAGAAATAAAArfiTr TATTCAGTAAGTAGCACTTTTCCRTftTATPPaTr&ArrTA(;RACCAACACA&A A
  ----------------- ---------------------- Î—Glu Hla Hla Phe Ain Vnl Typ Ain Thr Pm A«ip Rfn Amn Glu lya ^
ISO I too
GTGGÇCATGTGGAGTGACGTGGGCCTCTGCAAGAAGCGACCAAAACCTGGAGGAGGATGGAACACTGGGGGGAGCCGATACCCA 
Vd Ala Met Trp Ser Asp Vai Gly Leu Cys Lys Lys Arg i ^  Lys Pro Gly Gly Gly Trp Asn Thr Gly Gly Ser Arg Tyr Plro
CACCGGTACACCTCACTRCACCCGRAGACGTTCTTCGCTRGTTTTGRArrTCCTrGTAPPTTCTCArrrrPGTGGCrTATRGGT 
—His GIv. Hla. grO-Thr- Vai His Aln .Glu Alo-Leu I eu Ser Trp Phe Arg .«Sar <î«>r 5^ /^  Pm Vnl Rat Pro Pm Ain «Sat Vnl Trp
1150 1200
GGACAGGGCAGTCCTGGAGGCAACCGTTATCCACCTCAGGGAGGGGGTGGCTGGGGTCAGCCCCATGGAGGTGGCTGGGGCCAG 
Gly Gin Gly Ser Pro Gly Gly Asn Arg Tyr Pro Pro Gin Gly Gly Gly Gly Trp Gly Gin Pro His Gly Gly Gly Trp Gly Gin 
45 60
CCTGTCCCGTCAGGACCTCCGTTGGCAATAGGTGGAGTCCCTCCCCCACCGACCCCAGTCCCCCTACCTCCACCGACCCCGCTr 
- .Ser.LBU.AlQ Thr Ara Ser Ala Vnl Thr He Trp Arg leu Ser IVq Thr Ala Pro Thr I mi Gly Met Ser Thr Ala Pro Ala L«hi
1250
CCTCATGGAGGTGGCTGGGGCCAGCCTCATGGAGGTGGCTGGGGTCAGCCCCATGGTGGTGGCTGGGGACAGCCACATGGTGGT 
Pro HIS Gly Gly Gly Trp Gly Gin fVo His Gly Gly Gly Trp Gly Gin Pro His Gly Gly Gly Trp Gly Gin Pro His Gly Gly 
75 SO
GGAGIACCTCCACCGACCCCGGTCGGAGTACCTCCACCGACCCGAGTCGGGGTACCACCAGrnACCCCTGTCGGTGTACCACrA 
.. Arg Met Ser Thr Ala Pro Ala Leu Arp Met Ser Thr-Alo Pro Thr  Leu Gly Met Thr Thr Ala Pro Ser leu Trp Met Thr Thr
1300 1350
GGAGGCTGGGGTCAAGGTGGTACCCACGGTCAATGGAACAAACCCAGTAAGCCAAAAACCAACATGAAGCATGTGGCAGGAGCT 
Gly Gly Trp Gly Gin Gly Gly Thr His Gly Gin Trp Asn Lys Pro Ser Lys Pro Lys Thr Asn Met Lys His Val Ala Gly Ala 
105 120
CCTCCGACCCCAGTTCCACCATGGGTGCCAGTJACCrrGTTTGGGTCATTCGGTTTTTGCTTRTACTTCCTArArrGTCCTCCA 
_Ser_Ala .Pro Thr Leu Thr.Thr Gly Val Thr Leu Pro Val Phe Gly Thr Leu Trp Ph* Gly Val Hla Leu Met Hla Gya .«Ur
1400 1450
GCTGCAGCTGGAGCAGTGGTAGGGGGCCTTGGTGGCTACATGCTGGGAAGTGCCATGAGCAGGCCTCTTATACATTTTGGCAGT 
Ala Ala Ala Gly Ala Val Val Gly Gly Leu Gly Gly Tyr Met Leu Gly Ser Ala Met Ser Arg Pro Leu He His Phe Gly Ser 
135 150
CGACGTCGACCTCGTCACCATCCCCCGGAACCACCGATGIACGACCCTTCACGGTACTCGTGrGGAGAATATGTAAAACrGTrA 
- Ser_Cvs Ser Ser Cys His Tyr Pro Ala Lys Thr Alo .Val His Gin Ser Thr Gly His Ala Pro Arg tya Tyr Met tya Ala Thr
1500
GACTATGAGGACCGTTACTATCGTGAAAACATGCACCGTTACCCCAACCAAGTGTACTACAGGCCAGTGGATCAGTATAGTAAC 
Asp Tyr Glu Asp Arg Tyr Tyr Arg Glu Asn Met His Arg Tyr Pro Asn Gin Val Tyr Tyr Arg Pro Val A ^  Gin Tyr Ser Asn
165 ISO
CTGATACTCC.TGGCAATGATAGCACTTTTGTACGTGGCAATCGGCTTRRTTr.ACATGATGTCrGGTCACGTAGTrATATrATTG 
- VaLJIe .Leu Val Thr Val lie Thr Phe Vol -Hls. Val Thr Val Gly Val Leu His Val Val Pro Trp Hla lit» l eu llm Thr Vnl
1550 1600
CAGAACAACTTTGTGCATGACTGTGTCAACATCACAGTCAAGGAACACACAGTCACCACCACCACCAAGGGGGAGAACTTCACC 
Gin Asn Asn Phe Val His Asp Cys Val Asn He Thr Val Lys Glu His Thr Val Thr Thr Thr Thr Lys Gly Glu Asn Phe Thr
195 210
G.TCTTGTTGAAACACÆIAC.TGACACAGTTGTAGTGTCAGTTCCTTGTGTGTrAGTRGTGRTCGTGGTTrrrrrTrTTGAAGTGG 
Lou Val Val Lys His MeOaLThr Asp . VaL.Asp Cys Asp I eu Phe Val Cys Asp Gly Gly Gly Gly I mi Prn I a» Vnl Glu Gly
1650 1700
GAAACTGACATCAAGATGATGGAGCGAGTGGTGGAGCAAATGTGCATTACCCAGTACCAGAGAGAATCCCAGGCTTATTACCAA 
Glu Thr Asp He Lys Met Met Glu Arg Val Val Glu Gin Met O ^ lle  Thr Gin Tyr Gin Arg Glu Ser Gin Ala Tyr Tyr Gin
CJT.TGACTGTAGTTCTAr.TACCTCGCICACCACCTCGTTTArACGTAATGCGTrATGGTrTrTCTTAGGGTrrGAATAATGGTT 
- Phe Ser Val .Asp leu His ..His. Leu Ser His His le u l eu His Ala Asn Gly I en Vnl I A,, Phe Gly Im, lln Vnl Im,
1750 1795
CGAGGGGCAAGTGTGATCCTCTTCTCTTCCCCTCCTGTGATCCTCCTCATCTCTTTCCTCATTTTTCTCATAGTAGGATAGGGG
Arg Gly Ala Ser Val He Leu Phe Ser Ser Pro Pro Val He Leu Leu He Ser Phe Leu He Phe Leu He Val Gly •
240 255 264
GCTCCCCRTTCACAC.TAGGAGAAGAGAAGGGGARGArArTARGAGGAGTAGAGAAARGAGTAAAAAGAGTATrATrrTATrrrr 
Ser Pro Cys .Thr. Hls_Asp Glu_Glu.Arg _Gly_Acg Arg Him Agp Glu Glu A*p Arg Glu Glu Agn Lys Glu Tyr Tyr Gar Ion P r-n
1816
CAACCTTCCTGTTTTCATTATCTTCTTAATCTTTAC
GTTGGAAGGACAAAAGTAATAGAAGAATTAGAAATG 
Leu Arg Gly Thr lyg Mmt
results obtained here confirm those considerations. Southern 
blot analysis performed at this early stage confirmed that 
the PCR product obtained was PrP.
A comparison was then performed into the effects of differing 
concentrations of magnesium chloride on the amplification 
system thus far investigated. The results from this 
experiment showed that there was a definite optimal level of 
magnesium ions required for PCR. The optimal level found was 
ImM. It was also clear that for this set of primers both 
lower and higher than optimal levels of magnesium ions 
resulted in little or no product. Therefore, in this system 
different magnesium ion levels had a greater influence on 
product yield than on product specificity.
The next comparison performed was into the effect of 
different primer concentrations on product yield and 
specificity. Again, an optimal level (30 pmoles) was found 
which had a more significant influence on yield than on 
specificity.
The last comparison performed was into the effect of 
different dNTP concentration on product yield and 
specificity. As with the other biochemical comparisons an 
optimal concentration of dNTP was found (300)iM) ; but again 
its influence was greater on product yield than on product 
specificity.
The cloning strategy of using different enzyme restriction
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sites at the ends of the PCR primers, and precipitating both 
insert and vector together was successful in generating many 
clones containing the bovine PrP gene. On a theoretical 
basis all white colonies of sufficient size should contain an 
insert; but it was discovered that some of the selected white 
colonies appeared to contain no insert as judged by 
hybridization to a hamster PrP probe.
When the the bovine PrP gene was sequenced in both the 
forward and reverse directions the sequence data was found to 
be in total agreement. This suggests that the forward and 
reverse primers, and the sequencing method used were re­
liable. One of the bovine clones (C8) replaced the hamster
pEA974 probe in all subsequent hybridizations.
The PrP genes from three animals were sequenced. Two of the 
PrP sequences obtained in this study agreed entirely with 
that of a published sequence (Goldmann et al., 1991). The
third PrP sequence differed from the other sequences by a 
silent base change at position 234 (G to A) coding for
glutamine. This change occurs within the octapeptide region 
and this is not unusual as there are silent changes in each 
of the other octapeptide repeat segments. The question had to 
be addressed as to whether (in spite of the precautions 
taken) this base change was genuine or the result of a
PCR/cloning artefact. Subsequently, this sequence was shown 
to be genuine (chapter 6). All the PrP genes from the three 
different cows sequenced in this study had six copies of the 
octapeptide repeat motifs, like that of the published
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sequence (Goldmann et al., 1991). However, the published 
paper also stated that some bovine PrP alleles were found to 
contain five copies of the octapeptide repeat motifs. All the 
PrP genes from the other species sequenced to date have five 
copies of these octapeptide repeat motifs.
Codon usage comparisons showed that base distribution was not 
symmetrical with a strong bias for guanosine at positions 1 
and 2 and cytosine at position 3. The high occurrence of 
cytosine at position 3 is in keeping with animal nuclear 
genes which favour cytosine at that position. This base 
distribution reflected the higher GO content of the bovine 
PrP gene (55%). The high GO content of the bovine PrP gene is 
in keeping with the high occurrence of these two bases in the 
PrP genes of other species, and reflects the highly conserved 
nature of this gene.
Comparisons of codon usage of the bovine PrP gene with that 
of a database containing bovine genes suggests that there was 
some bias in the use of several codons. For example, the sole 
use of the - AAC - codon for asparagine, and the redundancy 
of at least two codons for those amino acids having six 
codons. The gê^^bank comprised 261 different bovine genes, 
therefore, with such a spread it is not unexpected that all 
codons coding for these particular amino acids should be 
represented but to varying degrees. In the case of the bovine 
PrP gene, the biased use of some codons may mean that the 
levels of t-RNA for that particular codon could in turn have 
some bearing on the levels of translation of the PrP gene.
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Preference for certain codons could also explain the 
conserved nature of the PrP gene especially since all the PrP 
genes from different species (chapter 9) sequenced to date 
have a strong preference for the - AAC - codon of 
asparagine.
A large ORF was observed in the DNA strand opposite the PrP 
transcriptional unit, a finding similar to that of 
Goldgaber's (1990) in humans. If this potential ORF was to be 
transcribed a protein similar in size (273) to the PrP 
protein would be produced. Whether this theoretical protein 
is actively synthesized in vivo remains to be determined. 
Hewinson et al.(1991) suggest that the fact that the first 
base of the codon on one strand corresponds to the third base 
on the other strand may provide a mechanism for maximum 
conservation of the two proteins. This provides a possible 
explanation of the high degree of interspecies conservation 
of the PrP protein.
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CHAPTER 5.
Analyses of Hindi! and Octapeptide Repeat Polymorphi sms 
Associated with the Bovine PrP Gene.
—180—
5.1.summary.
The distribution of octapeptide repeat and Hindll RFLPs were 
analysed in a large Holstein/Friesian dairy herd in which a 
large number of cases of BSE were occurring. Only animals 
homozygous (6:6) and heterozygous (6:5) for the octapeptide 
repeats were found in this herd. The overall ratio of 
homozygotes to heterozygotes was 4:1, and their distribution 
within confirmed BSE cases was 3:1: but these results were
not significantly different. Therefore, there was no link 
between the octapeptide repeat polymorphism and the incidence 
of BSE. Analyses of Hindll RFLPs revealed that 106 animals 
gave two restriction fragment bands (8.0 and 0.8 kb), whilst 
four animals gave one restriction fragment band (8.0 kb). All 
of the 16 BSE animals in this herd had two restriction 
fragment bands thus failing to establish any association 
between Hindll polymorphisms and the incidence of BSE.
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5.2. Introduction.
The bovine PrP gene structure obtained in the previous 
chapter gave a very uniform picture in that all three animals 
sequenced had six repeats of the octapeptide repeat motif 
-P-H-G-G-G-W-G-G- . This data agreed with the PrP sequence
reported by Goldmann et al. (1991) which, in addition to the 
PvuII polymorphism identified in our studies, also revealed 
the existence of two further polymorphisms within the coding 
region of the bovine PrP gene. The first concerned the number 
of octapeptide repeat motifs. Some animals were homozygous 
for this repeat motif, both alleles coding for six copies 
(6:6) of the octapeptide repeat motif. Other animals were 
shown to be heterozygous for the repeat motif, one allele 
coding for six copies and the other allele coding for five 
copies (6:5).
PrP sequence data from all the other species sequenced to 
date, e.g. human (Kretzschmar et al.. 1986), mink
(Kretzschmar et al.. 1992), hamster (Oesch et al.. 1985; 
Easier et al.. 1986), mouse (Locht et al ..1986; Westaway et 
al., 1981) , sheep (Goldmann et al ., 1990) has shown that they 
are all homozygous having five copies (5:5) of the 
octapeptide repeat motif. The only exceptions so far have 
been individuals with CJD from four families in which six 
extra copies of the octapeptide repeat motif were found 
(Collinge et al.. 1989, 1990 ; Laplanche et al., 1990; Owen 
et al.. 1989, 1990, 1991), whereas, normal members of these
families have five copies of this motif. Généalogie
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investigations have shown that all four families are related, 
suggesting a single origin of this motif. Other CJD patients 
were found who had an additional seven or nine copies of the 
octapeptide motif. Whilst examples of individuals having CJD 
linked to extra copies of the octapeptide repeat motif have 
been cited, other individuals have been identified who had a 
deletion of one octapeptide repeat (leaving four copies of 
this motif), or the addition of four extra copies of these 
octapeptide repeat, but in the latter individuals no signs 
of neurologic disease were found (Collinge et al 1990; 
Goldfarb et al..1990; Laplanche et al.. 1990; Owen et al..
1989, 1990, 1991).
The question arises as to whether the extra copy of the 
octapeptide repeat motif found in some cattle bears any 
relationship to the incidence of BSE. It was decided to study 
the possibility of a link between animals homozygous (6:6 and 
5:5) or heterozygous (6:5:) for the octapeptide repeat region 
and disease susceptibility. This was achieved by analysing 
their distribution in a large Holstein/Friesian dairy herd 
naturally infected with BSE.
The different forms of the bovine PrP gene, i.e. allelic 
variants with either 5 or 6 octapeptide repeats can 
conveniently be identified by carrying out PCR using primers 
which flank this repeat region. Such a PCR would produce one 
fragment in animals which are homozygous for the octapeptide 
repeats and two fragments in those animals which are 
heterozygous for these repeats. The two PCR fragments
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produced with heterozygotes differ from each other by 24 base 
pairs as would the single fragments produced by homozygotes 
(6:6) and (5:5) . This 24 base pair difference in PCR
products can be separated by electrophoresis through a 4% 
NuSieve GTG gel.
The base change at nucleotide 576 (a C to T transition) is a 
silent change in that both codons -AAC or AAT - code for the 
amino acid glycine. This base change also results in the 
deletion of a Hindll restriction site. Any possible linkage 
between this Hindll polymorphism and the incidence of BSE was 
investigated by carrying out RFLP analyses in the same 
naturally infected herd as above.
5.3. Results.
All basic methods used in this chapter are described in 
chapter 2. Any variations to basic methodologies are 
described where appropriate.
5.4 Case herd.
The herd studied was a large Holstein/Friesian dairy herd 
from Southern England in which, up to June 1991, 16 cases of
BSE had been confirmed out of a total of 110 animals blood 
sampled in 1988. Onset of clinical signs in animals with BSE 
was between five to six years of age, slightly higher than 
the average national age of four to five years. The animals 
were fed about 12kg (owner's estimate) of meat and bone meal 
between the ages of 1 and 4 months. In October 1988 blood 
samples were collected in heparinized vacuutainers from
-184-
selected animals, which were born in 1982-83 and were cohorts 
in which future cases of BSE were expected. 110 cows were 
used in this assessment. Of this population, 16 animals 
developed BSE, 55 were culled for commercial reasons, and the 
remaining 39 survived to 8-9 years of age.
5.5. Octapeptide Repeat Polymorphisms.
5.5.1. PCR Primers.
The octapeptide repeats start at base 160 and end at base 
309. The primers and the position they occupy within the PrP 
coding region are as follows :-
Primer 1: 5'-TGG AAC ACT GGG GGG AGC CGA TAC-3'. This was the
sense primer and started at base 99 (5'end) and ended at base
12;^ (3'end)
Primer 2: 5'-GCT GCA GCA GCT CCT GCC ACA TGC-3'. This was the
antisense primer and started at base 386 (5'end) and ended at
base 363 (3'end).
These primers produced a product of 287 basepairs with the 
six octa-peptide repeats and a 263 basepairs product with the 
five octapeptide repeats.
5.5.2. Nusieve Agarose Gels.
The method for preparing 4% NuSieve GTG agarose gels is given 
in chapter 2, section 2.7.3.
The PCR fragment given by the 6 octapeptide repeats and that 
by the 5 octapeptide repeats differed by only 24 basepairs. 
This difference was too small to allow these products to be 
differentiated on the basis of mobility using the standard
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agarose gels, Nusieve GTG agarose is a low gelling and 
melting temperature (65°C) agarose. It has a low viscosity 
and therefore can be used at high concentrations. This gives 
it the ability to resolve nucleic acid fragments less than 
1000 basepairs and can distinguish fragments as small as 8 
basepairs. It is thus ideal for distinguishing the 24 
basepair difference produced by the different octapeptide 
repeats.
An example of the separation of 5 and 6 octapeptide repeats 
is shown in Fig. 5.1.
In the case herd studied no animals were found which were 
homozygous for the 5 octapeptide repeats (5:5), i.e. no 
animals were found giving a single band of size 263 basepairs 
only.
Of the original 110 animals used in this study, DNA samples 
from seven animals could not be amplified by PCR. Therefore, 
only the remaining 103 samples were analysed for octapeptide 
repeats. Of these the number of animals which were homozygous 
for the 6 octapeptide repeats (6:6), i.e. produced a single 
band of 287 basepairs only was found to be 80. The number of 
heterozygotes (6:5), i.e. those animals giving two bands, one 
of 287 basepairs and one of 263 basepairs, was 23 giving a 
ratio of approximately 4:1 (Table 5.1). When only the BSE 
cases are considered, the number of homozygotes (6:6) was 12 
and the number of heterozygotes (6:5) was 4, giving a ratio 
of 3:1. The age of onset for the BSE homozygotes ranged from 
47 to 100 months, with a median age of 67 months. The age 
spread for the BSE heterozygotes was 62 to 74 months with a
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Figure 5.1. PCR of Octapeptide Repeat Region.
The octapeptide repeat region was amplified by PCR using 
primers which flanked this region. Alleles having six 
octapeptide repeats differed from those having five 
octapeptide repeats by an additional 24 bases. The five 
octapeptide repeats were separated from the six 
octapeptide repeats by electrophoresis through a 4% 
NuSieve agarose gel. DNA bands were visualized by 
staining with ethidium bromide. Lanes 1 and 15 are size 
markers/^, lanes 2 and 14 PCR controls (no DNA added to 
reaction tubes), lanes 3 -13 samples. An example of a 
homozygous (6:6) sample is found in lane ^ ,. An example 
of a heterozygous (6:5) sample is found in lanefP.
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Table.5.1. Summary of the Octapeptide Repeat 
Polymorphism Results.
BSE cases: there were 16 animals which showed clinical
signs of the disease and these animals were later 
confirmed as having BSE by histopathological 
examination. The statuatory regulations required that 
these animals were slaughtered as soon as the clinical 
signs became apparent.
Survivors: up to June 1991 these 39 animals were still
in this farmer's dairy herd showing no signs of clinical 
BSE.
Culls: these animals were slaughtered according to the
normal practices of dairy farming . There was no 
evidence to suggest that any of these animals displayed 
any clinical signs of BSE before slaughter.
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Table 5.1. Summary of Octapeptide Repeat Results.
BSE cases 
Survivors 
Culls
Total sample 
X2 = 0.056 (df = 1)
Octa-Repeats
6:6 6:5
12 4
33 6
35 13
80 23
-not significant at the 5% level.
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median age of 66 months. Statistical analysis using the Chi 
squared test showed that at the 5% level there was no 
significant difference between those animals which were 
homozygous for the octapeptide repeats, those animals which 
were heterozygous for the octa-peptide repeats and the 
incidence of BSE.
5.6. Hindi! RFLP Analysis.
Typical examples of Hindll restriction digests and a Southern 
blot are shown in Figures 5.2a. and 5.2b. respectively. These 
results show that cattle used in this study produced either 
two bands of 8.0 kb and 0.8 kb or a single band of 8.0 kb 
after Hindll digestion. The observation was made that some 
samples produced much thicker bands when probed, which led to 
the consideration that these thicker bands may have masked 
the presence of separate digest fragments of similar size 
which were not properly resolved on a 1% agarose gel. In 
order to examine this possibility, samples were 
electrophoresed through lower concentration gels e.g. 0.8%, 
0.7% etc. in order to separate bands of a similar size; 
however this procedure failed to resolve bands of different 
molecular weight as that seen in the 1% agarose gels.
The Hindu restriction digest results of all the animals used 
in this study are summarized in Table 5.2. These results show 
that 106 of the 110 animals, including all the 16 BSE cases , 
produced two bands. Only four animals (from the culled group) 
produced a single 8.0 kb band. As all 39 animals in the 
survivor group and 51 out of 55 of those animals that were
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Figure 5.2a. Hindll restriction digest pattern.
Lanes 2-13 show examples of bovine genomic DNA digested 
with Hindu, electrophoresed through a 1% agarose gel 
and stained with ethidium bromide.Lanes 1 and 15 had a 
lOObp ladder and a lambda/Hindlll molecular weight 
marker.
Figure 5.2b. Southern blot of Hindi! digest.
Lanes 1-14 show examples on a Southern blot of Hindll 
digests. The blot was probed with a bovine PrP probe. 
Hindu digestion produced 8kb and 0.8kb fragments or 8kb 
fragments only.
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Table 5.2. Summary of the Hindi! RFLP Results.
BSE cases; there were 16 animals which showed clinical 
signs of the disease and these animals were later 
confirmed as having BSE by histopathological 
examination. The statuatory regulations required that 
these animals were slaughtered as soon as the clinical 
signs became apparent.
Survivors: up to June 1991 these 39 animals were still
in this farmer's dairy herd showing no signs of clinical 
BSE.
Culls: these animals were slaughtered according to the
normal practices of dairy farming . There was no 
evidence to suggest that any of these animals displayed 
any clinical signs of BSE before slaughter.
194-
Table 5.2. Summary of Hindi! RFLP Results.
Hindu Hybridization Results.
8.0 + 0.8kb bands 8.okb band only
BSE cases 16 0
Survivors 39 0
Culls 51 4
Total sample 106 4
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culled produced two bands after digestion with Hindll it is 
unlikely that this polymorphism is linked to disease
susceptibility.
5.7.Discussion.
The herd studied comprised Holstein/Friesian cattle, a breed 
representing 90% of the national dairy herd. Onset of 
clinical signs in animals with BSE occurred between 5-6 years 
of age, which is only a slightly higher than national average 
of four to five years. The speed at which the clinical course 
of the disease progresses depends not only on the route of 
entry of the infectious agent but also on the dose, 
therefore, variations in the onset of BSE in different herds 
could be expected. In the present study the animals were fed 
about 12kg of meat and bone meal; but it cannot be assumed
that all the cattle received a uniform challenge because
contaminated feed may not have been distributed evenly 
through a batch of concentrates. This could exert an 
influence as to the number of animals developing the disease.
The observation that no animals were found which were 
homozygous for the 5 octapeptide repeats can best be 
explained by considering the general practice within the 
dairy cattle industry of using artificial insemination or 
stock bulls for breeding. This not only results in a smaller 
'bovine gene pool' compared to the sheep industry; but would 
mean that if the 'sire(s)' used in this herd was (were) 
homozygous for the 6 octa-peptide repeat then no 5 
octapeptide homozygotes would be found.
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Statistical analysis has shown that there was no significant 
difference between BSE-affected and unaffected animals in 
their distribution among either the homozygous (6:6) or the 
heterozygous (6:5) octapeptide repeat groups. These results 
could be interpreted in several ways. One interpretation 
would suggest that there was no direct correlation between 
6:6 or 6:5 polymorphisms and the incidence of BSE. This could 
then mean that either linkage occurs to an as yet undefined 
polymorphism of the bovine PrP gene or that disease 
occurrence and progression may not be modified by PrP 
genotype in cattle. It may be possible that the 6 octarepeat 
allele is dominant for susceptibility, and as it is of a very 
high frequency in the tested population any difference in the 
time of onset of BSE or pathogenesis would not be apparent.
The Hindu RFLP results show that there was no significant 
association between this polymorphism and the incidence of 
BSE. All the cattle except 4 exhibited an S.Okb band and a 
0.8kb band i.e. they were heterozygous for C/T at nucleotide 
576. The remaining 4 animals displayed a single band and were 
homozygous (T/T) at position 576. Again, these results 
suggest that either disease susceptibility occurs to an as 
yet undefined polymorphism or that the bovine PrP gene is not 
involved in the disease process. Recently, Ryan et al. (1991) 
have identified the same restriction site with the Hind II 
isoschizomer Hinc II. These workar^screened American cattle of 
different breeds and found 72.5% of the cattle had a single 
band of 6.6kb, 25.4% had both 6.6 and 7.4kb bands and 1.9 %
had only a 7.4kb band. Although this study involved only
-197-
cattle which were unaffected with BSE, nevertheless, the size 
of fragments and their frequency are difficult to relate to 
those in our study. The only possible explanations for the 
discrepancy in results could be due to differences in the 
size of PrP probe used, and differences in the breeds of 
cattle used in the respective studies.
Another possibility to be considered in the context of both 
the Hindu RFLP and the octapeptide repeat results is the 
possible linkage to the brain lesion profiles of infected 
cattle. So far the evidence from pathological studies of 
natural and experimental BSE cases has indicated a uniform 
pathogenesis (Wells, personal communication), which may be an 
indication that only one 'strain' of infectious agent is 
involved. In mice and sheep different strains of scrapie 
exist which can be recognised by characteristic brain lesion 
profiles they produce when inoculated into inbred strains of 
mice (Fraser et al.. 1988). Also characteristic are the 
respective incubation periods as determined by Sine and Sip 
genotype. For example, mice homozygous for the short 
incubation period allele (s7s7) when exposed to the ME7 
strain of scrapie have relatively short incubation periods 
whereas those homozygous for the long incubation period 
allele (p7p7) have prolonged incubation periods when 
challenged to the same strain. However, when the same mice 
are exposed to the 22A strain of scrapie the results are 
reversed, that is, si si mice having a longer incubation 
period than p7p7 mice. Although, to date, no incubation 
period gene has been identified in cattle, in mice and sheep
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there is a strong association between the PrP gene and the 
incubation period gene. By association, it would seem 
reasonable to expect a similar situation in cattle. The 
apparent lack of association between the incidence of BSE and 
the RFLP and octapeptide repeat results obtained in this 
study could be 'strain' related i.e. it may be more correct 
to say that there is no association between these two 
polymorphisms and the 'strain' of the infectious agent found 
in these animals.
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CHAPTER 6.
Sequencing of bovine PrP Gene using an Automated Sequencer
—200—
6.1.Summary.
Direct sequencing of the bovine PrP gene was achieved by 
amplification using a new forward primer. The amplified gene 
product was cleaned using a variety of protocols. The best 
clean up protocol in terms of quality of DNA template and 
yield was found to be Gelase. Early sequencing results 
indicated that up to 350 bases could be determined for a 
double stranded DNA template; but consistency and accuracy of 
sequence data varied due to technical limitations of the 
sequencing protocols. The use of new sets of forward and 
reverse primers spaced roughly 100 bases apart confirmed this 
view. Therefore, accurate sequence data on the automated 
sequencer was considered to be up to 200 base pairs from the 
primer. This was roughly the same read length as achieved 
with manual sequencing. Using these new primers direct 
sequencing of the PrP gene from six animals was compared 
using manual and automated methods. There was total agreement 
between the two sets of results. The data from the automated 
sequencer also confirmed the earlier result (chapter 4) that 
one animal had the base guanosine substituted by the base 
adenosine at position 234. The significance of this base 
change was investigated by sequencing the PrP gene from 
affected, unaffected and experimentally infected animals. 
There was no apparent link between this base change and 
disease susceptibility.
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6.2. Introduction.
In chapter 4, the bovine PrP gene was cloned into a plasmid 
vector and sequenced using a manual method. There was a 
requirement for more sequencing studies to be carried out, 
not only of more cattle PrP genes but also the PrP genes from 
other species such pigs and exotic bovids. It is thought that 
the causative agent in the BSE epidemic was transmitted in 
contaminated feed. Other species were fed the same 
contaminated feed; but their responses to the infectious 
agent were varied. Sequencing their PrP genes would allow 
comparison with cattle PrP genes to be made.
The strategy of cloning, before sequencing, the bovine PrP 
gene was successful, if time consuming. In order to sequence 
a larger number of samples a different strategy would have to 
be adopted. The route chosen (Figure 6.1.) was to amplify 
the relevant PrP gene from genomic DNA, purify the amplified 
product, then sequence the PrP gene using an automated 
sequencer (Applied Biosystems, model 373A). In order to 
validate the results of direct sequencing it was necessary to 
perform an initial comparison between the manual and 
automated methods.
The automated sequencer uses protocols which are based on the
same principle as that of manual sequencing i.e chain
35
termination (Sanger et al.,1977). Instead of the using -[S] 
labelled nucleotides, automated sequencer protocols use 
dideoxynucleotides labelled with fluorese^wi-dyes, a different
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dye for each of the four dideoxy terminators. The second 
major change introduced was that the sequencing protocol was 
to be based on a thermal cycling method using a cloned 
variant of the enzyme Tag polymerase (Amplitaq, Perkin 
Elmer). There are several advantages to be gained by adopting 
this protocol, they are :
- less sequencing template is required.
- secondary structure problems are greatly reduced, this is 
important as the PrP gene is - GC - rich.
- virtually eliminates secondary primer to template binding.
- Amplitaq is fast, highly processive and lacks exonuclease 
activity.
alkaline dénaturation step for double stranded DNA not 
usually required.
The principle on which the automated sequencer is based is 
summarized in Figure 6.2.
6.3. Results.
All basic methods used in this chapter including PCR clean up 
procedures and cycle sequencing are described in chapter 2. 
Any variations to basic methodologies are described where 
appropriate.
6.3.1. Amplification of PrP gene.
In chapter 4 the bovine PrP gene was amplified then cloned 
into a plasmid vector. The forward primer used in those 
experiments would not be suitable for the amplification of 
PrP sequencing template for direct sequencing. The reason for
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Figure 6.2. Schematic diagram providing an overview of 
the major principles involved in automatic sequencing.
Dye-labelled DNA fragments are loaded onto the gel. The
fragments are electrophoresed down the gel and are
separated according to size. When the fragments reach a 
fixed position above the lower buffer chamber, the
fluoresence of dyes is excited by light from a laser, 
which scans back and forth across this area of the gel. 
The fluorescence is collected by the photomultiplier 
tube after it passes through four different coloured 
filters, one for each dye. During the electrophoresis 
process, data is continuously collected across all lanes 
of the gel in the laser reading region. The DNA
sequencer is a real time electrophoresis detector i.e. 
bands are detected with the laser within a single 
horizontal plane on the gel as they pass that point. The 
collected data is analyzed automatically; but can be 
reconstructed, edited and printed at any time.
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this is that the PrP start codon (ATG) was in the middle of 
that primer, therefore, PrP product amplified and sequenced 
with it would result in the failure to determine the first 
few bases of the PrP gene, as sequence data can only be 
obtained starting a few bases downstream of a primer. When 
the PrP amplified product was cloned it was put into the 
polylinker site of a plasmid vector. As the polylinker site 
was a sufficient aujnber of bases downstream of the universal 
priming site the start of the PrP coding region could be 
sequenced. The reverse primer used to amplify the PrP gene in 
chapter 4, began about 40 bases downstream of the PrP stop 
codon, therefore, it was suitable for direct sequencing. The 
base sequence of the new forward primer was :
5'> CAT TTG ATG CTG ACA CGC TOT TTA <'3
The same cycling parameters were used to amplify the PrP gene 
as those used in chapter 4. The results show that the bovine 
PrP gene was successfully amplified using the new forward 
primer (Figure 6.3), producing a PrP product of 939 bp 
containing the whole of the coding region.
6.3.2. Preliminary sequencing studies using the automated 
sequencer.
Before a proper assessment of the automated sequencer could 
be made, some preliminary studies were necessary in order to 
optimize some of the protocols for use on the machine. A 
series of amplification tubes (16) together with controls (no 
DNA) were set up for each sample. Multiple amplifications, 
reduced the likelihood of sequencing errors due to PCR 
artefacts e.g incorporation of the wrong base. After PCR,
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Figure 6.3. PCR amplification of the bovine PrP gene 
using the new sense primer.
This figure shows that PCR amplification of the bovine 
PrP gene was successful using the new sense primer and 
the same concentrations of reagents and cycling 
parameters as those used to amplify the bovine PrP gene 
in chapter 4.
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the aqueous phases from the sample tubes were mixed and 
together aliquots prepared for purification of the DNA 
template. This stage was thought to be necessary because PCR 
primers and non-specific products could greatly influence the 
overall quality of sequencing e.g. number of bases that could 
be determined and yield of DNA template. A series of clean up 
procedures were compared and assessed using the same 
sequencing primer. Table 6.1. shows the type of clean up 
procedure and the percent recovery of DNA, and Figure 6.4. 
shows examples of sequencing chromatograms obtained after 
each of the clean up procedures. These results show that all 
the methods worked to a degree. For example, the procedure of 
phenol/chloroform extraction directly on the PCR product 
produced DNA template of sufficient quality to obtain some 
sequence data; but only a small number of bases could be 
determined (50 bases). The results of these studies were 
assessed in terms of DNA yield and quality of sequence (low 
signal to noise ratio and number of bases). The results can 
be summarized as follows :
- electrophoresis through agarose gels followed by the clean 
up procedure produced the best results.
- the yield of DNA was consistently higher with the use of 
TAB buffers compared to TBE buffers.
- the use of the enzyme gelase gave the best overall result 
and was used as the clean up procedure for all subsequent 
experiments. The agarose is digested by gelase and remains in 
solution on precipitation of the DNA by alcohol. DNA 
recovered by this method produced high yield and good quality 
sequencing template.
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Table 6.1. Comparison of DNA purification procedures.
PCR amplified products were purified using a variety of 
procedures. The majority of the procedures involved 
electrophoresis through a 1.2% agarose gel. DNA bands 
were visualized by staining with ethidium bromide. PrP 
bands were cut out, pooled, and an equivalent aliquot 
processed by each method. This process was carried out 
with both TAE and TBE as the gel buffer. Gelase (TAE) 
gave the highest recovery (spectrophotometer) and this 
was arbitrarily set at 100 percent, and DNA recoveries 
by all the other procedures were calculated as a 
percentage of this figure. In all cases the use of TAE 
as a gel buffer resulted in higher DNA recovery rates 
than TBE buffer. In addition three direct methods were 
also tried as a means of DNA purification. These results 
showed that the highest recovery was achieved with magic 
prep columns.
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Figure 6.4. Sequencing Chromatograms obtained after 
various PCR clean up procedures.
This figure provides examples of the quality of 
chromatograms (automated sequencer) obtained after each 
of the PCR clean up procedures (Table 6.1.). The 
following procedures were used after the PCR product was 
electrophoresed through a low melting agarose gel:
a) gelase digestion using TAE as the gel buffer.
b) " " " TBE " " " ".
c) magic prep using TAE as the gel buffer
II II II TBE " ” " ”
e) prepagene using TAE as the gel buffer.
f) " " TBE " " " "
g) phenol/chloroform using TAE as the gel buffer
h) " " TBE " " " ”
The following procedures were used directly on the PCR 
product :
i) magic prep
j) centricon columns 
k) phenol/chloroform.
Usable sequence data was obtained with all the methods 
tried; but the yield of PCR product and the number of 
bases which could be read varied (Table 6.1).
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6.3.3. Direct sequencing of the bovine PrP gene using the 
automated sequenced.
The PrP gene from two of the bovine samples that were 
sequenced by the manual method (chapter 4) were sequenced 
using the automated sequencer. The PrP genes were sequenced 
in both directions using the same primers that were used in 
the manual procedure. The raw sequencing data produced by 
each of the primers were aligned using a lasergene computer 
programme Figure 6.5. Comparison of these automated results 
with those obtained using the manual method (Figure 6.6) 
showed one bovine sample with six nucleotide differences (and 
three further nucleotides which could not be resolved by the 
automated sequencer) corresponding to six amino acid changes 
(possible nine in total) and the other bovine sample showing 
seven nucleotide and two amino acid changes. Careful 
examination of the chromatograms highlighted one possible 
area which might explain the discrepancy in the results. A 
different fluorescent dye is used for each of the four 
dideoxy terminators, but they do not produce the same 
intensity of signal when excited by the laser e.g the C deoxy 
terminator produces a lower intensity signal than a G or T 
deoxy terminator. With the double stranded DNA template used 
in this study the automated sequencer read lengths of between 
200 and 350 bases; but the intensity of all the signals 
decreases as chain termination increases and there comes a 
point, when for example, a genuine C is mistaken as a T 
because the intensity of the C signal is lower than a 
background T signal. The decision was taken to test this 
hypothesis by designing new sets of forward and reverse
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Figure 6.5. Schematic diagram showing computer alignments 
of PrP sequence data obtained with each primer.
The sequence data obtained with each of the forward and 
reverse primers are aligned using a lasergene alignment 
package. Each primer,its sequence length and position 
within the PrP coding region is shown in the schematic 
diagram of a typical PrP sequence.
-thick lines with numbers above refer to base positions 
within PrP coding region.
solid arrows refer to sequence obtained with forward 
primers.
-SF and G30 refer to forward primers, and the number 
following it to a specific forward primer (Table 6.2a).
dashed lines refer to sequence data obtained with 
reverse primers
- R refers to reverse primer, and the number following it 
to the specific reverse primers (Table 6.2b).
The alignment programme is based on three contributory 
factors. The first uses the Wilbur and LipmanA algorithm, 
where regions of similarity are found by constructing 
K-letter words (K-tuples). K-tuple size is the number of 
nucleotides in a unit of comparison e.g. bases that are 
equal to the K-value in length and form an exact match in 
both sequences are a -tuple. The second factor computes 
the similarity index, which is the number of matching 
bases divided by the sum of mismatching, matching bases 
and the number of gaps. Gap penalties (third factor)are 
set to cover gaps in a strand.
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Figure 6.6. Comparison of preliminary sequencing data 
obtained with the automated sequencer with that from 
manual sequencing.
The comparison of preliminary sequence data obtained 
with the automated sequencer for bovine sample (38/89) 
with data obtained by manual sequencing showed numerous 
differences . These base changes differences translated 
into at least six amino acid differences between the two 
methods. There could have been more amino acid 
differences because three bases could not be determined 
by the automated sequencer.
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Table 6.2a. List of forward sequencing primers.
Primers used to sequence the forward strand of the 
bovine PrP gene were chosen so that they were roughly 
100 bases apart and at least 20 bases long.
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Table 6.2b. List of reverse strand primers.
Primers used to sequence the reverse strand of the 
bovine PrP gene were chosen so that they were roughly 
100 bases apart and at least 20 bases long.
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primers spaced roughly 100 base pairs apart. The new primers 
are listed in Table 6.2a (forward) and Table6.2b (reverse). 
The same two samples were sequenced again and this time there 
was 100 percent agreement with the sequence data obtained by 
the manual method. This confirmed the hypothesis above and 
lengths up to 200 bases were considered reliable. At this 
stage it was decided to compare a total of six samples 
including two of the cloned PrP genes. To sequence the cloned 
PrP genes the forward and reverse universal primers were also 
used, and the precaution taken of denaturing the plasmid 
using sodium hydroxide before cycle sequencing. The results 
were in total agreement, including the 234 (G to A) base 
change found in one of the clones (chapter 4).
The greater sequencing capacity of the automated sequencer 
allowed the significance of the G to A transitions to be 
investigated by sequencing the PrP genes was from six animals 
known to have BSE, six unaffected animals and six 
experimentally challenged animals. All the PrP genes were 
identical in sequence, therefore, the results failed to 
reveal differences between affected ,unaffected and 
experimentally challenged animals.
6.4. Discussion.
The aim of this chapter was to validate the accuracy of 
sequence data obtained directly from amplified PrP gene 
products, using an automated DNA sequencer. The overall 
strategy proved successful e.g. the new forward PCR primer, 
the clean up procedures and cycle sequencing all worked. The
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automated sequencer greatly increased sample throughput; but 
there were limitations which were not anticipitated. The main 
limitation was that although a large number of bases (200-350 
bases) were obtained from double stranded DNA, consistency 
and accuracy could not be guaranteed. Therefore, a 
compromise had to be struck, accepting shorter read lengths 
by increasing the numbers of sequencing primers. By adopting 
this approach the read lengths, accuracy and reproducibility 
of both manual and automated sequencing were found to be the 
same.
The sequencing of bovine PrP genes using the automated 
sequencer confirmed the results obtained in chapter 4, i.e. 
that one animal had the base guanosine substituted by that 
base adenosine at position 234.
The possibility that this base change could be linked to 
disease susceptibility was investigated by carrying out a 
pilot study of its distribution in six affected, six 
unaffected and six experimental cattle. The PrP sequence data 
from the 18 cattle failed to prove a link between the 234 G/A 
polymorphism and the incidence of disease.
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CHAPTER 7.
Determination of the Nucleotide and Deduced Amino Acid 
Sequence of the Kudu PrP.
—226—
7.1. Summary.
The PrP gene of the exotic bovid kudu was amplified and 
sequenced using the same primers as those used to sequence 
cattle PrP genes. The distribution of bases to the different 
codon positions was not random and echoed the distribution 
pattern of PrP genes from other species. The kudu PrP gene 
was heterozygous for the octapeptide repeat region, having 
both five and six copies of this region. Therefore, the two 
alleles of the kudu PrP gene were 795 bases (six octarepeats) 
and 771 bases (five octarepeats) long. This corresponded to a 
deduced PrP protein of 264 and 256 amino acids respectively. 
Within the octarepeat regions there were seven base 
differences between the five and the six octarepeat alleles. 
Three base differences were silent; but the other four bases 
led to the presence of different amino acids at the 
respective positions within the repeat regions. The allele 
having six octarepeat regions had a serine and two glycines 
in segment one (Rl) replaced by proline, glutamic and 
aspartic acid respectively and in segment four (R4) a glycine 
in the six octarepeat allele was replaced by a valine in the 
five octarepeat allele. A large potential ORF was observed in 
the DNA strand opposite the PrP transcriptional unit.
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7.2•Introduction.
The first cases of BSE were diagnosed in 1986. Previous to 
these reports in cattle the only recorded cases of
scrapie-like diseases of ruminant species, other than sheep 
and goats, were in captive mule deer and rocky mountain elk
(Williams and Young 1980, 1982). Since 1986, sporadic cases
of scrapie-like spongiform encephalopathy have been recorded 
in exotic captive bovids in Great Britain. These incidents in 
exotic species appeared to be geographically and
contemporaneously related to the common source epidemic of 
spongiform encephalopathy in cattle (Jeffrey and Wells 1988; 
Wiiesmith et al.. 1988). The reasons for this assumption were 
that all affected animals have been from collections in the 
south of England where the incidence of TSE in cattle has 
been the greatest (Wiiesmith et al.. 1988 ; Kirkwood et al.,
1990). Exotic bovids were fed commercial dairy pellets which 
contained contaminated meat and bone meal; but from February 
1987 these pellets were replaced by browsing pellets which 
contained no meat and bone meal.
In this chapter the PrP gene of one group of exotic 
ungulates, greater kudu, was sequenced. There are several 
reasons for sequencing the PrP gene from this particular 
group of exotic bovids. The first is that cases of TSE have 
been reported in kudu born after the feed ban of 1987. This 
suggested that maternal or lateral transmission may have been 
involved. Epidemiological studies of scrapie in sheep 
indicate that direct natural transmission is the means of 
sustaining the disease within a population (Dickinson et al.,
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1974; Hourrigan et al.. 1979). Therefore, in this respect
kudu appear to follow the scrapie pattern in sheep, in that 
maternal and lateral transmission may occur (Kimberlin, 
1990). To date natural transmission has not been recorded in 
cattle. The second reason for sequencing the kudu PrP gene is 
that kudu appear particularly susceptible to spongiform 
encephalopathy and it does not appear to make any difference 
whether the disease was food borne, maternally or laterally 
transmitted. In domestic cattle the usual clinical course of 
the disease is between 30 to 90 days whereas in kudu the 
disease progressed so rapidly that death (naturally or humane 
euthanasia) occurs between 12 hours and three days after the 
onset of clinical signs (Kirkwood et ^ . , 1990, 1992).
7.3. Results.
All basic methods used in this chapter are described in 
chapter 2. Any variations to basic methodologies are 
described where appropriate.
7.4. Amplification of kudu PrP gene from genomic DNA.
Kudu belong to the same genus as cattle, therefore, it was 
decided to try the same amplification primers and cycling 
parameters as those used to amplify the bovine PrP gene. The 
results of kudu PrP gene amplification are shown in Figure
7.1. and confirm that the primers and cycling conditions 
worked.
7.5. Sequencing the repeat region within the kudu PrP gene.
Using the same argument as above, i.e. that of the 
relatedness between kudu and cattle, the same batch of
-229-
Figure 7.1. Amplification of the kudu PrP gene.
The kudu PrP gene was amplified from genomic DNA using 
the same primers and conditions used to amplify the 
bovine PrP gene. Aliquots of the PCR amplified PrP gene 
product were electrophoresed through a 1% agarose gel 
together with a lambda/HindiII size marker. DNA bands 
were visualized by staining with ethidium bromide.
Lane 1-4 : amplified PrP genes from different kudu. Lane 
1 was animal - 0346, lane 2 - Diana, lane 3 - Kaz, lane 
4 - Karla.
Lane 5 : no DNA control.
Lane 6 : lambda/Hindlll size marker.
- 2 3 0 -
6 5 4 3 2 1
- 2 3 1 -
sequencing primers were used to determine the sequence of the 
kudu PrP gene as were used to determine the bovine PrP gene 
sequence. The first major observation made from this sequence 
data (Figure 7.5) was that the kudu PrP gene contained six 
copies of the octapeptide repeat regions. This raised the 
question as to whether these animals were homozygous (6:6) 
or heterozygous (6:5) for the octapeptide repeats? For 
example, in bovines that were heterozygous for the 
octapeptide repeat region, the repeat elements of the six 
repeat allele were labelled Rl, R2, R3, R4, R5 and R6. The
five allele had the repeat elements Rl, R2, R4, R5, and R6.
The shared repeat elements were identical in cattle (Goldmann 
et al..1991) and, therefore, they were not easily identified 
when sequencing. To resolve this question, the decision was 
made to amplify the octapeptide region. The results are 
shown in Figure 7.2. and indeed show that the kudu studied 
here were polymorphic for these octapeptide repeat regions, 
having both five and six copies.
The next question to be addressed was which of the repeat 
elememts was absent in the five octapeptide repeat allele ? 
To answer this question, the repeat regions were amplified, 
separated, and the DNA extracted and sequenced in both 
directions. The results of sequencing the octapeptide region 
are shown in Figure 7.3. These results show that the best fit 
between the five and the six octapeptide repeats results in 
the absence of repeat segment R3 from the five octarepeat 
allele. This result was the same as that found in cattle.
The results also show seven base changes between the five and
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Figure 7.2. Amplification of the kudu octapeptide repeat 
region.
The octapeptide repeat regions from four kudu were 
amplified together with two bovine control samples. One 
bovine sample was heterozygous (6:5; lane 5) and the 
other homozygous (5:5; lane 6) for the octapeptide 
repeat region. Aliquots of PCR amplified product were 
electrophoresed through a 4% NuSieve agarose gel and DNA 
bands visualized by staining with ethidium bromide.
Lane 1-4 : kudu samples.
Lane 5 : bovine control sample (6:5)
Lane 6 : bovine control sample (5:5)
Lane 7 : no DNA control.
Lane 8 : 100 bp ladder.
All four kudu were heterozygous, having both five and 
six copies of the octapeptide repeat region.
- 2 3 3 -
7 6 5 4 3 2 1
- 2 3 4 -
Figure 7.3. Nucleotide sequence of the kudu octapeptide 
region.
The kudu octarepeat region was amplified. The five and 
six octarepeats were separated on a 4% agarose gel and 
the extracted DNA sequenced in both directions. The 
best alignment of the five and six octarepeats showed 
that the R3 repeat segment is absent from the five 
octarepeat allele. There are seven base differences 
between the two repeat regions. Repeat segment Rl has 
four base changes, segments R4, R5 and R6 have one base 
change each. The numbers 5 and 6 at the end of each line 
of sequences, refers to the sequence data obtained from 
the five and six octarepeat allele respectively.
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the six octapeptide repeat regions. The deduced amino acid 
sequence (Figure 7.4) of the region showed that three out of 
the seven changes were silent; but the remaining four base 
changes lead to amino acid differences. In repeat segment Rl, 
where the six octapeptide allele had the amino acids serine, 
glycine, glycine, in the five octarepeat they were replaced 
by the amino acids proline, asparagine and aspartic acid at 
the equivalent positions. In repeat segment R4, a glycine in 
the six octapeptide allele was replaced by a valine at the 
equivalent position of the five octapeptide allele.
Fragments of kudu PrP gene outside the octapeptide repeat 
region were amplified with appropriate primers and no 
evidence was found to indicate that there were other large 
base deletions or additions between the two alleles.
7.6. Complete sequence of the kudu PrP gene.
The complete sequence of the kudu PrP gene is shown in Figure
7.5. and refers to the allele containing six octapeptide 
repeat segments. Other than the changes within the 
octapeptide repeat region, which have been discussed above, 
there were no other changes between the five and the six 
octarepeat alleles in the remainder of the PrP sequence. The 
kudu therefore has ORFs of 771 (five octapeptide repeat 
allele) and 795 bases (six octapeptide repeat allele) leading 
to deduced proteins of 256 and 264 amino acids respectively. 
Thé corresponding theoretical molecular weights were 28,052 
and 28,647 Daltons. The two proteins had the same number of 
strongly basic amino acids (lysine and arginine) with 22 each 
; but different numbers of strongly acidic amino acids
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Figure 7.4. Deduced amino acid sequence of the five and 
the six octarepeat region.
An alignment was made of the deduced amino acid sequence 
of the five and six octapeptide repeat regions. Within 
the repeat region there are four amino acid differences 
between the proteins encoded by five and six octarepeat 
alleles. In repeat segment Rl where the six octarepeat 
protein has the amino acids serine, glycine, glycine, 
these are replaced by the amino acids proline, glutamic 
and aspartic acid respectively in the five repeat 
protein. In repeat segment R4 of the six octarepeat 
protein the amino acid glycine is replaced by the amino 
acid valine in the five octarepeat protein. The numbers 
5 and 6 at the end of each sequence of amino acids 
refers respectively to the data obtained from the five 
and the six octapeptide repeats.
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Figure 7.5. Nucleotide and deduced amino acid sequence 
of the kudu PrP gene.
The complete nucleotide and deduced amino acid sequence 
of the kudu PrP gene is shown. The sequence presented 
here is that of the allele containing six octarepeats. 
Those amino acids underlined in Figure 7.5. are replaced 
in the five octarepeat allele by those lisfred below.
Six octarepeats. Five octarepeats.
S (serine) P (proline)
G (glycine) E (glutamic acid)
G (glycine) D (aspartic acid)
G (glycine) V (valine)
The sequence of eight amino acids underlined are absent 
in the five octarepeat sequence.
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I l  150
TTTTGCAGATAARTCATCATGGTGAAAAGCCACATAGGCAGTTGGATCCTGGTCCTCTTTGTGGCCATGTGGAGTGACGTGGCC
Met Va! Lys Ser His Ile Gly Ser Trp lie Leu Val Leu Phe Val Ala Met Trp Ser Asp Val Ala 
1 15
I100 I150
CTCTGCAAGAAGCGACCAAAACCTGGAGGAGGATGGAACACTGGGGGGAGCCGATACCCGGGACAGGGCAGTCCTGGAGGCAAC 
Leu Cys Lys Lys Arg Pro Lys Pro Gly Gly Gly Trp Asn Thr Gly Gly S er Ang Tyr Pro Gly Gin Gly S e r  Pro Gly Gly Asn 
30 45
1200
CGCTATCCATCTCAGGGAGGGGGTGGCTGGGGTCAGCCCCATGGAGGTGGCTGGGGCCAGCCCCATGGAGGCGGCTGGGGCCAG 
Arg Tyr Pro SST Gin G|y. Gly Gly £ ly . Trp  Gly Gin Pro His Gly Gly Gly Trp  Gly Gin Pro His Gly GIv GIv T rp  Gly Gin
60 75 
1250 1300
CCTCATGGAGGTGGCTGGGGTCAGCCCCATGGTGGTGGTTGGGGACAGCCACATGGTGGTGGAGGCTGGGGTCAAGGTGGTACC
Pro His G!y Gly Gly Trp Gly Gin Pro His Gly Gly Gly Trp Gly Gin Pro His Gly Gly Gly Gly Trp Gly Gin Gly Gly Thr
90 105
1350 1400
CACGGTCAGTGGAACAAGCCCAGTAAGCCAAAAACCAACATGAAACATGTGGCAGGAGCTGCTGCAGCGGGAGCAGTGGTAGGG
His Gly Gin Trp Asn Lys Pro Ser Lys Pro Lys Thr Asn Met Lys His Val Ala Gly Ala Ala Ala Ala Gly Ala Val Val Gly
1450
GGCCTTGGTGGCTACATGCTGGGAAGTGCCATGAGCAGGCCTCTTATACATTTTGGCAGTGACTATGAGGACCGTTACTATCGT
Gly Leu Gly Gly Tyr Met Leu Gly Ser Ala Met Ser Arg Pro Leu Ile His Phe Gly Ser Asp Tyr Glu Asp Arg Tyr Tyr Arg 
135 150
1500 1550
GAAAACATGTACCGTTACCCCAACCAAGTGTACTACAGGCCAGTGGATCAGTATAGTAACCAGAACAACTTTGTGCATGACTGT
Glu Asn Met Tyr Arg Tyr Pro Asn Gin Val Tyr Tyr Arg Pro Vol Asp Gin Tyr Ser Asn Gin Asn Asn Phe Val His Asp Cys 
165 180
1600 1650
GTCAACATCACAGTCAAGCAGCACACAGTCACCACCACCACCAAGGGGGAGAACTTCACCGAAACTGACATCAAGATGATGGAG
Val Asn Ile Thr Val Lys Gin His Thr Val Thr Thr Thr Thr Lys Gly Glu Asn Phe Thr Glu Thr Asp Ile Lys Met Met Glu 
195 210
1700
CGAGTGGTGGAGCAAATGTGCATCACCCAGTACCAGAGAGAATCCGAGGCTTATTACCAACGAGGGGCAAGTGTCATCCTCTTC
Arg Val Val Glu Gin Met Cys Ile Thr Gin Tyr Gin Arg Glu Ser Glu Ala Tyr Tyr Gin Arg Gly Ala Ser Val Ile Leu Phe 
225 240
1750 1795
TCTTCCCCTCCTGTGATCCTCCTCATCTCTTTCCTCATTTTTCTCATAGTAGGATAGGGGCAACCTTCCTGTTTTCATTATCTT 
Ser Ser Pro Pro Val Ile Leu Leu Ile Ser Phe Leu Ile Phe Leu Ile Val Gly •
255 264
CTTAATCTTTACCAGGTTGGGGGAGGGAGTATCTACCTGCAGCCCTGTAGTGGTGGTGTCTCATAAAA
- 2 4 1
(aspartic and glutamic). The six octarepeat protein had 14 
acidic residues whilst the five octarepeat protein had 16 
acidic residues. This gave rise to a predicted isolectric 
point for the six octarepeat protein of 9.381, and the 
expected lower figure of 9.127 for the five octarepeat 
protein. The number of hydrophobic residues were the same, 
68 amino acids each. The six octarepeat protein had 73 polar 
residues compared to the 71 polar residues of the five 
octarepeat protein.
The PrP gene from four different kudu were sequenced, and all 
were found to have identical sequences. This is not 
surprising as all captive kudu in Great Britain are 
interrelated. One animal (Diana) sequenced is still alive and 
apparently not showing any clinical signs. The three other 
kudu have succumbed to TSE, namely, Diana's daughter, son and 
granddaughter. Diana's daughter died at 30 months of age 
(Kirkwood et al.. 1990), her granddaughter at 19 months of age 
(Kirkwood et al.. 1992), and her son at 24 months of age.
7.7. Codon Base Distribution.
The distribution of bases at each of the codon positions is 
not random (Table 7.1.) . The -GC - rich nature of the kudu 
PrP is reflected in the strong bias towards guanosine at 
codon positions 1 (35.0%) and 2 (32.0%) and towards cytosine 
at codon position 3 (33.2%). These codon distribution figures 
are similar to the figures at the equivalent position in 
cattle. The overall -GC- content of the kudu PrP gene is 
55.85 per cent which is similar to the overall -GC- content
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Table 7.2. Distribution of bases at each of the codon 
positions, hijn jkhe^ kudu PrP QBne. i
No. of times each Base (%)
base has occurred A C 6 T
Position 1 of codon 25.7 24.1 35.0 15.1
Position 2 of codon 29.8 17.0 32.0 21.2
Position 3 of codon 17.4 33.2 26.0 23.4
The base distribution of bases at each of the codon positions
was not random. There was a preponderance of guanosine at 
codon positions 1, an excess of guanosine at position 2 and a 
preponderance of cytosines at codon position 3.
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of 55.50 per cent in the cattle PrP gene. These distribution 
patterns are expected as PrP genes are highly conserved and 
in addition kudu and bovines belong to the same genus.
7.8. Anti-PrP Protein.
A large ORF has been found in the strand opposite the PrP 
transcriptional unit of both the five and six octapeptide 
repeat allele. The reverse strand of the five octapeptide 
repeat allele has the potential to encode eight amino acids 
fewer than the six octarepeat allele. In addition, the 
difference in base compositions between the two alleles leads 
to a possible seven different amino acids in the reverse 
protein as compared to the forward (PrP) protein difference 
of four amino acids. The kudu anti-PrP nucleotide sequence 
together with deduced amino acids is shown in Figure 7.7.
7.10. Discussion.
Kudu appear to be very susceptible to TSE and existing 
evidence suggests that food borne, maternal or lateral 
transmission is possible (Cunningham et al.,1993). Due to the 
close evolutionary relationship of kudu and cattle and the 
conserved nature of PrP genes, amplification and sequencing 
of the kudu PrP gene was achieved successfully using exactly 
the same set of primers as those used for the cattle PrP 
gene.
The base distribution at each of the codon positions in kudu 
confirms the general view that it is not random for PrP 
genes. There is a strong bias towards guanosine or cytosine
-244-
Figure 7.6. Nucleotide and deduced amino acid sequence 
of the Anti-PrP protein.
This figure shows the potential ORF in the strand 
opposite the PrP transcriptional unit. The ORF is 
present in both the five and the six octarepeat alleles. 
If this theoretical anti-PrP protein is synthesized, 
then the base difference (underlined) between the five 
and the six repeat alleles would result in a difference 
of seven amino acids between the two proteins.
P - refers to the PrP nucleotide and deduced amino acid 
sequence.
A - -refers to the anti-PrP nucleotide and deduced amino 
acid sequence.
! mark appears every 50 bases
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I l  150
t t t t g c a g a t a a r t c a t c a t g g t g a a a a g c c a c a t a g g c a g t t g g a t c c t g g t c c t c t t t g t g Gc c a t g t g g a g t g a c g t g g c c  d
Met Val Lys Ser His Ile Gly Ser Trp lie  Leu Val Leu Phe Val Ala Met Trp Ser A ^  Val Ala
A A A A CG T[:TA T.TYA G TAG IA C i:A C I.IT JC G G T G T A T C C G If:A A C C T A R R A rC A R R A R A A A C A rC G G T A C A rrT rA rT R rA rrR R  A  
Lys Ala Ser Leu Asp Asp Hls_HlS-Rhe .Aia_Va!_Tyr-A!a J h r Pro Asp Gin Asp Glu lys His Gly His Pro Thr Val His Gly
1100 I 150
CTCTGCAAGAAGCGACCAAAACCTGGAGGAGGATGGAACACTGGGGGGAGCCGATACCCGGGACAGGGCAGTCCTGGAGGCAAC 
Leu Cys Lys Lys Arg Pro Lys Pro Gly Gly Gly Trp Asn Thr Gly Gly Ser Arg Tyr Pro Gly Gin Gly Ser Pro Gly Gly A ai 
30 45
g a g a q g t t c tt c g c t g g t tjt g g a c c tc c tc c ia c c tt g tg a c c c c c c tc g g c t a tg g g c c c t g tc c c g tc a g g a c c t c c g t tg
Glu Ala I mu I au Ser Trp Phe Arg Ser Ser Ser PrQ_Val Ser Pro Pro Ala Smr Vnl Arg I au Ain Thr Arg Sar Ala Vnl
1200
CGCTATCCATCTCAGGGAGGGGGTGGCTGGGGTCAGCCCCATGGAGGTGGCTGGGGCCAGCCCCATGGAGGCGGCTGGGGCCAG 
Arg Tyr Pro Ser Gin Gly Gly Gly Gly Trp Gly Gin Pro His Gly Gly Gly Trp Gly Gin Pro His Gly Gly Gly Trp Gly Gin
60 75
G GG AIAG GTAGAGTCCCTCCCCCACCGACCCG AG TCG GG GTACCTCCACCG ACCCrG G TGG GG G TACCTG CG CCGArrCrGG Tr 
- A laJ Ie-T rp  Arg Leu Ser Pro Thr. Ala Pro Thr_Leu Gly Met Ser Thr Ala Pro Ala Leu Gly Met Ser Ala Ala Pro Ain I mu
1250 1300
CCTCATGGAGGTGGCTGGGGTCAGCCCCATGGTGGTGGTTGGGGACAGCCACATGGTGGTGGAGGCTGGGGTCAAGGTGGTACC 
Pro His Gly Gly Gly Trp Gly Gin Pro His Gly Gly Gly Trp Gly Gin Pro His Gly Gly Gly Gly Trp Gly Gin Gly Gly Thr
90 105
g g a g ta c c tc c a c c g a c c c c a g tc g g g g ta c c a c c a c c a a c c c c tg tc g g tg ta c c a c c a c c tc c g a c c c c a g ttc c a c c a tg g
_Arg Met Ser_Thn Ala Pro Thr Leu Gly Met Thr Thr Thr Pro Ser l eu Trp Met Thr Thr Ser Ala Pro Thr Leu Thr Thr Gly
1350 1400
c a c g g t c a g t g g a a c a a g c c c a g t a a g c c a a a a a c c a a c a t g a a a c a t g t g g c a g g a g c t g c t g c a g c g g g a g c a g t g g t a g g g
His Gly Gin Trp Asn Lys Pro Ser Lys Pro Lys Thr Asn Met Lys His Vol Ala Gly Ala Ala Ala Ala Gly Ala Vol Val Gly120
Æ IG C C A G T C A C n T J G T T C G G G T C A T T C G G T T J X T G G T T G T A C T T T G T A C A C rC T rrT rG A rG A C G T rG C rG T rG T rA C rA T rrr  
Vol Thr 1 mu Pro Val Leu Gly Thr Leu JppPhe.Gly Val Hls Phe Mat Hls Cys Gmr SAr  Rmr Gya Arg Rmr Gya Hlfi Tyr Pm
1450
GGCCTTGGTGGCTACATGCTGGGAAGTGCCATGAGCAGGCCTCTTATACATTTTGGCAGTGACTATGAGGACCGTTACTATCGT 
G ^  Leu Gly Gly Tyr Met Leu Gly Ser Ala Met Ser Arg Pro Leu Ik»^ His Phe Gly Ser Asp Tyr Glu Asp Arg Tyr Tyr Arg
GCGGAACCACCGATGTACGACCCTTCACGGTAC.TCGTCCGGAGAATATGTAAAACCGTCACTGATACTCCTGGCAATGATAGCA 
 Ala Lys Thr_ Ala Vol Hls Gin Ser Thr Gly Hls_Ala Pro Arg Lys Tyr Met Lys Ala Thr Vol lie Leu Vnl Thr Vol lie Thr
1500 1550
GAAAACATGTACCGTTACCCCAACCAAGTGTACTACAGGCCAGTGGATCAGTATAGTAACCAGAACAACTTTGTGCATGACTGT 
Glu Asn ^ t  Tyr Arg Tyr Pro Asn Gin Vol Tyr Tyr Arg Pro Val Asp Gin T ^ S e r  ^  Gin Ami Ami Phe Val Hls te p  Cys
£ J T -ITG TA C A TG G C A A TG G G G TTG G TTC A C A TiiA TG JX C G G JC A C C TA G TC A TA TrA TTG G TrTTG TTG A A A C A C G TA C TG A C A  
Phe-Vol Hls Vol Thr Val Gly Val Leu Hls Vol Vol Pro Trp Hls lie l^ ii lie Thr Val Leu Val Val Lys Hls Met Vol Thr
1600 1650
GTCAACATCACAGTCAAGCAGCACACAGTCACCACCACCACCAAGGGGGAGAACTTCACCGAAACTGACATCAAGATGATGGAG 
Val Asn lie  Thr Val Lys Gin Hls Thr Val Thr Thr Thr Thr Lys Gly Glu AÎsn Phe Thr Glu Thr Asp Ile  Lys Met Met Glu
195 210
CAGT.TGTAG.TG TCAG TTCGTCG TGTG TCAG TGG TG GTG G TGG TTCCCr.CTCTTG AAGTGRnTTTG ArTG TAGTTCTACTAr.CTC  
Asp Val Asp Cys Asp l eu I eu Val Cys A«p Gly Rly_GLy_Gly Leu Pro Leu Vnl Glu Gly Phm Sar Val Asp I au HIr Hls I au
1700
CGAGTGGTGGAGCAAATGTGCATCACCCAGTACCAGAGAGAATCCGAGGCTTATTACCAACGAGGGGCAAGTGTCATCCTCTTC 
Ang Val Val Glu Gin Met Cys lie  Thr Gin Tyr Gin Arg Glu Ser Glu A a  Tyr Tyr Gin Arg Gly A a  Ser Val lie  Leu Phe 
225 240
O C TfA C C A C C TfG TTTA C A C G TA G TG G G TC A TG G TC TC TC TX A G G C TC C G A A TA A TG G TTR G TrcrrG TTC A rA G TA G G A G A A G  
Ser..HlS..HlS .Leu Leu-Hls Alg Asp Gly Leu_Vgl I ftii Ser Phe Gly J e u Ser 11» Vnl I >»it 5k»r Pro Gys Thr Asp Asp Glu Glu
1750 1795 1816
TCTTCC^T^TGTjSATCÇTCCTCATCTCTTTCCTCAJTTTTCTCATAGTAGGATAGGGGCAACCTTCCTGTTTTCATTATCTT Ser Ser Pro Pro Val lie  Leu Leu lie Ser Phe Leu Ile  Phe Leu Ile  Val Gly •
255 264
AG AAGGGGAGGACACTAGGAGGAGTAGAGAAAGRAGTAAAAAGARTATCATCrTAirPnGGTTGGAAGGArAAAAGTAATAGAA  
Arg Gly_Arg_Arg Hls Asp Glu Glu Asp Arg Glu Glu Asn l ys Glu Tyr Tyr Ser Leu Pra Leu Arg Gly Thr Lys Met
CTTAATCTTTACCAGGTTGGGGGAGGGAGTATCTACCTGCAGCCCTGTAGTGGTGGTGTCTCATAAAA
GAAJTAGAAAIGGICCAACCCCCTCCCT£i^y^T^GAC:GTCGGGACATCACCACrACAGAGTATTTT
at each of the three positions. The percentage -GC - content 
and codon base distribution in kudu more closely resembles 
that of the cattle PrP gene than that of any of the other 
species that have been studied to date. This would be 
predicted as both belong to the same extended family.
Sequencing results showed that kudu were heterozygous for the 
octapeptide repeat regions, having both five and six copies 
of these repeats. This result was analogous to that of some 
cattle and suggests, that in the case of PrP genes, some 
breeds of cattle and kudu have a shared evolutionary pathway. 
This point is strengthened with the consideration that, 
except for some CJD patients where the existence of extra 
copies of these repeat regions has been demonstrated, all 
species sequenced to date have five copies of these repeats.
The two octarepeat alleles of cattle (Goldmann et al., 1991)
have been shown to have identical base sequences in their 
shared repeat segments (R1,R2,R4,R5 and R6). In kudu there is 
overall agreement with cattle with the R3 segment being 
absent from the five repeat allele. The kudu differs from 
cattle in that there are base differences between the 
octarepeat alleles. More significantly, four of the seven 
base differences have led to changes in amino acids at the 
respective positions. In segment Rl of the kudu, there are 
three amino acid differences between the two repeat alleles 
(which would confer different properties on them). At the 
first position of Rl the six repeat allele has the amino acid 
serine and the five repeat allele the amino acid proline. The
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latter amino acid is also found in cattle at this position. 
Serine has an uncharged polar R group (at physiological pH) 
and is more soluble in water than hydrophobic residues 
because of the hydroxyl group. Proline is a hydrophobic amino 
acid and therefore less soluble in water and also has a rigid 
R group which can affect the three dimensional structure of a 
protein. The six octarepeat allele also has four glycine 
residues; but in the five octarepeat allele two of these 
glycines have been replaced by glutamic and aspartic acid. 
Glycine residues are considered to have an uncharged polar R 
group. Glutamic and aspartic acids are strongly acidic 
residues, and if the isolectric points of the two alleles are 
compared, that of the five octarepeat allele containing the 
glutamic and aspartic acid is lower (pH 9.13) than that of 
the six repeat allele (pH 9.38). In repeat segment R4, a 
glycine in the six octarepeat allele is replaced by the 
residue valine in the five octarepeat allele. The properties 
of these two amino acids are different with valine being 
hydrophobic. It would appear that the amino acid differences 
of the two octarepeat alleles in kudu could give rise to PrP 
proteins which have vastly different properties. No 
conclusion can be drawn at this stage as to whether or not 
these changes are responsible for susceptibility of kudu to 
TSE or they have an affect on disease progression, i.e. the 
short time between detectable clinical signs of disease and 
death of the animal.
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CHAPTER 8.
Determination of the Nucleotide and Deduced Amino Acid 
Sequence of the Porcine PrP Gene.
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8.1. Summary.
The porcine PrP gene was amplified using the same primers and 
cycling parameters as those used to sequence the bovine PrP 
gene. The PCR derived template was sequenced directly using a 
combination of bovine and porcine specific primers on an 
automated DNA sequencer. Base distribution patterns and codon 
usage comparisons of the porcine PrP gene confirmed the 
highly conserved nature of both. The porcine ORF consisted of 
257 amino acids and contained a putative signal peptide, two 
hexapeptide and five octapeptide repeat regions, a conserved 
hydrophobic region, two potential N-1inked asparagine 
glycosylation sites and two cysteine residues with the 
potential to form disulphide bonds. The porcine PrP gene had 
two unique amino acids (tyrosine and alanine) positioned 
towards the C-terminal end of the protein. The strand 
opposite to the PrP transcriptional unit was observed to have 
a large potential ORF.
—250—
8.2. Introduction.
Epidemiological studies of the BSE outbreak in Great Britain 
has indicated a common source of infection. Cattle were 
exposed to a scrapie-like pathogen via consumption of 
contaminated feedstuffs - rendered meat and bone meal 
(Wilesmith et al .,1988). Over the same period pigs were also 
fed these contaminated feedstuffs but no natural cases of 
porcine spongiform encephalopathy have been reported in Great 
Britain. Surveys of the inclusion rate of meat and bone meal 
in the porcine diet varies with the type of diet (rearing or 
sow rations) which in turn is related to the age of the pig 
(Wilesmith, personal communication). The range of inclusion 
rate for rearing rations is from zero to 15 per cent, with 
the national average between 2 -3 per cent. The inclusion 
rate for fattening and sow rations is from zero to 9 per
cent, with the national average being 2 per cent (Wilesmith, 
personal communication). In comparison, the inclusion rate of 
contaminated feedstuffs in the bovine diet was lower with a 
national average of 1-2 per cent. This raises two 
possibilities, first, in spite of the higher (average) 
inclusion rates of contaminated meat and bone meal in their 
diets, pigs are resistant to natural disease. Second, it is 
also possible that pigs are not resistant to disease but
clinical signs are obscured by normal pig farming practices. 
The pig population of Great Britain is about 8 million, the 
majority of which are killed within 140 days of birth.
Breeding sows and boars survive to 3-5 years of age,
therefore they are the only animals in which the disease can
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manifest itself. TSEs have long incubation periods and it 
remains to be determined if the lifespan of these animals is 
of long enough duration for clinical signs to appear.
It has been demonstrated that the disease can be induced 
experimentally in pigs following parenteral challenge with 
BSE infected brain homogenates (Dawson et al.,1990). The 
paper reported the results of the transmission of BSE to one 
pig. Clinical signs appeared 69 weeks after inoculation and 
the animal was killed after 74 weeks.
The porcine PrP gene was sequenced because comparisons with 
TSEs in other species have shown that this gene appears to 
play a crucial part in the disease process.
8.3. Results.
All basic methods used in this chapter are described in 
chapter 2. Any variations to basic methods are described 
where appropriate. The porcine PrP gene was sequenced 
directly from PCR amplified product on the ABI automated 
sequencer.
8.3.1. FOR Of porcine PrP gene.
The PCR primers, dénaturation and cycling parameters used 
were the same as those used for the amplification of the 
bovine PrP gene from bovine genomic DNA (chapter 6). An 
example of the amplification of the porcine PrP gene is shown 
in Figure 8.1. These results show that a single DNA band (of 
expected size) was produced, thus indicating the suitability 
of these primers and conditions for amplifying the porcine
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Figure 8.1. Amplification of the Porcine PrP Gene.
The porcine PrP gene was amplified using the same 
primers and cycling parameters as those used to amplify 
the bovine PrP gene. An aliquot of the amplified product 
was electrophoresed through a 1% agarose gel, stained 
with ethidium bromide and photographed. Lanes 1 and 3 
are examples of amplified porcine PrP gene product from 
genomic DNA. Lanes 2 and 4 are PCR controls (no DNA 
present). Lane 5 is a 100 bp ladder.
- 2 5 3 -
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PrP gene.
8.3.2. Porcine PrP Sequence.
The amplified porcine PrP gene product was genecleaned as 
described in the previous chapter, prior to sequencing. The 
sequencing strategy adopted was the same as that previously 
used, i.e. to sequence both DNA strands of the porcine PrP 
gene. Initially, the sequencing primers used to determine the 
sequence of the bovine PrP gene were used to sequence the 
porcine PrP gene: but only seven out of the 14 sequencing
primers worked successfully. Nevertheless, taking the forward 
and reverse primers as a whole, sequence data for nearly the 
whole of the porcine PrP gene was obtained. In order to 
completely sequence both DNA strands, seven porcine specific 
primers were selected on the basis of results of the porcine 
sequencing data thus far obtained. In order to increase 
specificity the latter primers were synthesized as 24 base 
long oliginucleptides, and were designed using the Oligo 
computer programme^ to minimize the possibility of hairpin 
loop formation, primer dimers and nonspecific binding to 
other areas of the PrP gene (based on bovine, sheep and part 
of pig sequence). The seven pig primers and the bovine 
primers that they replaced are shown in Table 8.1. An example 
of porcine sequence data using the old bovine primer and the 
corresponding new porcine primer is shown in Figure 8.2. 
These results show that the bovine primer produced low 
signals and signal to noise ratios compared to the pig
primer which produced high signals and signal to noise 
ratios, thus, producing good sequence data. These seven
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Table 8.1. List of the porcine specific sequencing 
primers and the bovine primers that they replaced.
Initial sequencing results of the pig PrP gene showed 
that some of the primers used to sequence the bovine PrP 
gene were not sufficiently specific enough. Therefore, 
they were replaced by porcine specific primers. The 
porcine specific primers are in red.
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Figure 8.2. Chromatogram of part of Porcine PrP sequence 
derived using old (bovine) and new (porcine) primers.
Chromatograms A) old bovine primer and B) porcine 
specific primer, provide examples of the difference in 
quality of sequence data obtained using the porcine 
specific primers.Using some of the bovine primers led to 
lower signals: A: 148; C:191; G:144; T:120 and Ioîa/
signal to noise ratios. The replacement porcine primers 
produced higher signals: A:300; 0:196; G:446; T:187 and
signal to noise ratios.
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■)
A ATQ T TTTT GGQQOOCC C QAQ«NQGATC T CT A NTCTNGQ QNGTCNQ NNNA 
«0 70 _ 80 00 100
WQN3C4N7NTNAQ()OkGAANTNCNAANAAGr#B]NNT T TTTT TNTT1 
210 220 230 - 240 250 280
TTA rit*3CA' N AGAM^ NANCAG NACTMTNNNTN N NNGM^ AGTCf^ WCTOW GNG NC AT
370 380 300 400 410 420
■=)
i^ UGCTCTGCA /^ ÿAAGCG AOC^AAGCCTGGCGG AG GATGG A ACACTGGG’C
QAGGTGGCTGGGG ACAGCCCCACGGAGGOGGTTQONG ACAQCCCC
3Îo°^ ^CAGTA A^ Q^ CCGAA AACCAACA TGANGNAJNTGGCA GG330 340
primers replaced their bovine counterparts and together with 
the other primers used in sequencing the bovine PrP gene were 
used in uil subsequent sequencing of the pig PrP gene. The 
PrP gene from 14 pigs were sequenced and there was 100% 
agreement between the sequences.
8.3.6. Primary Structure of Porcine PrP.
The porcine ORF (Figure 8.3.) consists of 774 nucleotides, 
corresponding to a protein of 257 amino acids with a 
molecular weight of 27,730 prior to any post translation 
modifications. The sequence of the first 24 amino acids of 
the porcine PrP protein is consistent with that of a signal 
peptide (von Heijne, 1985), i.e. positively charged N 
terminus, hydrophobic core and a small uncharged residue 
(cysteine) at the putative cleavage site. The mature protein 
is predicted to commence at lysine residue 25 and have a 
molecular weight of 25,131 prior to post translational 
modifications. In common with the deduced PrP proteins from 
other species there are two possible asparagine-linked 
glycosylation sites at amino acid positions 185 and 201. 
There are two hexapeptide repeat motifs , the first 
-GGS/NRYP- is found between codons 37-42 and the second 
between codons 48-53. The deduced porcine PrP protein has 
also been found to have five copies of the octapeptide repeat 
motif - PQ/HGGGWQG - which begins at codon 54. The 
identification of the five octapeptide repeat motifs was 
confirmed by PCR of this region (Figure 8.4.)
8.3.4 Codon base distribution.
The distribution of bases for each of the codon positions was
-260—
Figure 8.3. Nucleotide sequence and deduced amino acid 
sequence of the porcine PrP gene.
The porcine PrP gene is 774 bases long corresponding to 
a deduced protein of 257 amino acids and it has five 
octapeptide repeat regions
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! 1 ! 5 0
TTTTG CAGATAAG TAATCATG GTG AAAAG CCATATAGGTGGCTG GATCCTCGTTCTCTTTGTG GCCG CATG GAGTG ACATAG GG
M et Val Lys S e r  His lie  Gly Gly Trp  He Leu Val Leu Phe Val Ala Ala T rp  S e r Asp He Gly 
 ^ M O O  M 5 0
CTCTGCAAGAAGCGACCAAAGCCTGGCGGAGGATGGAACACTGGGGGGAGCCGATACCCAGGGCAGGGTAGTCCTGGAGGCAAC
Leu Cys Lys Lys Arg P ro  Lys Pro Gly Gly Gly T rp  Asn T h r Gly Gly S e r  Arg Tyr Pro  Gly Gin Gly S e r  Pro  Gly Gly Asn
3 0  4 5
1200
CGCTATCCACCCCAGGGAGGGGGTGGCTGGGGACAGCCCCACGGAGGTGGCTGGGGACAGCCCCACGGAGGCGGCTGGGGACAG
Arg T y r P ro  P ro  Gin Gly Gly Gly Gly Trj> Gly Gin P ro  His Gly Gly Gly T rp  Gly Gin Pro His Gly Gly Gl^ T rp  Gly Gin 
1250 •300
CCCCACGGTGGCGGCTGGGGACAGCCCCATGGTGGCGGAGGCTGGGGTCAAGGTGGTGGCTCCCACGGTCAGTGGAACAAGCCC
P ro  His Gly Gly Gly T rp  Gly Gin Pro His Gly Gly Gly Gly Trp  Gly Gin Gly Gly Gly S e r His Gly Gin T rp  ly s  Pro
3 5 0  'AGTAAGCCGAAAACCAACATGAAGCATGTGGCAGGCGCCGCTGCAGCTGGGGCAGTGGTAGGGGGCCTCGGCGGTTACATGCTG
S e r  Lys P ro  Lys T h r Asn Met Lys His Val Ala Gly Ala ^ A l a  Ala Gly Ala Val Val Gly Gly Leu Gly Gly T y r Met Leu
1 4 5 0
GGGAGTGCCATGAGCAGACCCCTGATACACTTTGGCAGTGACTATGAGGACCGTTACTATCGTGAAAACATGTACCGTTACCCC
Gly S e r  Ala M et S e r  Arg Pro Leu He His Phe Giy S e r Asp Tyr Q u  Asp Arg Tyr T y r Arg Giu Asn M et T y r Arg T y r  Pro  
, 5 0 0  1 5 5 0AACCAAGTGTACTACAGGCCAGTGGATCAGTACAGCAACCAGAACAGTTTTGTGCATGACTGCGTCAACATCACCGTCAAGCAG
Asn Gin Val T y r T y r Arg P ro  Val Asp Gin Tyr S e r Asn Gin Asn S e r Phe Val His Asp Cys Val Asn H e T h r Val Lys Gin
1600 1650
CACACAGTGACCACGACCACCAAGGGGGAGAACTTCACCGAGACGGACGTCAAGATGATAGAGCGCGTGGTGGAACAGATGTGC
His T h r Val T h r T h r T h r  T h r Lys Gly Glu Asn Phe T h r Glu T h r Asp Val Lys Met H e Glu Arg Val Val Glu Gin Met Cys 
1 9 5  2 1 0
1 7 0 0
ATCACCCAGTACCAGAAAGAGTACGAGGCGTACGCCCAAAGAGGGGCCAGTGTGATCCTCTTCTCCTCCCCTCCTGTGATCCTC
H e T h r Gin T y r  Gin Lys G ^ T y r  Glu Ala T y r Ala Gin Arg Gly Ala S e r  Val He Leu Phe S e i^ S e r P ro  P ro  Val H e Leu
C TC A T C T C T TTC C TC C TTTTC C TC A TA G TG G G C TG Â G G G TG G C C TTTC TG TC G G C A TC A TC TTC TTA A TC TTTA TC A G G TTG G G
Leu H e S e r  Phe Leu Leu Phe Leu He Val Gly •
2 5 7
GG AG GGAATATCTACCTG CAGCCCTG TAGTG GTG GTG TCTCATTA
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Figure 8.4. Amplification of the porcine octapeptide 
repeat region.
The porcine octapeptide region was amplified using the 
same primers and conditions as these used to amplify the 
bovine octapeptide repeat regions. Aliquots of PCR 
products were electrophoresed through a 4% Nusieve 
agarose gel together with 6:5 and 6:6 octapeptide 
controls. The gel was stained with ethidium bromide.
Lane 1: control 6:6 octapeptide repeat.
Lane 2: control 6:5 octapeptide repeat.
Lane 3: porcine sample (5:5).
Lane 4: 100 bp ladder.
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Table 8.2. Percentage distribution of bases at each of 
the codon positions.
The distribution of bases at each of the codon positions 
was not random. There was a relative bias towards 
guanosine at codon positions one and two and cytosine at 
codon position 3.
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Table 8.2. Distribution of bases at each of the codon 
positions, w i _ t  hi n _t h e _ _ p o _ r c  i ne P nP g G ne.
No. of times each Base (%)
base has occurred A C 6 T
Position 1 of codon 25.1 24.2 36.0 15.7
Position 2 of codon 29.5 17.0 32.2 21.3
Position 3 of codon 15.1 39.9 28.7 16.2
The base distribution of bases at each of the codon positions 
was not random. There was a bias towards guanosine at codon 
positions 1 and 2 and cytosines at codon position 3.
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not random (Table 8.3). At codon position 1 there is a 
relative bias towards guanosine residues (36%) and a relative 
bias against thymidine residues (15.7%) with both adenosine 
and cytosine occurring in roughly equal proportions at 25.1% 
and 24.2% respectively. This distribution pattern at codon 
position 1 of the pig is very similar to that found in cattle 
(guanosine 35%, adenosine 25.7%, cytosine 24.9% and thymidine 
14.3%) . The base distribution levels at codon position 2 of 
the pig was again almost identical to that found in cattle 
with the occurrence of guanosine highest at 32.2% followed by 
adenosine (29.5%), thymidine (21.3%) and cytosine (17%). The 
equivalent base distribution at codon position 2 in cattle 
was guanosine 32.4% , adenosine 29.8%, thymidine 21.1% and 
cytosine 16.6%. At codon position 3 the levels of cytosine 
were highest at 39.9% followed by guanosine (28.7%), 
thymidine (16.2%) and adenosine (15.1%). This distribution 
pattern at codon position 3 of the pig was different to that 
found in cattle (cytosine 31.3%, thymidine 25.3%, guanosine 
24.1% and adenosine 19.3%).
The bias in favour of guanosine and cytosine residues at each 
of the three codon positions reflects the -GC- rich nature of 
the pig PrP gene. The percentage of - GC- residues in the 
coding region of the pig PrP gene is 59.3% which is 
consistent with the high levels of these residues found 
within the coding region of the PrP genes from other species, 
mouse (59.3%), hamster (58.6%), human (58.3%), sheep (55.5%) 
and bovine (55%). Therefore, the base distribution pattern 
found in the pig was as expected and reflects the highly 
conserved nature of PrP genes.
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8.3.7. Anti-PrP protein.
The DNA strand opposite to the PrP transcripitional unit in 
the pig was shown shown to have a large potential ORF (Figure 
8.5.). This observation, which was first noted by Goldgaber 
(1991) has also been noted to occur opposite the PrP 
transcriptional units in all other species sequenced to date. 
Within the area of the pig PrP sequenced no stop codons were 
found in the large potential ORF on the reverse strand. The 
observation was also made that the other two reading frames 
contained possible - ATG - start codons; but they also 
contained numerous stop codons, which, if translated would 
have led to peptides or short proteins.
8.4. Discussion.
The aim of the work carried out in this chapter was to 
sequence the porcine PrP gene. The route chosen was to 
amplify the porcine PrP gene by PCR followed by sequencing 
using an automated sequencer. Due to the conserved nature of 
PrP genes the same primers and amplification conditions used 
to amplify the bovine PrP gene were tried and found to work 
equally well on porcine genomic DNA generating template 
suitable for analysis in the automated sequencer.
The success of the porcine PCR using bovine primers and 
conditions suggested that it might be possible to use the 
same bovine sequencing primers. The results obtained with the 
bovine sequencing primers were variable, some primers working 
better than others. This provided an early indication that 
although PrP genes are highly conserved, there were some
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Figure 8.5. Nucleotide and deduced amino acid sequence 
of the porcine anti-PrP.
This Figure shows the sequence of the large ORF found 
opposite the porcine PrP gene (anti-PrP). No stop codon 
was found within the length of DNA sequenced.
P - refers to the porcine PrP nucleotide and deduced 
amino acid sequence.
A - refers to the anti-PrP and deduced amino acid 
sequence which is also underlined.
! marks appear every 50 bases.
-269-
Il 150
TTTTGCAGATAAGTAATCATGGTGAAAAGCCATATAGGTGGCTGGATCCTCGTTCTCTTTGTGGCCGCATGGAGTGACATAGGG D  
Met Val Lys Ser His Ile Gly Gly Trp Ile Leu Val Leu Phe Val Aka Aka Trp Ser Asp Ile Gly
AAAAGGTCTAI.I.CATTART.ACCACTTTTCGGTATATCCACf:RArrTAGGAGCAARARAAArArrRCf!CTAt!CTnArTGTATrrr A 
-lys Ala Ser. Leu Tvr Asp His His Phe Ala MeUyr Thr Ala Pro Asp Glu Asn Glu lys His Gly Cys Pro Thr Val Tyr Pro
1100 1150
CTCTGCAAGAAGCGACCAAAGCCTGGCGGAGGATGGAACACTGGGGGGAGCCGATACCCAGGGCAGGGTAGTCCTGGAGGCAAC 
leu Cys Lys Lys Arg Pro Lys Pro Gly Gly Gly Trp Asn Thr Gly Gly Ser Arg Tyr Pro Gly Gin Gly Ser Pro Gly Gly Asn 
30 45
£AGACGIJCTTCGCTRRTTTCGGACCGCCTCClACCTTRTGACCCCCCTCGCGTATRRRTCCCGTCCrATCACGArCTCrGTTR 
-Glu . Ala Leu Leu Ser Trp Leu Ara.AJa Ser Ser Pro Val Ser Pro Pro Aim Rmr Vgj Trp Prm l_mu Thr Thr Arg Ser Ain Vnl
1200
CGCTATCCACCCCAGGGAGGGGGTGGCTGGGGACAGCCCCACGGAGGTGGCTGGGGACAGCCCCACGGAGGCGGCTGGGGACAG 
Arg Tyr Pro Pro Gin Gly Gly Gly Gly Trp Gly Gin Pro His Gly Gly Gly Trp Gly Gin Pro His Gly Gly Gly Trp Gly Gin
60 75
GCGATAGGTGGGGTCCCTCCCCCACCGACCCCTGTCGGGGTGCCTCCACrRArrrCTGTCGCCGTRCCTCCGCCGACCrCTRTr 
-Aka.Ile-Trp Gly leu Sec.Pro Thr Ala Pro Ser Leu Gly Val Ser Thr Ala Pro Ser Leu Gly Val Ser Ain Ala Pro Ser I wii
1250 1300
CCCCACGGTGGCGGCTGGGGACAGCCCCATGGTGGCGGAGGCTGGGGTCAAGGTGGTGGCTCCCACGGTCAGTGGAACAAGCCC 
Pro His Gly Gly Gly Trp Gly Gin Pro His Gly Gly Gly Gly Trp Gly Gin Gly Gly Gly Ser His Gly Gin Trp Asn Lys Pro
90 105
fiOGGTGCCACCGCCGACCCCIGTCGGGGTACCACCGCCTCCGACCCCAGTTCCACCACrGAGGGTGCCAGTCACCTTGTTCGGG 
-Glv-Val Thr Ala Ala Pro Ser. Leu_Gly_Het.Thi^ Ala Ser Ala Pro Thr l eti Thr Thr Ala Gly Val Thr Leu Pro Vol l eu Gly
1350 1400
AGTAAGCCGAAAACCAACATGAAGCATGTGGCAGGCGCCGCTGCAGCTGGGGCAGTGGTAGGGGGCCTCGGCGGTTACATGCTG 
Ser Lys Pro Lys Thr Asn Met Lys His Val Ala Gly Ala Ala Ala Ala Gly Ala Val Val Gly Gly leu Gly Gly Tyr Met Leu
120
■TCATTCGGOTJT.TGGTTRTACTTCGTACACCGTCCGCGGCGACGTCGACrrrRTrACrATCrrrrGGAGnGGrrAATGTArGAr 
■Jhr Leu Am Phe.Glv Val-Hls leu Met_Hls..Cys.Ala Gly Ser Cys Ser Pro Cys His Tyr Pro Ala Glu Ala Thr Val His Gin
1450
GGGAGTGCCATGAGCAGACCCCTGATACACTTTGGCAGTGACTATGAGGACCGTTACTATCGTGAAAACATGTACCGTTACCCC 
Ser Ala Met Ser Arg Pro leu He His Phe Gly Ser Asp Tyr Glu Asp Arg Tyr Tyr Arg Glu Asn Met Tyr Arg Tyr Pro 
135 150
CCCTCACGQTAC.TCQTCTQQGGAC.TATGTGAAACCGTCACTGATACTCCTGGCAATGATARrACTTTTGTArATGGCAATGGGG 
-Pro .Thr Glv-Hls-Alo Ser-Glv Gln-Tyrjfal.-Lys Ala Jhr. Val He Leu Vol Thr Val Tla Thr Phm Vnl Hlg Vnl The Vnl Gly
1500 1550
AACCAAGTGTACTACAGGCCAGTGGATCAGTACAGCAACCAGAACAGTTTTGTGCATGACTGCGTCAACATCACCGTCAAGCAG 
Asn Gin Val Tyr Tyr Arg Pro Val Asp Gin Tyr Ser Asn Gin Asn Ser Phe Val His Asp Cys Val Asn He Thr Val Lys Gin 
165 180
IIGGTTCACAIGAIGTCCGGTCACCTAGTCATGTCGTTGGTCTTGTCAAAACACGTACTGACGCAGTTGTAGTGGCAGTTGRTG 
-Val leu HIS-VaLVal Pro Trp His He Leu Val AlaJVal Leu Val Thr Lys His Met Val Ala Asp Val Asp Gly Asp Leu Leu
1600 1650
CACACAGTGACCACGACCACCAAGGGGGAGAACTTCACCGAGACGGACGTCAAGATGATAGAGCGCGTGGTGGAACAGATGTGC 
His Thr Val Thr Thr Thr Thr Lys Gly Glu Asn Phe Thr Glu Thr Asp Val Lys Met He Glu Arg Val Val Glu Gin Met Cys
195 210
GTGTGTCACTGGTGCTGGTGGTTCCCCCTCTTGAAGTGGCTCTGCCTGCAGTTCTACTATCTCGCGCAGrArCTTRTrTArAnR 
..Val Cys HlS..GIy.Aro.Gly-Glv..Leu-PrQ Leu Val Glu Gly Leu Arg Val Asp Leu His Tyr leu Ala His His Phe Leu His Ala
1700
ATCACCCAGTACCAGAAAGAGTACGAGGCGTACGCCCAAAGAGGGGCCAGTGTGATCCTCTTCTCCTCCCCTCCTGTGATCCTC 
He Thr Gin Tyr Gin Lys Glu Tyr Glu Ala Tyr Ala Gin Arg Gly Ala Ser Val He Leu Phe Ser Ser Pro Pro Val lie Leu 
225 240
JAGTGGGTCAIG.GICmC.TCATGCTCCGCAIJÎCGGGTTTCTCCCCGGTCACACTAGGAGAAGAGGAGRRRARGArArTAGGAR 
-Asp GlY..Leu.Val .Leu.Ebe Leu Val Leu Arg Val Gly leu Ser Pro.Gly Thr His Asp Glu Glu Gly Gly Arg Arg His Asp Glu
1750 1774 1795
CTCATCTCTTTCCTCCTTTTCCTCATAGTGGGCTGAGGGTGGCCTTTCTGTCGGCATCATCTTCTTAATCTTTATCAGGTTGGG leu He Ser Phe Leu Leu Phe Leu He Val •
£AGTAGAGAAA£GAGGAAAAGGAG.TATCACCCGACICCCACCGGAAAGACAGCCGTAGTAGAAGAATTAGAAATAGTrPAArrr 
Glu Asp Arg Obr Glu Lys Glu Glu Tyr His Ala Ser Pro Pro Arg Giu Thr Pro Mftt
GGAGGGAATATCTACCTGCAGCCCTGTAGTGGTGGTGTCTCATTA
CCTCCCTTATAGATGGAnGTPGGGAPATrArPAPrAnAGAGTAAT
differences between the bovine and porcine PrP gene. Porcine 
specific primers were designed based on sequence data 
obtained from the above procedure. This strategy proved 
successful and the porcine PrP gene was completely sequenced 
in both directions. The sequencing data obtained in each 
direction showed no discrepancies providing evidence for the 
accuracy of the methods used. All 14 pigs sequenced were of 
the same breed and there was 100% agreement between the 
sequences. Therefore, no polymorphisms were identified within 
the coding region of the porcine PrP gene in the animals 
sequenced in this study.
Codon usage comparisons showed that base distribution was not 
random with a strong bias for guanosine at positions 1 and 2 
and cytosine at position 3. This bias in the base 
distribution pattern was almost identical to that found in 
cattle with the exception that at codon position 3 the levels 
of guanosine and thymidine were reversed. This base 
distribution pattern for the porcine PrP gene reflected its 
very high - GC - content (59.3%), which was in keeping with 
the high occurrence of these two bases in the PrP genes from 
other species, and further reflects the highly conserved 
nature of PrP genes.
The deduced porcine PrP protein has some characteristic amino 
acid structures in common with the PrPs from other species 
e.g. N-terminus signal peptide, two possible
asparigine-1inked glycosylation sites, two hexapeptide repeat 
motifs and five copies of the octapeptide repeat motif, 
indicating a common function for this protein in different
-271-
species. The number of octapeptide repeat motifs in the pig 
is consistent with the number found in the PrPs of all 
species sequenced, except for some bovine PrPs and some CJD 
patients. Applying the notation Goldmann used f
bovine PrPs, the R5 octapeptide repeat motif of cattle having 
six repeats is not present in pigs. The pig had two unique 
amino acids (tyrosine and alanine) positioned towards the 
C-terminal end of the PrP protein. These two unique porcine 
residues are found just before a serine residue which, in 
hamsters has been shown to be the attachment site of a GPI 
anchor on removal of the hydrophobic C-terminal. A more 
thorough comparison of the porcine PrP gene with the PrP 
genes from all the other species published to date is found 
in chapter 9.
The observation was made that the strand opposite the porcine 
PrP transcriptional unit contained a large potential ORF 
(anti-PrP). The same potential anti-PrP ORF has been observed 
in other species such as sheep, bovine, human, mouse and 
hamster; but unlike these species no stop codon was found in 
the pig anti-PrP within the length of DNA sequenced. 
Therefore, unlike the potential bovine anti-PrP which if 
translated would have 273 amino acids, the size of the 
potential porcine anti-PrP cannot be determined at present.
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CHAPTER 9.
Comparisons of the Nucleotide, Deduced Amino Acid and 
Predicted Secondary Protein Structures of PrPs from different 
Species.
-273-
9.1.Summary.
The PrP proteins from different species vary in size. The 
human PrP is 253 amino acids long, mouse and hamster 254
amino acids, sheep, bovine and kudu (five octapeptide
repeats) 256 amino acids, pig and mink 257 amino acids and 
bovine and kudu (six octapeptide repeats) 264 amino acids. 
Comparisons of PrPs from different species at both nucleotide 
and amino acid levels showed that the percent similarity of 
kudu, bovine and sheep were closer to each other than those 
of mouse, hamster, pig> human and mink. All PrPs have 
putative signal peptides, which fall into two broad groups. 
Cattle, sheep, pig, mink and kudu forming one group by having 
very similar signal peptides while human, mouse and hamster 
have similar peptide sequences and form the second group. All 
PrPs share two hexapeptide and five octapeptide repeat 
motifs, with kudu and some cattle having in addition alleles 
with six octapeptide repeat motifs. Amino acids 25 tol03 and 
112 to 149 comprise highly conserved regions within all PrPs. 
Altc PrPs also have a region of 20 amino acids within the
second conserved segment which meet the criteria of a stop
transfer effector. Although there is a cluster of variable 
amino acids towards the C-terminal end of the PrP protein, 
there is a serine residue present to which a 
glycosylphosphatidylinositol anchor could be attached. 
Hydrophilicity and antigenic plots show very little variation 
between the different PrPs. Similar results were obtained for 
predicted beta sheet and flexible regions and amphiphatic 
alpha helix structures, i.e. there was little variation
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between the different PrPs. Amphiphatic alpha helix 
predictions identified possible helical structures which 
could span membranes and were identified for all PrPs. 
Predictions of alpha helices showed some variations between 
different PrP proteins. Sheep PrP was predicted to have only 
one helical structure (codons 108 to 122); but this helical 
sequence was common to all PrPs.
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9.2. Introduction.
The PrP gene is widely distributed in the animal kingdom 
(Hope et al., 1988; Westaway and Prusiner 1986). The sequence 
data from PrP genes sequenced in this study (bovine, pig and 
kudu) has shown them to be highly conserved. The extent of 
the similarities or differences amongst PrP genes were 
examined further by comparing the PrP nucleotide and deduced 
amino acid sequences determined in this study with those 
published for other species (human, hamster,mouse, sheep and 
mink); The PrP nucleotide sequence published for the rat 
(Liao et al.. 1987) was not complete and because the portion 
sequenced did not reveal any unusual features, i.e. it was 
very similar to the mouse PrP nucleotide and deduced amino 
acid sequence it was excluded from this comparison.
The comparison of PrP sequences took two forms. The first was 
a direct comparison based on nucleotide sequences and 
included, for example, codon usages and amino acid 
composition of various segments of PrP genes. The second part 
of the comparison was based on the nucleotide and deduced 
amino acid sequences and involved computer predictions of 
possible secondary structures and included for example alpha 
helix, beta pleated sheet regions and hydrophilicity plots.
9.3. Results.
9.4. Similarity between PrP sequences from different species.
Results comparing the overall similarity between PrP 
sequences from different species are shown in Table 9.1. All
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results are expressed in terms of their identity to the 
bovine PrP sequence. They show that the percent identity of 
PrP sequences at the nucleotide level range from 79.2% for 
mice to 97.7% in kudu. These comparisons show that kudu and 
sheep are more closely related to bovines than mice and 
hamsters. The percent identity of the different PrPs at the 
amino acid level support this trend, and range from 97.7% for 
kudu to 82.4% for mice.
9.5. Comparison of codon usage between different species.
The results of a comparison of codon usage between the PrP 
genes available to date is shown in Table 9.2. The codon 
usage values for kudu shown in this Table are those of the 
six octapeptide repeat allele sequence (there was virtually 
no difference in codon usage in kudu between the six and the 
five octarepeat allele sequences). The results shown in Table
9.2. demonstrate the highly conserved nature of codon usage 
by PrP genes. The codon usage of the bovine kudu and sheep 
PrP genes was closer to each other than for any of the other 
species. This result would be expected because in 
evolutionary terms cattle, kudu and sheep are closer together 
than the other animals included in this study. Some examples 
of the many similarities of codon usage include asparagine 
where the codon usage of -AAC- ranged from 100% for the 
bovine, mink, pig and kudu PrP genes to 86% for the mouse 
gene. Another example of similarities of codon usage include 
the amino acids serine and leucine. Both of these amino acids 
could be potentially coded for by six codons; but in each 
case at least two codons (serine: UCG and UCA; leucine: UUG,
UUA and CUA) were either redundant or little used (<10%).
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Table 9,1. Comparison of the percent similarity between 
PrPs from different species at both the a) amino acid 
and b) nucleotide levels.
These results show that PrP genes are highly conserved, 
for example at the amino acid level the percent homology 
between cattle and kudu is 97.9% and between cattle and 
mouse it is 82.4%. At the nucleotide level the percent 
similarity between cattle and kudu is 97.5% and between 
cattle and mouse it is 76.9%
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Table 9.2. Comparison of codon usage by PrPs from 
different species.
This table compares codon usage by PrPs from all species 
published to date.
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UUA and CUA) were either redundant or little used (<10%) . 
There were some differences in codon usages between the 
different species. For example, the amino acid isoleucine can 
be coded for by three codons, all three of which are used in 
bovine, sheep, hamster, mink and kudu PrP genes; two codons 
are used in human and pig PrP genes; but only one codon (AUG) 
is used in the mouse PrP gene. The use of the - AUC- codon 
for isoleucine ranges from 100 percent for mouse to 50 
percent for mink. Another example where there are variations 
in codon usage occurs with the amino acid histidine which can 
be coded for by two codons - CAU and CAC-. There was a 
gradation in the use of these codons by the different 
species. For example, the use of the codon -CAU - varies from 
kudu PrP genes (73%), sheep (70%), bovine and mouse (67%), 
hamster (55%), human (50%), to mink and pig (40%).
9.6. Comparison of the major PrP amino acid parameters 
between different species.
A comparison of some of the major amino acid parameters of 
PrP proteins from different species is shown in Table 9.3. 
The total number of amino acids for each of the PrP proteins 
are: human (253), mouse and hamster (254 each), sheep (256),
mink and pig (257 each) bovine and kudu (256 or 264 each) .
In the case of bovine and kudu PrP proteins the figures of 
256 and 264 amino acids refer to alleles coding for five or 
six octapeptide repeat motifs. The figures for alleles with 
both the five and the six octapeptide repeat motifs of the 
kudu were included because there were some differences in
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amino acids between them, which gave rise to proteins of 
different properties. This was not presented for the bovine 
PrP proteins because, with the exception of the extra 
octapeptide motif, the five and the six octapeptide proteins 
have identical amino acids (Goldmann et al., 1991), and
consequently proteins with similar properties.
The total number of strongly basic amino acids (lysine and 
arginine) ranged from 21 for human to 23 for sheep PrP 
protein. The total number of strongly acidic amino acids 
(aspartic and glutamic ) ranged from 13 for sheep to 16 for 
the kudu PrP protein containing the five octarepeat motif. 
The number of strongly acidic amino acids in kudu containing 
the six octarepeat motif was 14, which was the same as that 
for the bovine, mouse, hamster, mink and pig proteins. The 
numbers of strongly basic and acidic amino acids have a great 
influence on the isoelectric points and the charge at pH 7.0 
of the various PrP proteins. For example, with bovine, mouse, 
hamster, mink, pig and kudu (six repeat motif) proteins the 
basic amino acids (total 22) are in excess over the acidic 
amino acids (total 14) by eight, giving an average 
isoelectric point of 9.38 and charges at pH 7.0 of 9.48. In 
the cases of human, sheep and kudu (five repeat motif) PrP 
proteins the excess basic amino acid residues over acidic 
residues are six, ten and six respectively. This gave rise to 
isoelectric points of 9.03 (human), 9.57 (sheep) and 9.13 
(kudu) and the corresponding charges at pH 7.0 were 7.46 
(human), 11.48 (sheep) and 7.46 (kudu). What significance 
these differing isoelectric points and charges at pH 7.0 have 
on the functioning of PrP proteins is not known. The PrP
-285-
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protein is known to be a membrane protein therefore a large 
number of hydrophobic residues would be expected. The number 
of hydrophobic residues ranged from 61 in human to 69 in the 
case of the pig PrP protein. Hydrophobic residues comprised a 
large percentage of the total number of residues in PrP 
proteins (24.1% in human to 26.8% in pig). The difference in 
the number of polar amino acids ranged from 69 (26.8%) for
the pig to 78 (30.6%) for the mouse PrP protein.
9.7. Comparison of PrP protein sequences from different 
species.
The results of a comparison of PrP protein sequences from 
different species is shown in Figure 9.1. The bovine PrP 
sequence formed the backbone to which all the other sequences 
were aligned. The codon position numbers described 
subsequently refer to the numbers shown in Figure 9.1. and do 
not refer to exact codon positions in the individual 
sequences; this was done for the purpose of clarity.
Signal peptide.
The N-terminal amino acid sequence of PrP proteins have the 
characteristic sequences which enable them to act as signal 
peptides. Sequence comparisons show that the putative signal 
peptide is 24 amino acids long in bovine (Goldmann et al., 
1991), pig, sheep (Goldmann et al., 1990), mink (Kretzschmar 
et al.. 1992) and kudu PrP proteins; but 22 amino acids long 
in human (Kretzschmar et a%., 1986), hamster (Easier et al., 
1986) and mouse (Locht et al., 1986) . The similarities in
sequence between the various signal peptides falls into two
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Figure 9.1. comparison of PrP proteins from different 
species: sheep (Goldmann et al.. 1990), human
(Kretzschmar et al., 1986), hamster (Easier et al.,
1986), mouse (Locht et al.. 1986;) and mink (Kretzschmar 
et al.,1992). The bovine PrP protein formed the backbone 
to which the PrP proteins from other species were 
aligned.
-288-
Figure 9.1. Comparison of deduced PrP proteins from different 
species.
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closely related groups, with bovine, sheep, mink, pig and 
kudu beginning with the amino acids MVKSHI. The second group 
which comprises human, mouse and hamster begins with the 
amino acids MANLS/G.
Conserved regions.
The sequence immediately following the signal peptide (amino 
acid 25 to 103) forms part of the most highly conserved 
region in all PrPs. A second region where very few changes
occur amongst the different PrPs is the region from amino
acids 112 to 149. In the middle of this second conserved
region (amino acids 124 to 143) there is a contiguous stretch
of 20 amino acids which meet the criteria of a stop transfer 
effector (STE). The STE segment is identical in all the 
species except for the human and hamster PrPs where one amino 
acid (valine) is replaced by a methionine.
Amino acid variations.
There are numerous occasions when only one of the PrP 
sequences shows an amino acid change e.g. at codons 83 and 91 
all the species have a glycine residue except for the mouse 
PrP which has a serine residue at both of those positions. At 
codon 198, the glutamine residue which is present in all the 
PrPs except for the bovine PrP where it is replaced by a 
glutamic acid residue.
There are many positions where one of either two different 
amino acids is present, and these are distributed relatively 
evenly between the different species. For example, at codon
-290-
107 the amino acid threonine occurs in bovine, human, mouse, 
hamster and kudu; but pig sheep and mink have a serine at 
that position. A second example is provided by the amino acid 
at codon 155 where bovine, pig, human and kudu have a serine 
residue, whereas, sheep, mink, mouse and hamster have an 
asparagine residue.
There are several positions where insertions/deletions of 
amino acids occur. The most obvious example are the extra 
octapeptide repeat segments in some bovine and kudu. At codon 
position 97 bovine, pig, sheep, mink and kudu have an extra 
glycine residue which is absent in human, mouse and hamster. 
At codon position 104 pig, human, mink, mouse and hamster 
have a glycine residue which is absent in bovine, sheep and 
kudu PrPs.
Codon positions 232 to 246 form a cluster in which numerous 
variations in amino acids between the different species 
occurred. Experimental work has shown that cleavage occurs 
between residues 244 and 245 and that in hamsters a 
glycophosphatidylinositol anchor is attached to serine 
residue 244 (Baldwin et al.. 1990; Stahl et al., 1990). 
Therefore, differences between species occur preceding to and 
including this cleavage site. Some examples include the 
insertion of the residues glycine and arginine at codons 240 
and 241 in the mouse and hamster PrPs. At codon position 246 
bovine, pig, sheep and kudu PrPs have the residue valine, 
whereas mink and hamster PrPs have an alanine, mouse PrP a 
threonine and the human PrP a methionine. The pig PrP
-291-
uniquely has tyrosine and alanine residues at codons 234 
and 238 respectively, all the other species have a serine and 
a tyrosine residue at the equivalent positions in their PrPs.
9.8. Comparison of predicted secondary structure of PrP 
proteins from different species.
Alpha helix regions.
Comparisons of predicted alpha helix regions (Chou-Fasman14; 
within the PrP protein for each of the species is shown in 
Figure 9.2. These results show that all PrPs have one alpha 
helix region in common. This region commences at about codon 
108 in sheep, pig, human, mouse, hamster, mink, and kudu 
(five octapeptide repeat) and codon 116 in the six octarepeat 
cattle and kudu. The sheep PrP protein is predicted to have 
only the one alpha helix region, whereas the other species 
are predicted to have one or more additional alpha helix 
regions of varying sizes. Besides the shared helix region, 
the pig has a second helical region (of equal size) between 
codon position 222-234 and the hamster has a larger second 
helix region between codon positions 198-224. The shared 
helix region in mouse is smaller than that predicted for the 
other species. PrP proteins are known to be membrane 
proteins, therefore, any membrane spanning regions would 
require a helical structure for the membrane spanning region.
Amphiphatic alpha helix regions.
Predictions as to possible membrane spanning regions were
further investigated by searching for possible amphiphatic
(EiSe/nlfO^ r^ etui’
alpha helix regions^ using the method of Eisenberg. The
-292-
Figure 9.2. Comparison of alpha helix regions within PrP 
proteins from different species.
Figure 9.2 shows the predicted alpha helix region 
(Chou,P-Y. and Fasman,G.D.,1974) for the various PrP 
proteins.
There were predicted differences in the number and 
position of alpha helices. For example, the sheep PrP 
was predicted to have only one alpha helix structure, at 
a position common to all the other PrPs (between amino 
acids 108-12 0) while hamsters were predicted to have an 
additional alpha helix region between codons 198-224.
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Figure 9.3. Comparison of amphiphatic alpha helix 
regions within PrP proteins from different species. 
Figure 9.3. shows the predicted alpha helix region 
(Eisenberg et al.. 1984) for the various PrP proteins. 
All PrPs were predicted to have very similar amphiphatic 
helix patterns. Possible membrane spanning regions in 
all PrPs include the PrP segment between codons 13 3 to 
173.
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results are shown in Figure 9.3. These results show that the 
predicted positions of possible amphiphatic helices, for each 
of the PrP proteins from different species, is virtually 
identical. Most of the predicted amphiphatic helical regions 
would be too small to span the cell membrane. The amphiphatic 
region starting at about codon 133 forming a continuous 
stretch of about 40 amino acids is a possible candidate. 
Correct helical coiling of this region would present a 
relatively hydrophobic "stripe" capable of interaction with 
membranes or other hydrophobic domains (Bazan et al., 1987; 
Bennett et al., 1992).
Beta sheet regions.
Comparisons of possible beta sheet regions (Chou- Fasman^/f^k 
within the PrP proteins from each of the species is shown in 
Figure 9.4. These results show an almost identical pattern of 
possible beta sheet formation within the different PrPs. The 
only observed differences were an addition of a small beta 
sheet region in the human PrP protein at about codon 136, and 
the absence of a beta sheet region at about codon 165. 
Hamster PrP proteins have an extra beta sheet region 
beginning at codon 204 which is absent in the PrPs from other 
species.
Flexible regions. CK.rf>Us,s. end lOSsO
Comparisons of possible flexible regions/k within the PrP
proteins from different species are shown in Figure 9.5.
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Figure 9.4. Comparison of beta sheet regions within PrP 
proteins from different species.
Figure 9.4. shows the predicted beta sheet regions (Chou,P-Y. 
and Fasman,G.D., 1974) for the various PrP proteins.
All the PrPs from the different species were predicted 
to have very similar beta sheet patterns.
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Figure 9.5. Comparison of flexible regions within PrP 
proteins from different species.
Figure 9.5. shows the predicted flexible regions 
(Karplus,S. and Schultz., 1985) for the various PrP 
proteins.
The predicted flexible regions for all the PrPs were 
virtually identical. The only observed differences were 
within the kudu PrP protein containing the five 
octapeptide repeat motifs, which had a break within the 
Targe flexible region at about codon position 73.
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Figure 9.6. Comparison of hydrophi11city plots of PrP 
proteins from different species.
Figure 9.6. shows the predicted hydrophilicity plots 
(Kyte,J. and Doolittle,R.F., 1982) for the various PrP
proteins.
The hydrophilicity plots for all the different PrP 
proteins were almost identical. The only marginal 
difference was the plot for kudu PrP containing five 
octapeptide repeat motifs , which had a slightly flatter 
plot within the repeat segment.
-302-
CO
LU
CJ
LUQ -
CO
_ l
s
LU
s
CO
g
D_
Q_
cmQ_
O
CO
g
X
ClO
cma>-
3
CO G) 
CO CJCO CM
-303-
These results show that an identical pattern of possible 
flexible regions is produced for each of the PrPs from 
different species. The only observed difference was for kudu 
containing five octarepeat regions, which had a break in the 
large flexible region at about codon 73.
Hydrophilicity plots. 3>ooUtn^,R-f;
Comparisons of the hydrophilicity plots^obtained for each PrP 
protein from different species is shown in Figure 9.6. These 
results show an almost identical pattern, the only observed 
difference being within the five octapeptide repeat region of 
the kudu where the plot is slightly flatter. For all PrPs, 
hydrophobic regions were found between codons 1-22, 114-142
and 233-256. The most hydrophilic regions in all PrPs were 
found between codons 23—35, 93—115, 178—190 and 218—232.
Antigenic index. n,B-fl.end W'&f, It; HSB)
Comparisons of plots of antigenic indice^k^or PrP proteins
from different species is shown in Figure 9.7. These results
are almost identical, the main exception being found within
the octapeptide repeat region of the mouse PrP (codons 70-80)
which had a higher index value than similar positions within
other PrPs. For all PrPs, areas of high index value (possible
antigenic epitopes) are centered around codons 30-40, 45-70,
98-112, 143-153, 155-162, 168-178, 192-202 and 220-228.
9.9. Phylogenetic tree. ^
A phylogenetic tree based on PrP protein alignments^ was 
constructed for all the species under consideration. The 
results are displayed in Figure 9.8. The results show that
—304—
Figure 9.7. Comparison of antigenic indices plots of PrP
proteins from different species.
Figure 9.7. shows the predicted antigenic indices plots 
for the various PrP proteins (Jameson,B.A. and Wolf,H.,
1988)
The predicted antigenic indices for the various PrP 
pjfoteins were very similar. Within the mouse octapeptide 
(codon 75) region a higher index value was observed as 
compared to the other PrPs.
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Figure 9.7. Phylogenetic tree showing the evolutionary 
relationships between the PrP proteins from different 
species.
The figure shows a phylogenetic tree based on PrP 
protein alignments. The results show that kudu and 
bovine PrPs have a closer evolutinary relationship than 
the PrPs from other species. Similarly, mouse and 
hamster PrPs are more closely related to each other than 
to PrPs from other species.
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bovine and kudu PrPs are closely related and that these two 
species in turn were closer to sheep PrP than the other
species under consideration. Mouse and hamsters PrPs were
closer to each other in evolutionary terms compared to the
PrPs of other species.
Discussion.
Results comparing the percentage identity at both the
nucleotide and amino acid levels show the highly conserved 
nature of PrP genes. As expected, the closer the evolutionary 
relationship between the different species, the greater is 
the similarity of their PrP genes. This point is exemplified 
by the high degree of similarity (97.7%) between bovine and 
kudu PrP genes at the nucleotide and amino acid levels. If 
the assumption that the PrP protein performs the same 
function in all the species studied is correct, then a high 
degree of similarity amongst PrPs would be expected.
The theme of the conserved nature of PrP genes between the 
species is further consolidated by comparisons of codon usage 
by PrP genes from different species. An example typifying 
this view is provided by the results of codon usage for the 
amino acids serine and leucine where the same two and three 
codons (respectively) out of six possible codons were either 
redundant or little used. As with the comparison of PrPs at 
the nucleotide and amino acid levels there were some 
differences in codon usage between the different species. The 
amino acid isoleucine provided a good example where all three 
possible codons were used in some species e.g. bovine, sheep
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while only one codon was used by mouse PrP. When comparisons 
of codon usage by PrP genes from different species is 
considered as a whole, then the closer similarities in codon 
usage by bovine, kudu and sheep PrP genes becomes evident.
Comparisons of the major amino acid parameters of PrP 
proteins from different species emphasized the similarities 
in types of amino acid groupings. Although there were 
variations in the total numbers of amino acids within each 
group between the different species. Variations in the total 
numbers of strongly basic amino acids (range - human 21 
residues to sheep 23 residues), and strongly acidic residues 
(range - sheep 13 residues to kudu 16 residues), led to PrPs 
from different species having different isolectric points 
(range - human 9.03 to sheep 9.57), and charge at pH 7.0 
(range human 7.46 to sheep 11.48). At this stage no 
conclusion could be drawn as to whether or not these charge 
differences have any bearing on the functionality of 
individual PrP proteins.
Comparisons of the amino acid sequences of PrP proteins from 
different species, taken in conjunction with computer 
analyses and experimental data allow certain deductions about 
PrP proteins to be made. All PrPs have N-terminal sequences 
which are consistent with them acting as signal peptides, 
i.e. positively charged N-terminus, hydrophobic core and a 
small uncharged residue at the putative cleavage site (von 
Hejne, 1985). Whilst all the PrPs exhibited these 
characteristics they did not have the same sequences but fell 
broadly into two groups. The first group consisted of bovine,
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sheep, kudu, pig and mink PrPs and had putative signal 
sequences of 24 bases beginning with the amino acids MVKSHI. 
The second group consisted of human, hamster and mouse PrPs 
and were 22 bases long and beginning with the amino acids 
MANLS/G. Signal peptides direct the translocation of proteins 
into the lumen of the endoplasmic reticulum where they are 
cleaved off (Easier et al.. 1986; Hope et al.. 1988; Turk et 
al., 1988). The presence of signal peptides would be a
prerequisite if PrPs are to function as membrane proetins.
There are regions common to all the PrPs which are highly 
conserved. Within one of these conserved regions there is a 
contiguous stretch of 20 hydrophobic residues, present in all 
PrPs, which is a likely candidate for a STE . The STE segment 
is thought to be involved in positioning PrPs across 
membranes. These results, taken in conjunction with the 
observation that hydrophobic residues comprise a large 
percentage of the total number residues in PrP protein (24.1% 
in humans to 26.8% in pig), are consistent with PrP being a 
membrane protein, and indeed supports some of the initial 
studies indicating that PrP co-purified with membranes 
fractions (Millson et al., 1971).
Computer analyses suggest that each of the PrPs contains two 
cysteine residues which can complex together forming a loop 
of about 34 amino acids. Within this loop there are two 
possible glycosylation sites involving arginine residues. 
This observation is consistent with experimental evidence 
where nine different verities of oligosaccharides have been
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reported as being attached to asparigine residues within PrP 
proteins. (Endo et al..1989; Haraguchi et al..1989).
Hamster and neuroblastoma cell culture experiments have shown 
that a C-terminal domain is removed from PrP proteins and a 
glycophosphatidylinositol anchor (GPI) is attached (Caughey 
et al.. 1989; Baldwin et al..1990; Stahl et al., 1990). In
the case of hamster PrP 23 amino acids are removed from the 
C-terminus and the amino acid anchor attached to serine 
residue 231. Comparisons of the PrP amino acid sequences from 
different species has shown considerable variation in and 
around the possible cleavage site but all PrPs have a serine 
residue (codon 245) to which a GPI anchor could be attached.
Predicted beta sheet regions and flexible regions showed very 
little variation between the PrPs from different species. 
These results support the conserved nature of PrP genes and 
also point to a common function. Similarly, hydrophilicity 
and antigenic index plots showed very little variation. This 
could mean that in the case of antigenic index predictions, 
areas identified as possible epitopes were the same for all 
PrPs, therefore, antibodies raised successfully against 
peptides from one species would be expected to cross react 
with PrPs from other species. Predicted alpha helix 
structures showed some variation between the different 
species. Sheep PrP was predicted to have only one alpha helix 
region, which is common to all the other PrPs. The PrP 
protein is a known membrane protein, therefore, this shared 
alpha helix structure could possibly span the membrane.
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Alternative predictions of membrane spanning segments based 
on amphiphatic alpha predictions identify different areas 
within PrP proteins which can span membranes.
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CHAPTER 10.
Concluding remarks and final discussion.
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10.1 Principle conclusions and final discussion.
Restriction fragment length polymorphism studies of bovine 
PrP genes using a variety of enzymes have^shown associations 
between specific restriction patterns and TSE susceptibility, 
e.g the restriction enzyme Xbal can discriminate between 
strains of mice having long incubation periods from those 
strains having short incubation periods, when exposed to 
given strains of scrapie. Restriction fragment length 
polymorphism analyses and PrP sequence studies in cattle 
have identified two restriction enzymes (PvuII and Hindll, 
which have revealed polymorphisms in and around the bovine 
PrP gene (Goldmann et al.. 1991). In both cases, no 
association between the distribution of these two 
polymorphisms and disease susceptibility was established. 
These results showed that in cattle disease susceptibility 
could be associated with an as yet unidentified polymorphism. 
To investigate this further, bovine PrP gene sequencing 
studies were undertaken.
The strategy of amplifying the bovine PrP gene using PCR 
primers with different restriction sites (Hindlll on the 
forward primer and EcoRI on the reverse primer) in order to 
facilitate directional cloning into a plasmid vector was 
successful. Initially, the bovine PrP genes from three 
animals were sequenced using a standard manual procedure. The 
sequencing results showed that for two animals there was 
total agreement with a published bovine sequence (Goldmann et 
al., 1991) . The third animal had a base change - G to A - at
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base position 234. This base change was shown not to be due 
to any PCR or cloning artefacts and was confirmed when the 
PrP gene was sequenced from the same animal using an 
automated sequencing procedure. The base change at position 
234 was a silent change as both possible codons coded for the 
amino acid glycine.
The bovine PrP gene sequence obtained in the initial study 
showed that cattle had six copies of an octapeptide repeat 
motif. All other species sequenced to date have five copies 
of this repeat motif, with the exception of certain CJD 
patients whose PrP genes contained extra copies of these 
repeat motifs (Collinge et al .. 1989; Owen et al.. 1989).
Goldmann et al. (1991) showed that some cattle were 
heterozygous for these octapeptide repeat motifs having 
alleles coding for either five or six copies. In this thesis 
the distribution of the octapeptide repeat motifs in cattle 
were studied in a high incidence herd. Identification of 
alleles containing five or six copies of the octapeptide 
repeat motifs was only possible by PCR amplification of this 
region and the separation of the amplified alleles by 
electrophoresis through a 4% NuSieve agarose gel. There was 
no correlation between the allelic distribution of these 
repeat motifs and incidence of disease. In the case herd 
studied, animals were either homozgous (6:6) or heterozygous 
(6:5) for the octapeptide repeat motif; but other animals 
with BSE which were homozygous (5:5) for the octapeptide 
repeats have also been identified (Dawson, personal 
communication).
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As none of the PrP gene polymorphisms so far identified were 
linked with BSE susceptibility, further sequencing of bovine 
PrP genes was carried out. The numbers involved meant a 
different sequencing strategy had to be adopted, namely 
sequencing directly from PCR amplified products using an 
automated sequencer. This required the design of a new 
forward primer as the position of the primer used previously 
did not allow the PrP start codon to be sequenced. The new 
primer worked well with the existing PCR parameters. 
Multiple amplifications of each sample were carried out in 
order to minimize PCR artefacts; a practise that is strongly 
recommended when direct sequencing is involved. Excessive 
read lengths (greater than 350 bases) led to inaccuracies, 
therefore read lengths for the automated sequencer were 
arbitrarily set at 200 bases. This was found to produce 
consistent and accurate results when compared to manual 
sequencing of the same sample. The sequencing strategy 
adopted allowed for a greatly increased throughput. The PrP 
genes from natural BSE cases, unaffected and experimentally 
animals were sequenced. All the sequence data were identical 
with the exception that some animals had a silent base change 
at position 234 (G TO A). This base substitution was not 
confined to any one group of animals, i.e. in the naturally 
affected group three animals had a guanosine and three a 
adenosine at position 234; a similar result was found in the 
unaffected group of animals.
No apparent association between bovine PrP sequences and 
disease susceptibility was identified. This raises the
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possibility that polymorphisms in the bovine PrP gene are not 
involved in modulating the disease process and would make it 
unusual amongst PrP genes sequenced to date, and suggests 
that other mechanisms are involved, e.g. the regulation of 
PrP expression may vary between cattle, and this may be 
significant. Experiments with transgenic animals in which 
hamster PrP genes have been inserted into mice have shown 
that increasing the copy number of the hamster PrP gene can 
influence the speed at which the disease progresses, i.e. 
more normal PrP is expressed and thus available for 
conversion to the diseased isoform . However, it could be 
argued that transgenic mice are unusual in having PrP genes 
from two different species, which further complicates the 
situation. In order to address the question of levels of 
expression, sequences upstream from the PrP start codon and 
downstream from the stop codon would have to be determined 
from selected animals. Such sequence data could provide 
information as to the nature of the promotor(s) involved but 
may also provide information about possible sequences to 
which potential transcription factors could bind .
The coding region of the porcine PrP gene was sequenced and 
shown to consist of 774 bases corresponding to a deduced 
protein of 257 amino acids. The porcine PrP gene was shown to 
have many features common to the bovine and other PrP genes. 
For example, there was a putative signal peptide sequence 
which was similar to those found in cattle and sheep, and 
different to, those found in human, hamster and mouse PrP 
genes. In common with the PrP from other species there were
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two hexapeptide and five octapeptide repeat regions, and a 
highly hydrophobic conserved region located almost centrally 
within the PrP gene. There were two amino acids which were 
unique to the porcine PrP gene positioned towards the 
hydrophobic C-terminus of the PrP protein. In hamsters, this 
C-terminus portion is removed and a GPI anchor attached. 
Whether these unique amino acids in the porcine PrP alter the 
confirmation of this portion of the protein, and hence 
influence either the manner in which the GPI anchor is 
attached to the PrP protein or its interaction to the cell 
membrane, remains to be determined. Whether or not these 
changes within the porcine PrP gene influence the resistance 
of pigs to infection could be investigated by inducing these 
mutations in the hamster PrP gene, and then creating 
transgenic mice containing these mutated hamster genes. Such 
transgenic mice could be challenged with diseased hamster 
brain homegenates both intracerebral and oral routes. Such 
challenge studies with transgenic mice would be compared with 
those using transgenic mice containing normal hamster PrP 
genes.
PrP genes sequence from the exotic bovid, kudu, were also 
sequenced and found to have one allele having five 
octapeptide repeat regions and the other with six. This 
result was found to be similar to that of some cattle. The 
allele with six octapeptide repeat regions had a sequence of 
795 bases and the five octarepeat allele 771 bases, 
corresponding to proteins of 264 and 256 amino acids 
respectively. There were seven base changes and four amino
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acid changes within the octapeptide repeat region between the 
two alleles. Other than the octapeptide regions, there were 
four other amino acid differences between the kudu and bovine 
PrP sequences. The kudu PrP gene had features in common with 
PrP genes from other species, for example a signal peptide, 
two hexapeptide repeats, a conserved hydrophobic region, two 
possible N-linked asparagine glycosylation sites and two 
cysteine residues which could form disulphide bonds. Kudu 
appear to be highly susceptible to the TSE agent, but whether 
the changes within the octapeptide region between the two 
alMes are significant in determining the response of kudu to 
disease remains to be determined. The number of kudu 
available for study is small, thus restricting opportunities 
for further investigations in these animals. To date no 
polymorphisms have been identified which indicate disease 
susceptibility in cattle. In view of the kudu findings one 
possibility would be to investigate whether or not there are 
any differences within the octapeptide regions between the 
two alleles in cattle. Initially, alleles from affected and 
unaffected animals heterozygous for the octapeptide repeat 
region would be sequenced, as these can be carried out 
immediately. The second approach which should be adopted, 
especially in cattle which are homozygous for the octarepeat 
allele (homozygous five and homozygous six) in which it will 
be difficult to separate the alleles (techniques such as 
dénaturation gradient gel electrophoresis could be 
developed), would be to use oliginucleotide specific probes. 
Palmer et al. (1991) have shown that in the human disease, 
CJD, amino acid variations at codon position 129 (methionine
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or valine) could be identified by using specific probes which 
differ by only one base. Specific probes designed to 
recognise the kudu polymorphic sequences in the five and the 
six octarepeat motifs could be applied to bovine samples.
Distribution of bases at each of the codon positions for 
bovine, pig and kudu PrPs was not random. In each case there 
was a strong bias towards guanosine at codon positions 1 and 
2 and cytosine at codon position 3. The bias towards 
guanosine and cytosine was a reflection of the high - GC - 
content of these PrP genes (55.5-59.1%) and is consistent 
with the high - GC -content of the PrP genes from other 
species and the highly conserved nature of PrP genes.
Codon usage comparisons reflected both similarities and 
differences between the bovine PrP gene and 261 genes in a 
bovine g&abank. For example, for the amino acid glutamine 
the two codons -CAG and CAA - are used in roughly the same 
proportions. By contrast the amino acid asparagine can be 
coded for by two possible codons, but there was strong bias 
towards of one of these (AAC). All 11 asparagines found in 
the PrP gene are coded for by this codon; whereas the bovine 
gene library uses both codons and in the ratio 2:1 (AAC:AAU). 
For those amino acids where several possible codons are 
available, e.g. serine with six possible codons, the bovine 
gene bank used all the codons in contrast to the bovine PrP 
gene where at least two out of the possible six codons were 
redundant. Biased codon usage can by itself influence levels 
of expression because the availability of transfer-RNAs which
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could be rate limiting. There are no species genebanks for 
the pig and kudu, therefore similar comparisons for the pig 
and kudu PrP genes could not be made.
Comparisons of the nucleotide sequences and deduced amino 
acid sequences of PrPs from all the species sequenced to date 
further supported the observation that PrP genes are highly 
conserved. At the nucleotide level the degree of similarity 
ranged from 79.9% to 97.7%, while at the amino acid level it 
ranged from 82.4% to 97.7%. These results also showed that in 
evolutionary terms cattle were closer to kudu and sheep than 
to pigs, mice, hamster, mink and humans. All PrPs had 
putative signal peptides, two hexapeptide repeat segments, 
five/six octapeptide repeat segments, 20 amino acid conserved 
hydrophobic region almost centrally within the PrP protein, 
two possible N-linked glycosylation sites and two cysteine 
residues which could form a disulphide bond. In addition, all 
the PrPs had a C-terminal signal peptide. If PrPs perform a 
common function, which seems likely, then this degree of 
similarity between the different species would not be 
unexpected. There were some amino acid differences between 
PrPs from different species, but no patterns were observed 
which allowed those species which are more susceptible to 
disease to be distinguished from those that are more 
resistant. With this degree of conservation it is not 
surprising that predicted secondary structures such as 
beta-sheets together with hydrophilicity plots, flexible 
regions and possible antigenic epitopes are superimposable on 
each other. Predicted alpha-helices showed some variations,
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with sheep PrP protein predicted to have only one alpha-helix 
while those from other species were predicted to have more. 
It is interesting to note recent studies (Gasset et al.,
1992) in which peptides corresponding to the predicted 
alpha-helical region of the Syrian hamster PrP protein 
spontaneously formed amyloids after synthesis (shown by congo 
red staining). Infra-red spectroscopy showed that these 
amyloids exhibited secondary structures composed largley of 
beta-sheets. The authors proposed that conversion of normal 
PrP to the diseased isoform involves the transition of some 
alpha-helices to beta-sheets.
Goldgaber (1991) observed that there was a large ORF (called 
anti-PrP) in the strand opposite the PrP transcriptional unit 
in patients with the human diseases GSS and CJD . The three 
species sequenced in this study all had large ORFs in the 
strand opposite the PrP transcriptional unit, with two of 
them (bovine and kudu) also having stop codons within the 
area sequenced, which, if translated would result in proteins 
of 273 amino acids. No stop codon was found in the anti-PrP 
strand of the pig within a similar area sequenced. It has 
been described for four independent proteins that peptides 
encoded by antisense sequences correspond structurally to 
binding proteins or receptors (Ghiso et al., 1990; Brentani 
et al., 1988; Elton et al., 1988; Bost et al., 1985). 
Therefore, if the putative anti-PrP protein is translated 
then the differences between the pig anti-PrP and those of 
cattle and kudu may contribute in some way to the apparent 
differences in susceptibilities of these species to disease.
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All the other species sequenced to date, i.e sheep, human, 
hamster and mouse, have large ORFs and stop codons which if 
translated would produce proteins of similar sizes to those 
of cattle and kudu; but the mink anti-PrP ORF if similarly 
translated would produce a truncated protein of 180 amino 
acids. Searches of the other possible reading frames in 
cattle, kudu and pig revealed that there were numerous 
possible start and stop codons which if translated would not 
yield proteins of any size. Recent studies (Moser et al.,
1993) showed that a 4.5 kb mRNA could be detected, using a 
sense riboprobe, which shared homology with the anti-sense 
strand (as demonstrated by hybridization studies) but that it 
was derived from another gene. This result therefore 
suggested that the anti-PrP protein may be encoded by another 
gene. This finding does not invalidate the possibility of a 
functional anti-PrP protein being produced by the 
transcriptional unit opposite the PrP unit.
The conversion of the normal PrP protein to the diseased 
isoform, which has been shown to co-purify with infectivity, 
and the association of PrP polymorphisms with disease would 
suggest that the PrP protein has an important function. 
However, other studies using transgenic mice in which the PrP 
gene has been deleted have indicated that these animals 
appear to function normally, and do not develop TSE following 
challenge; a result which appears to partially contradict the 
experimental evidence stated above. The function of PrP is 
not known and it has been a matter of speculation. Since PrP 
has been shown to be a membrane protein, some of the
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suggestions as to function range from cell adhesion 
molecules, to signal transduction molecules, to receptor 
molecules (Stahl et al.. 1987; Mobley et al.. 1988; Cashman 
et al., 1990). One indication as to the possible function of
PrP comes from studies of a putative chicken brain factor 
with acetylcholine receptor inducing activity (ARIA). ARIA 
increases the rate of nicotinic acetylcholine receptor 
(nAchR) incorporation on the surface of cultured chicken 
myotubules (Usdin and Fuschbach 1986). Searches of databases 
of both nucleic acid and protein sequences have shown that 
there is some homology between the ARIA factor and mammalian 
PrP. The homology between ARIA and the bovine PrP gene (six 
octarepeats) was 43% at the nucleic acid level and 33.7% at 
the deduced amino acid level. Although this percentage 
identity appears low when compared to the homology between 
mammalian PrPs, there are certain key features which are 
similar between the two proteins. ARIA is found within a 
single exon and has eight copies of a hexapeptide repeat 
segment comparable to PrP's octapeptides, a nearly identical 
20 amino acid hydrophobic domain, two cysteines and three 
potential N-linked glycosylation sites. Both proteins have 
putative N-termini signal peptides, similar signal sequences 
at the C-termini and have been shown to have GPI anchors. It 
remains to be determined whether ARIA is the chicken PrP. 
Early experiments have shown that purified mouse PrP has no 
ARIA bioactivity on chicken myotubes (Gabriel et al., 1992); 
but further studies are required.
Overall, this thesis has generated more information on PrP
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gene structure thereby increasing our knowledge and 
understanding of the molecular biology of PrP genes. For 
exampley three species with varying susceptibilities to TSE 
were sequenced and both pig (more resistant) and kudu (more 
susceptible) have unique amino acids differences at possibly 
key positions which may influence the respective responses to 
infectious agent. The pig with its two unique amino acids 
near the GPI attachment site and kudu with four amino acid 
differences within the octapeptide repeat region between the 
two alleles. None of the polymorphisms identified in or 
around the bovine PrP gene in this thesis has been shown to 
be associated with disease susceptibility in cattle. This 
merely confirms the view that much work still needs to be 
done to aid our understanding of this unusual disease.
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Appendix I 
Amino Acids and Thier Symbols
Amino Acid Single Letter Code Triple Code
Alanine A Ala
Cysteine C Cys
Aspartic acid D Asp
Glutamic acid E Glu
Phenylalanine F Phe
Glycine G Gly
Histidine H His
Isoleucine I lie
Lysine K Lys
Leucine L Leu
Methionine M Met
Asparagine N Asn
Proline P Pro
Glutamine Q Gin
Arginine R Arg
Serine S Ser
Threonine T Thr
Valine V Val
Tryptophan W Trp
Tyrosine vY Tyr
